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A predictive 3D similarity workflow approach has been developed using a set of modular 
Java computer programs that implement algorithms that aim to capture the key 
components of a 3D similarity search and aim to incorporate methods that address both 
the similar property principle and molecular recognition paradigms. This approach will 
expect as input a single query molecule conformation (at least one conformer is required 
per molecule) and will identify molecules that are similar to it when compared with a target 
database of 3D conformations.  
 
This workflow is achieved by first mapping each of the molecular conformation’s geometric 
coordinates, together with atomic property data, to abstract representative models 
referred to as fuzzy pharmacophore objects.  A geometric partitioning approach maps full 
geometric atomic coordinates to a reduced point representation for a molecule in order to 
capture the overall global shape of the molecule in relatively few points. This sort of 
“reduced points” approach for molecular representation was first suggested by (Glick  et 
al., 2002) in the context of Protein active site identification. Pharmacophore classifications 
are applied to the molecular fragments via mapping of internal constituent group atoms 
and their properties in order to assign the amount of potential interaction type present. 
The classifications are Hydrophobic, Aromatic, Acceptor, Donor and Hydrophilic and each 
atom can be mapped to several of these type definitions. Thus we have assigned a 
biologically relevant code to each of the fragments.  These fuzzy pharmacophore object 
abstract representations will naturally provide a summary level description of a whole 
molecule in a relatively small number of geometric points. 
 
Two such objects are then aligned to minimise the RMSD between points and the volume 
and properties overlap is evaluated in order to derive global 3D similarity scores for each 
alignment. One alignment method is to systematically align representations and is in 
essence a triangle and tetrahedron matching search technique. The second alignment 
method is based on graph theory and parameterised maximal common substructure or 
clique detection is applied to a correspondence graph constructed using two 
representations, followed by minimal RMSD alignment of the evaluated Bron-Kerbosch 
cliques with the Kabsch rotation algorithm. This provides an alternative and more efficient 
approach to systematic alignment since the systematic approach is limited to aligning four 
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points maximum. A volume and property overlap scoring function is used to compare two 
such fuzzy pharmacophore objects and the resultant Tanimoto coefficient is used for 
ranking. Initially representations of similar size and with equivalent numbers of points 
(typically three to six points) are compared and are considered shape searches. 
Subsequently, objects of different scales and representations are compared in a sub-shape 
search sense, whereby a smaller object could feasibly be searched for within a larger 
object. The graph theoretical approach to alignment and clique detection facilitates shape 
and sub-shape search automatically by including the entire representation or just the 
cliques in scoring. 
 
In principle there are many potential ways to overlay two molecules and the sub-shapes or 
fragments contained within each molecule. Each alignment can score differently and 
certain alignment orientations will maximise or minimise certain aspects of the scoring 
criteria. Hence, several key alignments are feasible between two conformations which may 
define some or all of each molecule that is biologically active in a given context. An 
alignment and associated maximal volume and properties overlap score is used to rank 
order the molecules by normalised similarity. When applied to a target database evaluated   
similarity measures are used to order the list for proposed biological activity. The overall 
workflow is thus described as a hybrid shape / properties comparison and fragment based 
biosteric similarity search. The volume distribution and by implication shape, as well as 
mass derived pharmacophore feature density overlap scores, are determined and thus this 
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Chapter 1 - Introduction 
1.1 - Biological molecules and medicinal chemistry 
 
Human beings and many higher order animals are constituted from and intrinsically rely 
upon naturally occurring carbon and heteroatom based molecules as well as some heavy 
metals such as calcium, iron, zinc and of course the most ubiquitous of substances, water. 
Thus, there has been an innate need for a variety of such organic molecules by people 
throughout human history. Based on this need, more recently humans have observed and 
then copied nature directly, creating synthetic organic molecules and thus the academic 
subject of organic chemistry has emerged. Furthermore, organic molecules which can be 
used as human and animal medicines in order to relieve inflictions and to cure illness and 
stop disease and suffering have been of particular high priority. Thus an understanding of 
molecular structure and function within the context of animal cell models is a key research 
area. The core concepts of molecular structure and the transformative chemical reactions 
found within organic chemistry form the basis for biology and biochemistry theories since 
many of the naturally observed molecules are pivotal to the internal mechanisms and 
correct functioning of living organisms via chemical reactions. The correct operation of cells 
is controlled directly by protein found within the aqueous cell environment. In order to 
sustain life, these proteins are in a constant equilibrium state with each other and many 
other dissolved small organic compounds in the cell (Teague  et al., 2003). Disease often 
arises when normal functioning is interrupted and this can occur due to both genetic and 
environmental factors. Thus, the field of medicinal chemistry has emerged which attempts 
to apply rational concepts, in order to discover new drug molecules whose inherent 
properties correct or regulate errant biological processes. The primary concern in this area 
is with molecular structure and the functional rationalisation of the intrinsic shape and 
properties of biologically active molecules. Although often leading to complex behaviour, 
the chirality or handedness of molecules can be a predominant feature. Protein active sites 
are inherently chiral due to their constitution of amino acids each of which is also chiral. 
This is shown by the Thalidomide case which exemplifies that molecular recognition is a 
three dimensional (3D) concept and that effects are based upon the 3D shape and property 
distribution of a molecule (Corey  et al., 2007; Stryer  et al., 1995). 
 As an inventive species, in more recent times, human beings have developed synthetic 
chemistry techniques in order to create useful medicinal molecules, hopefully for the 
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benefit of society. As such, we are primarily concerned with the classes of organic 
molecules that can act as drugs. There are many classes of chemical compounds that have 
the physical structural and functional properties to interact with proteins within enzyme 
reaction mechanisms. Important classes of molecules include the amino acids, alkaloids, 
heterocyclic molecules, vitamins and steroids. One method of identifying potential drug 
molecules is to try and synthesise and test natural product mimics. In particular, molecules 
found from animal, vegetation and marine sources have been found to have profoundly 
interesting structures and equally extreme effects on the human body and have been used 
effectively by many early civilisations for healing purposes. The synthesis of these and 
similar molecules is now a highly prized and often an academically challenging endeavour 
(Nicolaou  et al., 1996). The reactions encountered during such challenges are often then 
published and applied to create new synthetic molecules of interest. Thanks to many 
advances in synthetic organic chemistry techniques, many chemical transformations are 
well documented and are available for general use.  
Modern drug discovery efforts and the pharmaceuticals industry can now use some of the 
more robust reactions to routinely synthesise complex organic molecules which can be 
entirely novel. It is often stated that the number of known synthesised organic molecules is 
considerably smaller than the number that it might be possible to synthesise. The actual 
possible chemical space is effectively infinite and there are more molecules feasible than 
matter in the universe available to construct them (Fink  et al., 2007). More recently, solid 
phase combinatorial chemistry techniques have been developed in order to facilitate even 
more efficient molecule production methods and as a result a greater variety of synthetic 
molecules can be created, often using simple synthetic transformations. Molecules of 
interest are tested for biological activity and this is often referred to as screening. Putative 
active molecules can have their structures modified to optimise their properties in order to 
become drug candidates and this is referred to as lead optimisation. Clinical trials with 
animal and humans are often the next phases in order to develop a viable medicine. 
However despite these scientific advances, drug discovery is an economically inefficient 
exercise largely due to the fact that vast numbers of molecules need to be tested and thus 
material costs are high and the end result is often relatively few active molecules that are 
developed into acceptable marketable drugs.  
In conjunction with the medicinal chemistry efforts described above, rational drug design 
and computational chemistry techniques have also been developed that aim to apply 
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additional logic and relevant mathematical concepts to the field of drug discovery. Often 
such techniques can be applied using very powerful computers to complete the 
calculations involved and as such the virtual screening paradigm has evolved. Virtual 
screening attempts to emulate on a computer the predictive equivalent to high throughput 
screening. The term covers a variety of computational methods that can be applied in order 
to prioritise compounds for biological screening with the aim of increasing the chance of 
finding active compounds compared to screening compounds at random. Rational drug 
design commences with the identification of a protein structure to regulate. Often the aim 
is to decrease the protein’s activity in an errant biological process within organisms cells. If 
it is possible to modulate the protein’s natural function by using a small molecule then such 
proteins are often referred to as being “druggable” (Brenke  et al., 2009). Organic 
molecules that are considered as potential drugs should be “drug-like” in terms of their 
solubility and ease of transport to the affected cells within the organism. These properties 
are often summarised by drug-like filters such as the Lipinski rule of five (Lipinski  et al., 
2001).  
The core principles used to provide a sensible framework for modelling organic molecules 
within rational drug design are the similar property principle and 3D molecular recognition. 
The similar property principle states that molecules that have similar structural properties 
should have similar biological activities (Johnson  et al., 1990). Thus given a molecule of 
known activity, similarity search can be used to rank order a dataset of molecules on 
similarity to the active. The top scoring candidates are then good candidates for testing. 
Molecular recognition is based on the fundamental assumption of the lock and key concept 
(Walsh  et al., 1979), which assumes that any given molecule that interacts favourably with 
a receptor will have, to some extent,  exhibit complementary shape and property 
distributions to that receptor’s active site based upon 3D atomic positions. An active site is 
a critical portion of a biological molecule that acts as an interface to other molecules over 
space.  Organic molecules act as regulators which control enzyme reaction mechanisms and 
protein conformation populations which are in equilibrium and are integral to biological 
activity cascade pathways in the cell (Teague  et al., 2003). This interaction controls the 
behaviour and morphology of the complex and the change of shape of the protein from an 
active form to an inactive form and vice versa.  Small molecules are recognised in a highly 
selective manner by proteins and this status has evolved over a very long time period since 
the beginnings of life on our primitive Earth (Stryer  et al., 1995).  
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3D similarity methods aim to capture the shape and 3D properties of molecules based on 
the concept of molecular recognition. For a small molecule to be able to bind to a protein it 
should have complementary size, shape electron density to the active site of the protein. 
Although many 3D similarity methods have been developed, the complexity of modelling 
molecular recognition is such that the methods are limited in their accuracy. As such it is a 
difficult task to develop an approach that accurately correlates 3D molecular structure with 
biological activity. Hence, it is not considered to be a currently solved problem, due to the 
inherently complex electronic nature of molecules (Fukui  et al., 1997).  
The primary aim of the work described in this thesis is to develop a novel 3D similarity 
method for comparing two molecules and deriving a numerical similarity index. Given an 
input query organic molecule of biological interest, the method can be used to iteratively 
process and score a set of target organic molecules. The molecules can then be rank 
ordered on similarity to the query.  The effectiveness of the method is evaluated by 
measuring the extent to which known active molecules are ranked higher than inactive 
compounds, often referred to as decoys. Molecules are numerically evaluated on their 
similarity to the query molecule in terms of basic 3D shape and property distribution. The 
rationale is that molecules evaluated to be similar to the query defined by such 3D criteria, 
should exhibit approximately equivalent biological behaviour and thus should be good 
candidates for biological testing.  
1.2 – Thesis structure 
 
The structure of this thesis is as follows. Chapter 2 explores virtual screening concepts and 
approaches in further detail. The virtual screening techniques that have evolved into 
operation are reviewed in order to place similarity search in general context. Chapter 3 
reviews the existing 3D similarity search techniques and discusses representation, 
alignment, scoring and flexible search in order to set the scene for the following chapter. 
Chapter 4 explains in detail the approach developed to complete the rigid molecule shape 
and sub-shape 3D similarity search method. Chapter 5 presents the results of the rigid 
scoring function for two different alignment methods as applied to sets of virtual screening 
test data. Chapter 6 presents conclusions followed by suggestions for how these methods 
might be extended and improved. 
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Chapter 2 – An overview of virtual screening 
2.1 - Introduction 
 
Virtual screening is the application of computational techniques to prioritise molecules 
(either real or virtual) for biological testing. Virtual screening includes both ligand and 
structure based approaches. A ligand based approach is when only small molecule data is 
available and thus the nature of the protein active site can only be inferred by the set of 
active molecules available. A structure based approach is when information about the 
protein receptor is available to consider and this is usually in the form of protein crystal 
coordinates with or without a ligand bound in the active site. The availability of data largely 
dictates which virtual screening approach can be adopted (Wilton  et al., 2003). It is the job 
of the virtual screening protocol to prioritise a set of compounds such that those selected 
for testing have a greater chance of exhibiting activity than a random selection of 
compounds. There are numerous virtual screening approaches and the key classes of 
approach are presented below. A review of virtual screening in the context of real 
screening can be found here (Walters  et al., 1998).  
 
 
2.2 – Virtual screening techniques 
2.2.1 - Ligand based virtual screening 
 
In the absence of protein structural data, then virtual screening is referred to as ligand 
based. When known data is limited to a single active molecule then substructure search 
and similarity search methods are the most relevant screening approaches to adopt. If an 
active series of molecules is available then pharmacophore elucidation may be attempted 
to derive the best query for a subsequent search. If both active and inactive molecules are 
known, then machine learning methods can be used to derive a model which can then be 





2.2.2 - Substructure search 
 
Graph based substructure search is a 2D method (more recently extended to 3D) of 
searching for molecules that contain a given fragment and are therefore potentially part of 
the same chemical series and so should adhere to the similar property principle and 
produce biologically similar molecules. A substructure search will return a list of molecules 
that contain the substructure with no notion of ranking. A substructure search can produce 
a diverse set of molecules from a single query and the same substructure can be found in 
both simple and complex molecules. A substructure search is usually composed of two 
stages. First a fast screen is completed using a fragment based fingerprint to eliminate 
~99% of molecules that cannot match followed by a detailed subgraph matching 
procedure. One downside of this method is that if a molecule identified by this approach is 
already patented then it is likely all the other hits are too as it is normal for an entire series 
of molecules to be patented. Patents are often submitted as “Markush” structures which 
normally are constructed as a core structural template with connected points of variation. 
Graph theoretical methods and substructure search are reviewed extensively by Leach 
(Leach  et al., 2007c). Substructure search use in virtual screening is reviewed by (Merlot  et 
al., 2003). 
 
2.2.3 - Similarity search 
 
The similar property principle (Johnson  et al., 1990) was introduced in chapter 1 and states 
that molecules with similar structures are  likely to have similar biological properties and 
activities. There are many possible ways to represent molecules and compare similarity 
between two molecules and much research has been completed on systematic molecular 
similarity comparisons (Good  et al., 1998; Martin  et al., 2002; Willett  et al., 1998). 
However, while the general principle holds there are also many counter examples where 
similarity does not correlate with biological activity well. This is exemplified by so called 
activity cliffs that are examples of pairs of molecules that by most derived similarity indexes 
are determined to be highly similar but due to the absence of a single key functional group, 
the actual biological activity is highly diminished between the two molecules (Leach A  et 
al., 2001b; Tropsha  et al., 2008). Activity cliffs do however highlight the key nature of 
specific molecular recognition which is described above. Similarity search usually involves 
the use of global similarity indexes to compare and rank molecules on the assumption that 
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rank order reflects or relates to biological activity. Similarity search is usually adopted at 
the initial stages of drug discovery projects when data is limited, to a single, or several 
active molecules.  
 
The similarity between two different molecules is an abstract concept with no absolute 
measure in existence, the closest concept to real physical similarity perhaps being the 
continuous charge distribution field (Carbo  et al., 1980). Similarity search therefore relies 
upon the generation and use of numerical descriptors to represent the molecules. 
Similarity search descriptors are sometimes classified as 1D, 2D and 3D which infers 
increasing sophistication in the representation of the molecules. As complexity of the 
descriptors increases so does the computation required to derive that representation. A 
study of the effectiveness of simple descriptors is given by (Bender  et al., 2005). 2D 
fingerprint descriptors are usually represented as binary vectors where each bit represents 
a substructural fragment. For a given molecule, a bit is set to one if the substructure is 
present in the molecule otherwise it is set to zero. Examples of 2D fingerprints include 
DAYLIGHT, MACCS and UNITY fragment based fingerprints (Wild  et al., 2000). Topological 
shape indices are another example of molecular descriptors that are based on molecular 
connectivity (Hall  et al., 2001; Leach  et al., 2007a). 3D descriptors are arguably the most 
sophisticated descriptors and allow comparisons based on molecular surface area, volume 
and shape. 3D similarity methods are discussed in chapter 3.  
 
A similarity coefficient is required in order to quantify the similarity of a pair of molecules 
based on the chosen molecular descriptors. There are a number of such coefficients in 
common use which are constructed from the descriptors in slightly different ways and thus 
can potentially give different results. Perhaps the most common coefficient in use is the 
Tanimoto coefficient. For molecules A and B represented by binary fingerprints the 
Tanimoto coefficient is given by c / (a+b-c) where c is the number of bits set to one in 
common, a is the number of bits set to one in molecule A and b is the number of bits set to 
one in molecule B (Willett  et al., 1998). A comparison of the derivation and merits of 
different similarity coefficients related to molecular size is discussed by (Holliday  et al., 
2003). A review of similarity search and some useful descriptors is given by (Glen  et al., 
2006). Which descriptors are most relevant to biological activity is still under debate with 




2.2.4 - Pharmacophore classification and elucidation 
 
A pharmacophoric feature is a functional group which is classified in terms of potential 
interaction behaviours with other groups. Several fundamental pharmacophore type 
classifications are established which are listed as follows (Wolber  et al., 2008). The 
Hydrophobic classification is any atom or group of atoms that do not mix well with water, 
typically carbon in any hybridisation state or any of the halogens. Hydrophobic groups tend 
to mix together to exclude water as typified by micelles. The Aromatic type is any group of 
atoms such as carbon or indeed heteroatoms (O,N) that are considered by the Huckel rules 
to be part of an aromatic system. Aromatic groups can interact with each other via pi 
stacking orbital interactions in several orientations. Hydrogen bond donors are any group of 
atoms that can donate a Hydrogen bond. Typically this means an electronegative atom with 
a hydrogen atom attached usually limited to N, O. Hydrogen bond acceptors are atoms that 
can accept a Hydrogen bond. Typically this means any atom that has at least one electron 
pair that it can donate to form an H-bond with an appropriate donor. Hydrophilic is a 
further classification that describes affinity for water and is essentially similar to acceptor. 
Atoms or functional groups which contain a formal charge are also sometimes used as 
pharmacophore features. 
 
A pharmacophore is the 3D arrangement (Leach  et al., 2010) of such functional groups that 
are required for activity or binding to a protein. Different functional groups that interact in 
the same way are referred to as being biosteric, for example NH and OH or Cl and CF3. An 
early recognition of pharmacophore groups was made by Ehlrich in 1909 who commented 
that a pharmacophore is “a molecular framework that carries the essential features 
responsible for a drug’s biological activity”. A more modern definition of a pharmacophore 
by Nicklaus in 1998 is “The minimum structural features necessary for enzyme binding” 
(Milne  et al., 1998). Pharmacophores can be defined in 2D or 3D whereby 2D topological 
pharmacophores are defined by biosteric groups that are separated by bond distances. 
However 3D pharmacophores, as defined by feature distance constraints, are considered to 
be a more realistic interpretation since molecular recognition as described above is known 
to be a 3D event. A pharmacophore can be derived from a series of active molecules and 
normally involves generating a 3D alignment of the molecules in order to attempt to 
identify the geometry of the features they have in common. The pharmacophore can then 




The alignment is usually completed using the most rigid molecule as a template and then 
increasingly flexible molecules, according to rotational bond count. Molecules are aligned 
according to their common features and the best alignment is chosen by evaluating a 
scoring function which usually consists of several terms almost always including a volume 
and energy term. Many approaches to pharmacophore elucidation exist, the first being the 
active analogues approach (Marshall  et al., 1979), and more recent examples are 
GALAHAD (Richmond  et al., 2006) MOE’s GUI and alignment methods (Labute  et al., 2001) 
and PHASE (Dixon  et al., 2006). If a protein structure is available then docking is the most 
popular virtual screening method of choice employed (see below), however, alternative 
ways to build structural data into similarity and pharmacophore methods are increasingly 
being explored (Ebalunode  et al., 2008). For example, excluded volume information can be 
used in query construction to avoid steric clash between the ligand and protein. 
2.2.5 - Pharmacophore database search 
 
The primary use of an elucidated pharmacophore is in a database search so as to identify 
molecules that contain the same features in the same geometric arrangement. This can be 
achieved using 3D substructure searching with the query being defined by the 
pharmacophore. Similar to 2D substructure search, 3D substructure search is best 
approached by first completing a fast screening step using 3D fingerprints in order to 
eliminate molecules that cannot match as they simply do not have a particular geometric 
arrangement of features. 3D fingerprints are binary fingerprints that indicate the presence 
or absence of geometric features such as a pair of atoms at a specified distance, or a 
valence or torsion angle for a given pattern of atoms. Database molecules that pass the 
screening step are subjected to a more intensive geometric search which usually involves a 
subgraph isomorphism substructure search for example using the Ullmann algorithm 
(Ullmann  et al., 1976). Conformation flexibility of the database structures is handled either 
by generating an ensemble of conformers each of which is treated as rigid or by 
implementing a flexible search method (Brint  et al., 1987a; Leach  et al., 2007c; Sheridan  





2.2.6 - Machine learning methods 
 
Machine learning is a relatively recent concept which is employed when activity data is 
available for both active and inactive molecules. The molecules with known activities form 
a training set that is input to the machine learning method which then attempts to learn a 
model which best separates the training set into actives and inactives. Once the optimum 
model is determined it is possible to apply it to predict the probabilities of activity of 
molecules in a given test set. Two common examples of machine learning methods are 
Binary Kernel Discrimination (BKD) and Support Vector Machines (SVM). In the case of BKD 
a chemical similarity kernel function is trained. The relative success of this method is 
reported as being dependent upon the number of false actives in the training set and the 
choice of similarity coefficient used in the kernel function (Chen  et al., 2006a). For SVM’s a 
hyper-plane is defined which separates active and inactive observations for a given 
descriptor. Unclassified points (molecules in the test set), are assigned as active or inactive 
based upon distance and sign relative to the hyper-plane. Molecules that are furthest on 
the positive side of the defined hyper-plane have highest predicted activity (Warmuth  et 
al., 2003). 
2.2.7 - Structure based virtual screening 
 
The static and dynamic 3D structure of proteins can be obtained by using techniques such 
as X-ray crystallography or NMR spectroscopy. Many structures have been resolved to date 
and many more will be in future with the availability of the synchrotron light source. Much 
of this data is compiled and available for use from the Protein Data Bank (RCSB  et al., 
2010). If the crystal structure data of the protein is available then this can be incorporated 
into the virtual screening approach. In the case of pharmacophore search, if a bound ligand 
exists then this can be used to define a pharmacophore query and knowledge of the active 
site can be used to define excluded volumes so as to build into the query an effective size 
and shape constraint. However, the most popular structure-based virtual screening method 
is protein-ligand docking which is discussed further below. Proteins can exhibit 
homogeneous or heterogeneous activity and are categorised as such to help explain the 





2.2.8 - Docking and scoring 
 
Frequently when protein structural information is available then docking is employed in 
order to determine the estimated binding affinity between a given small molecule and a 
protein structure. Docking is a general term which encapsulates methods that predict the 
likely interaction pose of two molecule conformations and score the pose according to 
predicted free energy change of binding. The docking problem can be thought of as a 
combination of a search strategy to traverse the six degrees of freedom in the search space 
and a scoring function which attributes an energy value to a complex formed between 
protein and ligand in a particular pose state. Docking programs are evaluated using known 
protein-ligand complexes where the target pose is typically that of the natural substrate 
bound crystal structure and generally any method that can reproduce the same pose within 
2 Å root mean square deviation (RMSD) is considered to be accurate.  
 
Docking is useful for predicting the binding mode of known actives and for the 
identification of new molecules that are predicted to bind well which is how it is used in 
virtual screening, The state of the art docking treats each ligand as flexible and proteins as 
semi-flexible. The best methods predict experimental pose data ~70% of time (Leach  et al., 
2006; Warren  et al., 2006). However they are more limited in the ability to predict binding 
affinities accurately over an entire active series. Picking the correct docking program for a 
given target can produce better results with a particular class of proteins. Building the 
correct physical chemistry model is a key aspect of docking. The original docking tool, 
‘DOCK’ (Moustakas  et al., 2006) uses spheres to define an active site and then sphere 
centres are mapped to atom centres in a small molecule. Examples of much cited docking 
tools which consider protein side chain flexibility are GOLD and FlexX and a study which 
compares these approaches is given by (Sato  et al., 2006). Several reviews of docking are 
available (Taylor  et al., 2002; Warren  et al., 2006).  
2.2.9 – QSAR 
 
Many of the virtual screening techniques described previously are employed at the lead 
generation phase to suggest new molecules for enquiry. Quantitative structure-activity 
relationship (QSAR) techniques are often used during the later lead optimisation stage, 
when sets of actives and inactives are already well defined. A QSAR model can be 
constructed which aims to capture the exact nature of the relationship between the 
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numerical descriptors (real or calculated) and the biological activity in terms of a linear or 
non-linear numerical correlation (Cramer  et al., 1988). If a suitable model is derived it can 
be used to assess new molecules for predicted activity and when used in a predictive way is 
a type of virtual screening. The early days of QSAR were dominated by Corwin Hansch who 
pioneered the use of physical properties such as log P (Logarithm of Octanol:water 
partition ratio, considered to relate to cell permeability) and physical constants such as 
NMR resonance effect parameters and adopted the established Hammett equations for use 
in building correlation models against biological activity using such physical variables 
(Hansch  et al., 2011; Hansch  et al., 1991). 
Comparative Molecular Field Analysis (Cramer  et al., 1988) is a  grid-based QSAR approach 
which can be used to correlate molecular field data with biological activity in order to 
determine a QSAR model. Partial least squares is used to define the relationship between a 
molecule’s field grid representation and its biological activity. A 3D grid is constructed 
around a molecule so that the 3D Cartesian coordinates of all atoms are entirely enveloped 
by it. As such the molecule is represented as a scalar field. At each lattice point, two 
interaction energy values are evaluated to model the steric and electrostatic fields for the 
entire molecule (over all atoms) with a probe sp3 Carbon atom and a +1 charge. The steric 
contribution is modelled using the Lennard-Jones (6-12) potential parameterised using the 
Tripos force field. The electrostatic or coulombic interaction is modelled using 1/r and 
assigned Gasteiger/Marselli atomic charges.  Two molecular field grids are aligned and 
compared by fixing one and traversing the degrees of freedom of the other. A technique 
termed “Field fitting” is used, that drives the alignment, based on the minimisation of 
RMSD of both of the evaluated interaction energies over all lattice points and as such 
molecules are aligned according to how similar they are with respect to the two interaction 
characteristics.  
2.2.10 – Evaluation of virtual screening methods 
 
A predictive virtual screening method will produce a list of molecules to test in a relevant 
biological assay. This list will either be in ranked order in the case of a similarity search or 
docking experiments, or simply a “Boolean” hit list in the case of a substructure or 
pharmacophore search. The next step in the process is to test the molecules for biological 
activity in the relevant assay and use the results in a new round of virtual screening to 
determine if the results correlate with the predictions. This type of iterative feedback 
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mechanism is standard practice in scientific approaches, used to refine hypotheses. Ideally 
one might compare virtual screening predictions to real assay results in order to evaluate 
the effectiveness of different methods at identifying new drug molecules. However, this is 
often untenable in terms of the material cost associated and so standard test sets of 
molecules with known associated biological activity referred to as “actives” can be used to 
test the effectiveness of a given virtual screening method. Example sets available are the 
DUD (Huang  et al., 2006), WOMBAT (Good  et al., 2008) and MUV (Rohrer  et al., 2009) 
data sets. Further to this, non-active “decoys” can be introduced, to determine if the 
protocol is identifying the correct molecules and enrichment rates, relative to a random 
selection. Thus it is possible to quantify how useful a method is at identifying active 
molecules. The Enrichment factor (EF), Recall and Area under curve (AUC) measures 
employed in chapter 5 are discussed in a recent evaluation of 3D ranking methods in virtual 
screening (Kirchmair  et al., 2008). A good evaluation of the performance and limitations of 
3D similarity search using the DUD set is given by (Venkatraman  et al., 2010). Please also 
see section 3.5 which presents an evaluation of 2D and 3D methods. 
2.3 - Summary 
 
This chapter has described an overview of virtual screening approaches. Often when data is 
limited to a few actives a ligand based approach is adopted, such as similarity search. If an 
active series is available then a pharmacophore elucidation might be possible. If protein 
structural information is available then pharmacophore search can be extended to include 
or exclude volume and also then docking experiments are possible. If inactives are also 
known then machine learning methods can be used for building a predictive model. The 










Chapter 3 - 3D similarity search methods  
 
3.1 - Introduction 
 
This chapter presents a discussion of three dimensional (3D) similarity approaches that 
have been developed to date for use in virtual screening experiments. A variety of 
approaches have been introduced and then further developed concurrently by different 
authors, over a number of years. Thus this review is organised by method rather than 
chronologically. Each method is broadly categorised on four key attributes and thus the aim 
is to present concepts and components and how they are interleaved in the various 
methods. Firstly, the molecular representation and any operations required in order to 
map a molecule to the internal molecular, structural or spatial representation. Second, the 
search and alignment method employed to superpose two molecular representations, if an 
alignment is required. Third, the scoring function(s) used to evaluate the quality of the 
alignment of two representations or, more generally, if no superposition is applied, the 
scoring function used to indicate the quantitative similarity of the two molecules. The last 
aspect is the method by which conformational flexibility is optionally handled.  Method 
performance is also mentioned briefly if it is obvious that a substantial number of 
operations are being executed to achieve the similarity calculation.  
3D similarity searching is a relatively new phenomenon essentially derived from the 
fundamental idea that if molecules exhibit similar electron density over space, then they 
will have similar characteristic properties, as originally proposed by Carbo (Carbo  et al., 
1980). 3D similarity approaches vary in complexity. At the simplest level 3D features are 
captured as binary vectors which represent the presence or absence of geometric features. 
The binary vectors can then be compared using a similarity coefficient to give an alignment-
independent similarity method. Alignment methods are computationally more complex 
since they require a superposition step. Various approaches have been developed including 
graph representations and representing the surface, shape and electrostatic field 
properties of molecules. This chapter begins with a discussion of alignment-independent 
methods which are then followed by methods that require an alignment step. Each 
similarity search program normally requires as input a query molecule or a pre-aligned 
active series of molecules which is then mapped to an internal representation to use as the 
query (if several active molecules are available, this query might be the result of a 
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pharmacophore elucidation or other superposition process). A target database of drug-like 
molecules is converted to conformers to search. Each conformer is converted to a format 
that is directly comparable with the query molecule representation. A comprehensive 
discussion on alignment dependence of similarity search methods is given previously by 
Lemmen (Lemmen  et al., 2000). 
Chirality, or optical isomerism, is a highly important consideration in drug design. 
Handedness is born out of the fact that a tetravalent Carbon atom with four different 
bonded attachments always has two mirror image forms referred to as enantiomers (Corey  
et al., 2007). This is a result of the tetrahedron shape it forms through the necessary sp3 
hybridisation state required for the four covalent bonds. Proteins are constructed from a 
small set of amino acids all of which are chiral except for the simplest Glycine. This leads to 
the fact that proteins themselves contain many chiral centres and thus any protein and its 
active sites are likely to have diastereoisomeric properties where diastereoisomers are 
molecules that contain more than one chiral centre and are not meso compounds. Thus, 
small molecule enantiomers can exhibit remarkably different biological properties within a 
given active site. The most often cited example of the biological effects of chirality is the 
thalidomide tragedy. Unresolved enantiomers administered as a mixture resulted in foetal 
abnormalities caused by one of the enantiomers (the other enantiomer cured morning 
sickness). To avoid complications often drug companies will aim to develop symmetrical 
heterocyclic molecules or employ asymmetric synthesis techniques (Procter G  et al., 1996). 
Other forms of isomerism have a less dramatic effect on the activity (Corvalan  et al., 2009). 
It is now an FDA requirement for the chirality of a drug molecule to be absolutely defined. 
3D similarity search scores should inherently consider the difference between enantiomeric 











3.2 – Alignment-independent 3D similarity methods 
 
Several 3D similarity methods are alignment-independent, i.e. they are based on 
descriptors of molecules that can be compared independent of a molecular alignment step. 
This can lead to significantly faster processing compared to alignment-dependent methods 
since achieving a relevant alignment is normally a computationally intensive phase, see 3.3 
below. Examples of methods that are independent of an alignment step are discussed here. 
Several alignment-independent 3D similarity methods use a representation generated from 
a molecular surface definition. Atoms are modelled as intersecting spheres of different radii 
(typically Van Der Waals radii) centred at the atomic nuclei with the union of spheres giving 
rise to a hypothetical molecular surface (and volume). 
Pharmacophore keys employ bit string vector representations generated by mapping 
distance restrained 3 or 4 point configurations which are extracted from a molecule and 
binned into a bit string vector. The approach has been extended from 3 to 4 points which 
encode stereochemistry but require a longer vector. In this approach, all the possible 
arrangements of pharmacophore typed atoms (donor/acceptor) and the distances that 
define the relationship between these annotated points are determined (there can be 
several extracted from a single conformer) and binned into a binary (1 or 0) vector for a set 
of conformers that represent the molecule. As such the molecule is represented by the 
presence or not of specific arrangements of typed points within a range of distance 
tolerances. Pharmacophore keys can be compared using a similarity coefficient without the 
need for any further superposition or alignment making this potentially a very rapid 
approach. The representation is a pharmacophore distribution and hence the similarity 
score is a global measure since it considers whole molecules (Leach A  et al., 2001a). In a 
related approach Autocorrelation vectors use eight atomic properties, two examples of 
which are VDW radii and Electronegativity. Heavy atom (any atom, except Hydrogen and 
often is one of C,N,0,S) pairs are allocated to discrete bins which represent a specified bond 
separation count / distance. Partitioning which represents the distance between atomic 
properties (between 0-20.3 Å) for all property combinations yields the autocorrelation 
vector representation.  Auto-correlation vectors of equal dimensions can be compared 
rapidly by Euclidean distance difference over all elements and rigid search is implemented 
without alignment and by using a sum of element distance score (Rhodes  et al., 2006). 
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Representations can be constructed using the concept of pharmacophore points as 
discussed in the previous chapter. In the SQUID approach the concept of Potential 
Pharmacophore Points (PPPs) is used. Each derived PPP represents the centre of one of six 
feature types which include cationic, anionic, polar, hydrogen bond donor, acceptor and 
hydrophobic (Renner  et al., 2004). An associated radius which defines both feature 
fuzziness and model resolution is defined. PPPs represent local feature density maxima 
which have defined cluster radii which control the fuzziness of the representation in terms 
of size and numbers of points. This has a direct effect on the feature weighting, since 
feature density is weighted based upon local atom membership within the defined 
proximity. A correlation vector of 420 dimensions is constructed from a set of PPPs and the 
inter-point distances between them. Twenty evenly spaced distance bins each contain 
character classifications based upon combinations of possible PPP interaction types.  All 
PPP pair combinations are mapped to suitable bins in order to give the correlation vector 
representation. No alignment is necessary between two correlation vector representations 
which can be compared using a similarity coefficient.  
Reduced point representations are found in several alignment-independent based 
methods. An example of a reduced point representation (non-pharmacophore) is in the 
Ultra fast Shape Recognition approach (USR), where a molecule is considered as a 3D 
system of bound particles. A binning of inter-atomic distances is completed for four defined 
reference points within the molecule. These points include the centroid and several 
extrema relative to the centroid. The distances to all other atoms are used as the basis for a 
distribution with characteristic mean, variance and skewness values. For each of the four 
points, statistical measures are determined and a shape vector of length 12 real valued 
elements is constructed. USR is alignment-independent and all derivation is completed on 
internally sampled atomic coordinates. The speed of the method is “ultra fast” due to the 
independence of a computationally demanding molecular alignment stage. The Manhattan 
distance is used to compare two vector representations with 1 being the most similar and 0 
being most dissimilar (Ballester  et al., 2011). 
The solvent accessible molecular surface is defined using a probe sphere with a radius 
equivalent to a water molecule which is rolled over the VDW surface spheres as defined 
above. The locus defined by the moving sphere centre defines the solvent accessible 
surface (Richards  et al., 1983). The Connolly molecular surface or re-entrant surface is 
similar to the above definition except it is the inward facing path traced by the probe 
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sphere surface rather than one defined by the sphere centre (Connolly  et al., 1983). 
Accurate VDW radii have been determined from various X-ray crystallography experiments. 
Correlation with the De-Broglie equation suggests the VDW radius of an atom corresponds 
to the distance between the nuclei and outermost electron (Bondi  et al., 1964). 
In the Ray tracing approach to similarity searching, a solvent accessible surface is defined 
for a molecule. The surface is triangulated using an algorithm which partitions the surface 
into evenly spaced triangles. A ray is projected from a random chosen triangle on the 
surface and is optically reflected using the correct incidence angle onto a different path 
which then interacts with new surface elements in the ray’s path. This is allowed to 
continue until a specified number of valid reflections are completed giving a distribution of 
items referred to as “ray-trace segments”.  In this way the internal volume occupied by the 
molecule is traced out, until some termination criterion has been met. Segment culling is 
also applied which deliberately removes ray segments that define local reflections and do 
not contribute to global shape distributions. The set of ray traced segments for a molecule 
are then represented as a distance based distribution histogram which bins each segment 
according to length. Two such histograms can then be compared and scored using a 
similarity measure based on relatively simple “difference” statistics. The histograms 
effectively represent shape as defined by the bounded surface area. The method was 
extended to capture inverse protein surface properties. Although no alignment is necessary 
to compare two molecules, it can be a computationally intensive approach if a fine 
resolution of the representation is used (Zauhar  et al., 2003).   
In the Molprint3d method, molecular surface points are characterised according to 
interaction energies which are evaluated at each point on the defined surface based on a 
number of different probe types. These energies are mapped from continuous values to 
discrete ones in order to construct a binary vector which is a surface interaction fingerprint 
of the molecule. Two fingerprint vectors can be compared using the Tanimoto coefficient 







3.3 – Alignment-dependent 3D similarity methods 
 
3.3.1 - Overview 
 
Molecular alignment is a general term used to describe the approach of overlaying 
chemical structures in order to facilitate evaluation of a similarity score or to derive a 
pharmacophore hypothesis by establishing common feature overlap (Richmond  et al., 
2006). A useful review of molecular alignment methods was compiled by (Lemmen  et al., 
2000) who categorises alignment approaches in terms of the molecular representation, as 
either atom centred (Gaussian) or point based scalar fields, the scoring function to optimise 
over all space (RMSD or overlap integral) and how flexibility is modelled - rigid or flexible 
(ensemble or dynamic rotational) in the search. Most methods are based on 
representations of whole molecules. However, it is clear that sub-shape alignment is 
becoming an increasingly important concept since frequently only portions of molecules 
are involved in molecular recognition. Principal moment alignment is a common way of 
placing molecules into a normalised form such that each molecule’s principal moment 
extends down a common axis and each molecule’s second moment exists in a common 
plane – this provides a good starting point for further comparisons but is not guaranteed to 
give the ideal alignment in terms of potential interaction overlap. A recent discussion on 
molecular alignment (Chen  et al., 2006b) suggests that the final accuracy of an alignment is 
primarily dependent upon the choice of initial template molecule, used as query, often this 
is chosen to be the least flexible molecule.  
 
In alignment-dependent similarity searching, often the optimal alignment is determined 
using a scoring function. In order to maximise the value of a scoring function in the least 
number of steps, two molecular representations are often first aligned by superimposing 
their geometric or mass weighted centroids and this is often referred to as putting the 
molecules into the same frame of reference. The internal principal moments can also be 
aligned with the axes. Subsequently, derived superpositions are scored iteratively after 
local transformations (rotational/translational) are applied by the search protocol which 
can be implemented in either a deterministic or non-deterministic (random) fashion. In 
order to make alignment tenable, the continuous nature of superposition must be made 
discrete by conducting the search at a specified resolution. Thus, a local maximum score at 
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a specified resolution can be obtained. There is no known analytical method of determining 
if the true global maximum has been observed at any point in a search and as such, search 
approaches need to be either completed exhaustively, or terminated after a given number 
of operations or if some threshold value in the score is achieved. Implementing 
computational parallelisation using hardware and software, randomisation elements or use 
of pertinent information about the search states already observed (i.e. Genetic Algorithms, 
Simplex optimiser, Quasi-Newton) can also achieve maxima more rapidly. 
3.3.2 – Graph theoretical methods 
 
Many alignment-based approaches employ graph theoretical techniques and in particular 
clique detection methods are prevalent. A clique is defined as a fully connected graph 
(Johnston  et al., 1976). Each clique represents a mapping between a set of points in one 
representation query Q and a set of points in the other representation target T. When 
comparing two molecules, a correspondence graph, which is a node/vertex mapping 
between two graphs, is constructed and maps equivalent points in the two graph 
representations according to node type. Thus each node in the correspondence graph 
represents a pair of nodes, one from each molecule. Edges are formed in the 
correspondence graph if the corresponding distances within the original graphs are within 
some tolerance. The Bron-Kerbsoch algorithm (Bron  et al., 1973) is a well established and 
rapid method for the identification and extraction of all the cliques that exist in a 
correspondence graph (Brint  et al., 1987b). The Bron-Kerbosch method grows cliques via 
search pruning (Calzals  et al., 2008).  
CLIP (Candidate Ligand Identification Program) is a 3D similarity approach which compares 
pharmacophore points using graph theoretical methods (Rhodes  et al., 2003). Sets of 
pharmacophore points are identified within a molecule based upon mappings of atom 
types to pharmacophores such as Oxygen or Nitrogen to donor/acceptor and represented 
as the nodes of a graph. The mappings identified by the cliques are then scored based on 
the number of nodes in the mapping. 






3.3.3 – Surface area representation 
 
Several examples of clique detection algorithms can be found with molecular surface 
representations. The surface patch alignment method defines surface patches on a 
Connolly molecular surface. Each point and associated circular patch is classified as 
belonging to one of six classes of surface type based upon local maximum and minimum 
curvature. Curvature is defined as the rate of change of angle at a point with respect to 
distance travelled along a trajectory that is on the local surface. Molecules are represented 
as sets of characterised surface points. A correspondence graph is constructed between 
two surface point representations according to the node classifications. The Bron-Kerbosch 
clique detection algorithm is then applied in order to identify the sets of matching patches 
between two molecular surface representations. The cliques extracted are then used to 
align the two molecules by similar surface patch overlap using a suitable transformation. 
This is reported as local search rather than a global comparison since it is only possible to 
overlap a fraction of each surface which is assumed to share binding characteristics to the 
protein surface. RMSD of the mappings represented by cliques found gives a partial shape 
match index (Cosgrove  et al., 2000).  
In the Surfcomp tool a solvent accessible molecular surface is subject to an initial 
triangulation and is partitioned into approximately equal sized patches each represented 
by a point (Hofbauer  et al., 2004). Critical points are defined as convex, concave and saddle 
points by use of a canonical curvature surface fitting technique. The point set representing 
the molecular surface is then relaxed in order to give a uniform distribution of points about 
the surface of equal area. Points are chemically typed using local atomic properties such as 
donor, acceptor and electrostatic potential. Surface regions defined in the proximity of the 
critical points are mapped from 3D to 2D using harmonic shape filtering in order to derive a 
circular representation of the surface characteristics. A correspondence graph is 
constructed between two critical point representations that are to be assessed for 
similarity. Nodes are mapped to each other based on a fuzzy chemical environment 
similarity criterion between 0 and 1. The 2D surface region patches represent a 3D 
potential energy surface and are also compared for similarity using a correlation coefficient 
at the node equality stage. A distance criterion between nodes is also implemented to 
define edges in the correspondence graph. The Bron-Kerbosch algorithm is applied to 
extract the cliques formed in the correspondence graph. The nodes mapped in the cliques 
identified are aligned using least squares fitting for subsequent scoring.  Cliques of typically 
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2-4 points were identified for scoring by the search stage. The two critical point sets that 
constitute the clique are aligned via centre of gravity superposition and a rigid body 
transformation used to minimise RMSD. Typically alignments below 2 Å total RMSD are 
retained for solution clustering and the final RMSD is effectively the score index, with a 
smaller RMSD indicating a better solution. Similarity scoring occurs at the node equality 
stage of the correspondence graph construction and is intrinsically part of the final score. 
The authors concluded that the method was best suited for partial surface similarity 
matching.  
Further approaches that compare molecular surface representations by alignment and 
scoring exist. In the Surface point matching approach two uniform surface point 
representations of molecules are compared using a function of RMSD to give a similarity 
coefficient between two molecules. The Kabsch algorithm (Kabsch  et al., 1976), which 
defines a rotation to align two sets of points, is used to generate the transformation 
required to align sets of surface points with the minimal RMSD. It is stated that either 
clique detection of surface points via correspondence graph or substructure overlay of 
small sets of atoms would give the best starting alignment for input into the Kabsch 
alignment (Baum  et al., 2006).  
The Kabsch algorithm is a key component of the methods described in the thesis chapter 4. 
3.3.4 – Spherical grid field representation 
 
An early example of use of a spherical icosahedral grid is Superposition by PERMutation 
(SPERM). Atomic properties such as steric, electrostatic and hydrophobic contributions for 
each atom in the molecule are projected on to the points of an icosahederal approximation 
of a sphere. The distance between the defined VDW surface and each tessellation point is 
used in the calculation which assigns a property magnitude to each point. The effect of the 
molecule’s atoms can be evaluated at each node in the icosahederal in a spherical manner 
which encapsulates the whole molecule. Two such icosahedral grids are aligned by origin 
and one is fixed in orientation. Both molecules are evaluated initially at their principal 
moment aligned superposition. The query molecule is transformed through many 
rotational states to provide a set of grids for comparison to a target. An approach is 
adopted that eliminates degenerate rotations using the symmetry properties of the 
icosahederal. The RMSD difference between each property integrated over all grid points is 
calculated and the alignment chosen that minimises RMSD. An RMSD score of 0 means the 
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two molecules are equivalent at that rotational state and any other RMSD is a measure of 
dissimilarity and thus is convertible into a measure of similarity (Perry  et al., 1992). 
In the Spherical Harmonics approach, an icosahedral spherical grid is used in order to 
provide sample points in space near to the molecular surface and at each vertex the all 
atom probability density function is evaluated in order to indicate the proximity of mass to 
surface area (Mavridis  et al., 2007; Ritchie  et al., 1999). A 3D molecular surface envelope 
defined by a characteristic radial distance function can be approximated using the 
expansion of a set of spherical harmonic basis functions up to a specified resolution and 
about an origin such as the centre of mass of a molecule. The spherical harmonics functions 
are a known set of complex tabulated trigonometric/exponential functions that operate on 
the spherical polar coordinates that define spherical projections such as the set that define 
a surface approximation. The spherical harmonic functions operate upon the spherical 
coordinates defined for each vertex and the assigned probability density at each vertex to 
“stretch” the “real” molecular surface on to the sphere. A high probability density will 
indicate the propensity for a local “knob” near a vertex and a low density a “hole”. The low 
order harmonics define spheres and ellipsoids and finally complex lumpy shapes emerge 
simulating globular molecular surfaces. With a slight re-arrangement of the expression a 
vector of characteristic coefficients for the expansion can be extracted that define surface 
and shape as a set of global descriptors. Two such vector representations of different 
molecules can be compared and scored using a simple distance difference function over 
each element. A Quasi-Newton method is used to search and define the minimal distance 
between the coefficients and the maximal overlap of the surfaces. The descriptors 
evaluated can be rotated during the search and surface overlay optimised. The nature of 
the expansion ensures that each element is directly comparable. Low order spherical 
harmonics can capture the main features of a molecular surface for the purposes of fast 
shape search and surface similarity comparison.  
3.3.5 – Grid field representation 
 
There are several approaches that use non-spherical or rectangular grids to encapsulate 
field based representations. BRUTUS is a grid field rigid body molecular superposition and 
similarity search method. A field based alignment of charge distribution and defined VDW 
shape are completed. Representations are rectangular grids and interpolation (constructing 
new data points based upon existing data points) is used to define a further intermediate 
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grid by which nearest neighbour points are mapped. This new grid, located ‘between grids’ 
can then used with an alignment to evaluate similarity. Different atomic partial charge 
distribution models are used and compared and the study concluded that it is possible to 
use relatively coarse grids effectively for similarity searching. An initial set of starting 
alignments are determined systematically using coarse transformations and then gradient 
based optimisation is employed to determine the optimal solutions. The search is 
implemented by holding one of the molecular energy fields static while rotating and 
translating the other molecule field grid representation. In this way it is stated that the field 
should not need to be re-evaluated after each rotation/transformation. The Brutus method 
uses the Hodgkin index, shown in figure 3.1, which is defined as twice the common 
descriptor overlap normalised by the properties of the two objects, as the similarity 
coefficient of two grid energy field representations of different molecules (Ronkko  et al., 
2006; Tervo  et al., 2005).  
Tanimoto 
 







	 ×  
Hodgkin/Dice 
 
 +  
 
Figure 3.1 - The most commonly used Similarity coefficients Tanimoto, Carbo and 
Hodgkin/Dice are defined for reference. Q and T are identity overlap and C is the 
evaluated common overlap of Q and T. 
3.3.6 – Atom and reduced points field representation 
 
SEAL Steric and Electrostatic Alignment is an electrostatic grid based approach with atoms 
represented as weighted Gaussian functions. The Gaussian pre-factor is set to the sum of a 
number of terms which involve the product of the partial charges and the VDW radii from 
each contributing atom which is raised by an integer power to further differentiate atom 
type volumes. The search is implemented using rotations and translations of one molecule 
with respect to the other in an exhaustive fashion. All transformations are about the centre 
of mass (not the geometric centroid) which for both molecules are initially mapped to the 
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origin. Quaternions are utilised to apply rotations in conjunction with a rational function 
optimisation and “golden section search”.  The search is reported as being computationally 
demanding. Maximal volume and point charge alignment is the primary aim of the tool and 
good results were observed with the approach (Kearsley  et al., 1992; Smith  et al., 1991). 
As such a volume overlap and electrostatic overlay score is combined within a single 
expression and summed over all atom combinations. Similarity values are reported in the 
range from -1 to 0 where -1 is a perfect alignment. A later report describes how multiple 
molecule overlays are achieved by scoring composite super molecules with successive 
molecules in a series (Feher  et al., 2000).  
Gaussian approximations of atomic electron density were used by Good et al, in order to 
compare two molecules on electrostatic overlap. Electrostatic potential is normally 
evaluated outside of the VDW defined surface. Electrostatic potential is the potential 
between an H+ ion at a point in space and all points of interest (charged atoms). Atom 
based Gaussian approximation with 2 or 3 Gaussian terms are used to model Molecular 
Electrostatic Potential for atoms at specified distance in space. A Gaussian expansion 
approximates a coulombic type 1/r expression. Representations are aligned using simple 
rules and least squares fitting to judge the best fit for scoring. The scoring employs the 
Hodgkin index (figure 3.1), equivalent to the Dice coefficient (Good  et al., 1992; Good  et 
al., 1993).  
Accurate, high-order, hard-sphere overlap approximations to volume and surface area 
were originally defined by (Gibson  et al., 1987) but these are computationally exensive to 
compute. Grant et. al. recognised that the volume of a molecule could be calculated much 
more efficiently if the atoms are modelled by Gaussian functions (with the function 
decaying rapidly so that the atoms are treated as “soft” spheres) rather than using hard 
spheres such as those in a CPK space-filling model. They then developed a shape based 
similarity method in which Gaussian representations are used to enable volume overlap of 
two molecules to be calculated rapidly (Grant  et al., 1995). A review article on the cross 
over from grid based to Gaussian based evaluation of MEP and volume overlap is given by 
(Good  et al., 1998). Molecules can be treated as atom based field representations using 
Gaussian or radial distribution functions to model local electron density, whereby each 
atomic nucleus has a characteristic mathematical decay function negating the need for 
large computationally intensive grid representations. Thus, grid based field approximations 
have been subsequently replaced by Gaussian based approximations to a field and also 
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hybrid approaches have been defined.  In a given molecule, atoms are modelled as 
intersecting spheres of different radii centred at the atomic nuclei.  
Reduced grids or field graph based representations such as FBSS (Field Based Similarity 
Search) employ clique detection alignment. The search is implemented and explored using 
two different combinations of representation and search approach. FBSS MEP using GA 
uses atom based Gaussian representations and is scored for MEP overlap and similarity 
after an alignment using a genetic algorithm based search. A genetic algorithm is used to 
control and explore the rotations and translations of the rigid search in order to determine 
the optimal alignment for similarity scoring between molecules. The Carbo index (figure 
3.1) is used to score, which is the common descriptor overlap divided by the root of the 
product of the identities (Wild  et al., 1996). FBSS MEP using Field Graphs employs the 
concept of a field graph. The field graph consists of maximal positive and negative MEP 
vertices extracted from the grid representation of the MEP. Two field graphs are compared 
using the Bron-Kerbosch maximal common subgraph isomorphism algorithm giving a field 
graph alignment as determined by the set of cliques evaluated. Effectively a smart search 
strategy is built around Gaussian based MEP similarity scoring (Thorner  et al., 1996; 
Thorner  et al., 1997).  
FlexS is a similarity search method which is built around the alignment technology RIGFIT - 
(Rigid body Superposition). The representation is based upon Gaussian functions as applied 
to model volume and four physio-chemical properties of atoms. Steric (VDW) contribution, 
partial charge, hydrophobic and hydrogen bond potential weightings are used to represent 
a molecule which is partitioned into rigid fragment constituents. The tool will align multiple 
sets of Gaussian fields one fragment at a time. The function is optimised using a three 
phase search which optimises rotations and translations. The RIGFIT search is the most 
complex part. After an initial process to determine a number of starting point orientations, 
the first two phases are executed and described as separate rotational and translational 
optimisations in Fourier space. Rotations are applied by quaternions and translations 
completed by the application of Fourier transforms. A further real space optimisation is 
then completed in order to fine tune the approximate alignments. The RIGFIT approach is 
that of rigid fragment placement and alignment which will align fragments and 
subsequently whole molecules. The Hodgkin index (figure 3.1) is used as a suitable 
normalised guide to optimised alignment of the Gaussian function overlap. For the latter, 
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the index indicates how chemically similar two molecules are. FlexS and RIGFIT are 
reported separately (Lemmen  et al., 1998a; Lemmen  et al., 1998b). 
The FieldAlign program by Cresset is a field graph approach which uses a reduced form of a 
grid using points defined at interaction energy extrema. An Oxygen probe atom is used to 
evaluate a scalar interaction value at 120 initial field points placed on a solvent accessible 
molecular surface. Four potential physical interactions types are evaluated at each grid 
point using equations that operate on atomic distance and charge as defined by the XED 
force field. Each point is characterised with steric, electrostatic (+/-) and hydrophobic type 
interactions thus the field point extrema are assigned an evaluated magnitude. The 
representation can thus be considered as a potential interaction grid. This initial grid is 
reduced to define a set of extrema points for each interaction type. Two field graphs 
representing two molecules are first aligned using a clique detection algorithm followed by 
least squares fitting in order to give a set of best possible starting alignments.  
The nodes are matched by type and a penalty applied for distance deviation between two 
points in the correspondence graph.  The initial alignments are simplex optimised in order 
to give the field super-position that maximises the similarity coefficient. Similarity is 
measured using a normalised field overlay measure based on the Dice coefficient which 
takes into account the magnitudes of the potential energy at the points. Points in one field 
are used to sample points in another field. This approach models potential molecular 
behaviour over space as oppose to structural similarity and thus the method is reported as 
being applicable to scaffold hopping over several target classes (Cheeseright  et al., 2006).  
In the ShaEP method, field points are annotated around a molecule according to some 
simple geometric rules such as ring normal and bond projections. At each point in the grid, 
all atoms in the molecule are used to compute an electrostatic potential using Coulomb’s 
law and a shape density value using a Gaussian representation for each atom. The 
continuous values are mapped to discrete ones in order to label the nodes and the 
representation is considered as a minimal potential interaction grid. Two field graphs are 
compared using a maximally connected common subgraph isomorphism (clique detection) 
algorithm. Vertices and edges are first compared for compatibility during correspondence 
graph construction which defines node equality by a tolerance of 0.5 between electrostatic 
potential and the dot product of the shape descriptor greater than 0.86. A distance 
tolerance of less than 1 Å for edge tolerance is applied. The cliques are optimally aligned 
using the scoring function as guide and the superposition amended using “dual 
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quaternions” which simulate a “screwing” motion of one graph relative to another. The 
aligned field points identified and mapped during the clique detection stage are scored 
using a combined weighted Gaussian/volume overlap and electrostatic score. The 
weighting used is the difference between the electrostatic potential score evaluated at 
each mapped point. These are normalised in order to give a comparable similarity measure. 
The tool is reported to overlay many crystal bound ligand coordinates with themselves with 
over half having accuracy of under 0.5 RMSD (Vainio  et al., 2009). 
An alignment dependent method, developed at Sheffield referenced in chapter 5 is 
summarised here. A molecular field representation generated by the GRID program 
(Goodford  et al., 1985) and is mapped to a wavelet thumbnail extrema representation via 
a compression algorithm that is widely utilised in the area of electronics and signal analysis. 
Input fields calculated using different probe types and at arbitrary molecular orientations 
are transformed into the compressed representation, which is subsequently aligned using 
the Bron-Kerbosch clique detection algorithm. The alignments with the smallest RMSD are 
retained as solutions to score and scoring is achieved by constructing a Tanimoto 
coefficient (figure 3.1) of the two aligned representations which yields the overall similarity 
score of query and target molecule. Compression extent was initially examined in order to 
ensure that key field information is retained in the representation (Martin  et al., 2010). 
 
3.3.7 – Shape and hybrid approaches 
 
3D Shape based methods are based on the assumption that two molecules that have the 
same volume (defined by Gaussian atom representations) are also considered to be 
equivalent in terms of shape (OpenEye, 2002; OpenEye 2008). These approaches have used 
the atom based Gaussian functions in the construction of the molecular representation. 
ROCS or Rapid Overlay of Chemical Structures is such a 3D similarity shape search method. 
Individual atoms are modelled as simple characteristic spherical Gaussian functions that are 
suitably parameterised to reflect the specific electron decay characteristics of each atom. 
This representation can be used to define an overlap between two atom types 
parameterised by distance. Once converted to a spherical coordinate representation, 
integration to give an expression for volume overlap between such atom types is 
completed.  As such obtaining the volume overlap between two atom types over discrete 
distances is relatively fast from a list of pre-evaluated volume overlap values. Both the 
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query and target molecules are initially aligned by geometric centroid. The six degrees of 
freedom (three rotational and three translational) are traversed systematically by affine 
transformations of one of the molecules and the volume overlap scoring function re-
evaluated for each superposition until a maximum is found. Clearly, this sort of alignment 
approach is potentially highly demanding computationally although ROCS addresses this 
with the use of fast look up table. A normalised Tanimoto shape similarity coefficient 
between 0 and 1 is used to score the alignment. An extension to the basic approach is 
ROCS (colour) which includes user defined chemical property overlap and similarity using 
the colour force field which is described as the “Mills and Dean” implementation (Mills  et 
al., 1996). Six types of chemical functionality are identified (donor, acceptor, cation, anion, 
hydrophobe and ring system) using Simplified Molecular Arbitrary Target Specification 
(SMARTS) and included in the alignment to give a chemical overlap score. A pH of 7 is 
assumed for the protonation state and additional bespoke Simplified Molecular Arbitrary 
Target Specification (SMARTS) definitions can be included by the user. This approach has 
been widely adopted in the industry to compare the shape similarity or volume overlap of 
two molecules (OpenEye, 2002; OpenEye 2008). In a recent development and associated 
enrichment study, the negative images of several protein active sites were extracted using 
a detailed geometric casting algorithm. This data structure termed a “pseudo ligand” was 
used to build queries in the tool Shape4 which is a shape property search tool created using 
the ROCS shape toolkits. When compared to ROCS and ROCS (colour for several target 
proteins the results were reported as comparable. This approach is an early adopter of 
integrating protein structural data into a 3D similarity approach (Ebalunode  et al., 2008). 
Some approaches are effective hybrids of grid and Gaussian field representations. 
CatShape is an example of a multi stage method that employs a volume overlap followed 
by surface fitting stage. Initially a shape database for all conformers is created that 
captures key volume and moment information for a fast shape search screen, which is used 
to rapidly filter molecules. Each molecule is orientated by its three principal moments and 
bounded in a suitable box. A set of indices including the principal moments and volume are 
generated to represent a molecule as a fingerprint and this is referred to as a shape filter 
database which is the basis for the comparative screening of molecules in terms of size and 
shape. A relatively limited search is conducted in order to maximise the volume overlap 
between two molecules. Since the molecules are already aligned, further adjustments in 
alignment are required for fine tuning and this is termed the grid based electrostatic fit 
stage of the filtered molecules. A grid is deployed and points defined within the VDW 
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surface of the molecule, as defined by a compound of spheres at each atom as well as 
points defined on the surface, are used to define a molecular volume.  The surface defined 
is subsequently used as a boundary definition in an electrostatic fitting operation. Thus at 
each surface and volumetric grid point a potential interaction energy consisting of a VDW 
and electrostatic term is assigned. The search consists of 6 minor rotations of ~5 degrees 
each and translations of ~0.5 Å. The second stage of scoring involves fitting volumetric grid 
points of one molecule into the surface bounded space and determining the VDW and 
electrostatic interaction energy between the volume grid of one molecule and the surface 
grid of another (Hahn  et al., 1997).  
Feature Map Vectors (FMV) is another example where both grid and Gaussian constructs 
are used in the representation. A grid is placed around a canonically orientated molecule 
(PMA) and grid points evaluated and assigned values according to their proximity to a VDW 
surface. Further terminal points defining shape/dimension extremes and skeleton points 
defining the molecule’s “back bone” are determined and assigned one of six chemical 
feature types as well as vectors based upon local principal moments. Chemical feature 
points are represented in 3D space each characterised by a weighted Gaussian function. A 
systematic alignment of all combinations of triangles as extracted from the terminal and 
skeleton points is completed. Geometric triangle matching (using side length and angle 
criterion) are then used to rapidly eliminate dissimilar molecules based upon vertex RMSD. 
Triangle pairs that survive this phase are promoted for feature, direction, (sub-) shape 
scoring and similarity scoring. A simple chemical feature score at each vertex for Boolean 
chemical type matching thus further eliminates alignments. A direction score is applied to 
the vectors assigned at each vertex in order to measure their divergence using the angle 
between them. The vectors represent local moments and volume distribution. A detailed 
Shape/Volume alignment scoring using the scalar field grid points is employed in order to 
determine a Tanimoto score between 0 and 1. A final feature map vector score between 
two feature maps is defined by the proximity of the overlap of weighted Gaussian 
representation aligned by sub-shape alignment. A Tanimoto coefficient is used in scoring. A 
pharmacophore elucidation and alignment phase for molecules of quite different sizes are 
found to be equivalent and indeed many active series crystal structures show large 
variation in size and features.  The feature map alignments were reported as being close to 




3.3.8 – Pharmacophore and reduced points concepts 
 
Some alignment-based similarity approaches employ the concept of pharmacophore 
classification in their construction as well as the concept of reduced points. In the MOE 
flexible pharmacophore alignment module from the Chemical Computing Group 
(www.chemcomp.com) an approach for the alignment of small molecules is stated. This 
method is a 3D similarity approach whereby molecules are aligned and scored in a multi-
objective fashion. Atoms are represented as a set of spherical Gaussians each with an 
assigned pre-factor weighting to model a particular property. Properties such as volume, 
donor/acceptor, Aromaticity, Surface exposure and physical properties such as log P and 
molar refractivity are assigned as weights (Booleans or Percentages) to each atom giving it 
a characteristic vector of features to be modelled as feature densities that decay with 
distance. Two Gaussian representations can be superposed and the feature density overlap 
can be determined using an integrated exponential product overlap expression over all 
atom combinations between each molecule. The first stage of alignment involves an initial 
overlay of three random atoms from each molecule. A random Incremental Pulse Search is 
implemented which is described as a hybrid of a random search with an energy 
minimisation. For each comparison a ceiling number of tests are defined and RMSD value is 
used to determine if a better alignment has been achieved. A good alignment is deemed as 
one that yields a maximal overlap of volume as well as all the pharmacophore and other 
properties with a minimal amount of internal strain energy. A vector of Tanimoto 
coefficients is output as a fingerprint with a similarity index between 0 and 1 for each 
pharmacophore property type. Different alignments can yield different maxima across all 
properties. A particular parameterisation whereby emphasis is placed on volume, aromatic 
and donor/acceptor feature types is reported to replicate crystal structures well (Labute  et 
al., 2001).  
A pharmacophore concept is also used in the FEPOPS (Feature Point Pharmacophores) 
method, which uses reduced point representation of a molecule (Jenkins  et al., 2004). The 
3D coordinates of each conformation are partitioned by the K-means algorithm, up to four 
points. Each point is assigned 5 features according to atom group membership. Feature 
types include physical assignments such as LogP and pharmacophore classification such as 
donor/acceptor. Four feature points are used since it is claimed these more adequately 
describe the shape than three points while retaining chirality information. Conformers are 
generated using enumerated protonation states and a suitable partial charge model 
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assigned. Conformers are merged into representatives using the clustering algorithm K-
medoids. A representative set of conformers is then mapped to vector representations 
which encode the feature types as pharmacophore type classifications such as partial 
charge and log P in addition to donor/acceptor. FEPOPS does not carry out a full alignment, 
instead alignment is simulated by imposing an order on the features in the vector according 
to the sum of charge magnitude at each point, which is used to map or align similar points 
in the query and target representations. This alignment then facilitates a Pearson 
correlation coefficient scoring approach with a linear score index between -1 and 1. 
Reduced point representations have been used in 2D similarity search methods (Gillet  et 
al., 2003) where rings and linkers were used to construct the representation. Rings are 
defined as aromatic or aliphatic rings and linkers are variable size aliphatic chains that 
connect rings and other functional groups.  
3.3.9 – Triangle matching using geometric hashing 
 
LigMatch is a ligand based reduced points method which aims to systematically match 
triangles with atom typed vertices but is related to a more complex method that also 
involves a grid representation of a protein active site. The reduced point representation is 
all the heavy atom triplets, which are extracted from the query and target “atom 
constellations” within a specified atomic distance cut-off. This yields two sets of triangle 
coordinates to be compared with each vertex containing an array of atom types present 
which are element matched using a geometric hashing approach. These atom types are 
limited to [C,N,O,S,P]. All triplets are aligned using a least squares routine which derives a 
rotational and translational matrix to align two triangles with minimal RMSD. The score is 
derived using the number of incident atoms between each triangle vertex after alignment 
and is referred to as the atom-atom score (Kinnings  et al., 2009). 
3.4 – Conformations and molecular flexibility 
 
Sir Derek Barton was an early pioneer to attribute observed molecular properties directly 
to observed molecular conformation (Barton  et al., 1956). In general a single molecule can 
adopt many distinct (and in principle, an infinite possible number of) 3D arrangements. If 
one also considers the possible tautomeric and protonation states for a molecule then this 
further increases the different 3D arrangements possible. Considering a small molecule in 
isolation (vacuum) then the rotational bonds can potentially provide complete free rotation 
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of one fragment or functional group with respect to another and thus the global flexibility 
of a molecule is often considered to be related to the number of rotational bonds present. 
However, the actual number of conformers is likely to be considerably less due to potential 
energy or steric barriers to rotation when large groups are eclipsed, whereby one fragment 
effectively physically blocks the free rotation of the other. In addition, intra-molecular 
interactions whereby a stable arrangement is adopted by forming non-bonding interactions 
between atoms or groups in the same molecule over potentially a relatively large distance 
can also control the conformations adopted. Considering the small molecule in solvent is 
also required since this is the medium in which it is normally found. Solvent effects are 
highly influential on the actual conformations adopted in solution, for example, water 
molecules can “bridge” an intra-molecular interaction. If we consider the small molecule in 
the context of approaching the receptor active site then the so called inductive effect might 
also operate. The conformation of the small molecule is changed based on its proximity to 
the receptor possibly instigated initially by long range forces such as Van der Waals. The 
electron density is gradually polarised / perturbed in the presence of the large molecule. 
Clearly, the natural conformers that are adopted by a molecule are complex to model and 
the discrete poses are often rationalised using a conformational energy argument which 
may consider several of the effects mentioned here (Leach  et al., 2007b; Smellie  et al., 
1995).  
 
Chemical databases typically consist of molecules stored as 2D topological representations 
(Leach  et al., 2007c). Chemical databases in 2D can be converted to 3D conformers by 
using a structure generation program such as CONCORD or CORINA (Sadowski  et al., 1994). 
Conformational analysis techniques are applied to generate 3D conformers using QM/MD 
and molecular mechanics techniques. Conformer generation is a computationally intensive 
process which is usually only completed once with the conformers stored. A description of 
a typical molecular mechanics force field for conformer generation is given by (Leach  et al., 
2007b). The number of conformers produced is often controlled by an energy threshold.  
 
The recent resurgence of interest in many 3D virtual screening approaches is largely the 
result of the emergence of accurate force fields  which facilitate the rapid generation of 
vast databases of artificial 3D molecular conformations (Halgren  et al., 1998). A typical 
drug-like molecule can potentially map to several hundred different discrete conformations 
over all space. Conformation generation carefully places the atom in space depending, 
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often considering both bonding and longer range non-bonding interactions. Artificial 
conformer generation protocols should reproduce the static bioactive poses as determined 
by X-ray crystallography within the ensemble of allowed conformations produced  else few 
relevant poses will be discovered (Bostrom  et al., 2003). Ideally, conformations are 
generated that consider intra-molecular and solvent effects. If such considerations are 
absent then such approaches may not be ideal for virtual screening if they do not consider 
the conformations adopted in solution.  
The methods by which conformational flexibility is handled, is thus a further facet of many 
3D similarity search approaches and a common aim is to extend standard rigid search to 
incorporate flexible search, to account for inherent molecular flexibility. In this way, it is 
assumed that the molecules are being modelled more accurately by including some or all of 
the possible conformations they can adopt. Flexibility is normally modelled in one of two 
ways. The first method, implements single torsional bond rotations at a specified resolution 
in order to define the possible conformers of a single molecule and this is often completed 
at program run time.  Examples of tools that adopt this flexible search approach are 
FlexS/RIGFIT, MOE (random or pre-defined rotations are inherent in the search strategy), 
FEPOPS (VDW clash are eliminated and similar conformers merged) and FBSS (torsional 
angle steps are built into GA chromosomes) which all implement flexible search in this way.  
The alternative and more often adopted approach is to use a set of conformers which are 
enumerated in advance and this is usually termed as the “ensemble approach”. Such 
conformers are often required to be significantly different, normally using RMSD or energy 
as a measure of the difference of each individual conformer and thus a representative set 
of conformers is possible. Each conformer is then individually scored using a rigid search 
method and results summarised. Examples of tools that adopt this approach are ROCS, 
SEAL / Catshape (a diverse representative set is used in both these cases), ShaEP, LigMatch, 
Feature map Vectors, Surface patch alignment, Pharmacophore keys (ensembles of 
conformers are mapped to bins) and FBSS (field graphs). Flexibility adds significant 
computational overhead since more data states are required to be processed. In theory, 
flexible search is a more accurate model of possible real molecule behaviours but in reality 
the gain in accuracy is currently difficult to quantify. The accuracy of the molecular overlay 
of several important approaches is discussed relative to experimentally derived X-ray 
crystal structures and initial choice of query template is found to be more influential than 
the actual alignment method. Further to this, the accuracy of molecular overlay can 
actually decrease dramatically when introducing flexible search (Chen  et al., 2006b).  
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3.5 – Evaluation and comparison of 2D and 3D methods 
 
Despite the 3D nature of molecular recognition, an important study has shown that 2D 
representations such as DAYLIGHT, UNITY2D and MACCS show a greater propensity to 
resolve actives from decoys in virtual screening experiments when compared to 3D 
similarity methods (Brown  et al., 1996). Of the 3D methods investigated, interestingly it 
was noted that the 3D potential pharmacophore points (PPP) approach which encodes 
atoms that can form non-covalent interactions and other inherently 2D information into 
three point triangle representations, tended to give results comparable to 2D descriptors.  
ROCS and the colour force field is considered as another bench mark method for 3D 
similarity searching. This approach is based upon molecular volume overlap additionally 
including Nitrogen and Oxygen chemical properties. The accuracy of ROCS, FlexS and SEAL 
are compared and discussed in the study by (Chen  et al., 2006b). The first two approaches 
(ROCS/FlexS) are found to be equivalent in terms of method overlay accuracy and the 
quality of the input query molecule used as template was determined as the most 
important factor in achieving sensible replication of the X-ray determined ligand 
coordinates. A comparison of several field based (Gaussian and grid based) search tools 
CatShape, FBSS, ROCS is given by (Moffat  et al., 2008). It was shown that ROCS colour and 
UNITY 2D fingerprints actually gave the best results and also that flexible search only yields 
marginal improvements over rigid search. The method FEPOPS, which also employs a PPP 
approach (with four points deemed as appropriate to resolve chirality) is stated as giving 
results that are comparable to 2D methods such as DAYLIGHT and MACCS fingerprints 
(Jenkins  et al., 2004).  Molprint3D results are reported as being comparable to 2D 
fingerprints (Bender  et al., 2004). 
3.6 – Summary 
 
This chapter has aimed to discuss 3D similarity concepts and present an overview of a 
range of 3D similarity approaches that have been developed and adopted in rational drug 
design. The majority of 3D similarity methods aim to achieve an alignment of surface, 
volume (and by implication shape) or chemical properties such as electrostatic fields. A few 
are alignment independent and have been developed with an often stated increased 
performance as a significant benefit. However, it is questionable if any of these methods 
resolve chirality sufficiently. Summary level approaches that aim to introduce speed 
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enhancements are also emerging but their use is questionable, since accuracy relative to 
the full atom shape description and scores is not apparent (Nicholls  et al., 2010).  
Application of flexible search often does not improve results. Sub-shape search methods 
are rapidly emerging since frequently only fragments of a given active molecule are actually 
involved in the molecular recognition and binding with the rest of the molecule being 
solvated in water. This is a particularly important consideration in a pharmacophore 
hypothesis or elucidation phase since a global similarity alignment may not achieve the 
correct contextual pharmacophore overlay. The use of rectilinear grids for representing 
fields has been replaced by atom based mathematical functions which simulate molecular 
fields by modelling electron density. The introduction of “field graphs”, molecule grid 
representations of extrema points, which are relatively reduced in size and only include key 
energetic points over space, is another more efficient way to model the interaction 
potential and spatial environment about a molecule. The next chapter presents a novel 3D 
similarity summary level approach that aims to compare molecular volume and biological 
property distribution (Pharmacophores) overlap using two distinct alignment methods. A 
further discussion on evaluating the effectiveness of similarity search methods is briefly 
















Chapter 4 - Reduced points fuzzy pharmacophore vector 
representations and their usage in 3D similarity scoring functions and 
molecule correlation vectors 
4.1 – Introduction and method context 
 
This chapter presents a novel ligand-based 3D similarity search approach which endeavours 
to solve the problem of identifying 3D equivalences, between biologically active molecules. 
This approach is suggested as a hybrid shape/pharmacophore search method and is 
described in terms of the molecular representation, the alignment methods applied to pairs 
of such representations and the scoring function applied to two superposed 
representations which evaluates the quality of the alignment. The molecular 
representation is described as “Reduced points fuzzy pharmacophore vectors” and is a 
summary description of a molecule in terms of shape and pharmacophoric properties 
distributions. Since there will generally be fewer points in the representation than atoms in 
the molecule this is considered a reduced point representation. The term “fuzzy” is used 
since the representation reflects an amount of pharmacophore type character in a 
specified region of space (volume) and thus crudely models the presence of electronic 
characteristics relevant to biological interactions. An alignment-based approach is 
considered necessary in order to be able to resolve the important drug-like molecule 
property of chirality (Leach  et al., 2010) by the use of volume (implied shape) and 
properties overlap. The defined points generally represent molecular fragments, each with 
a specific amount of pharmacophore type character, rather than atoms or functional 
groups as is the case with many other similarity methods (OpenEye  et al., 2002; Rhodes  et 
al., 2003).  
The use of K-means to derive a reduced representation is also employed in the FEPOPS 
method as described in chapter 3 (Jenkins  et al., 2004). FEPOPS alignment and scoring 
features make it significantly different to the method described in this chapter, confirming 
the novelty of this approach (Please refer to the description in section 3.3.8). The main 
difference in this approach is that a full alignment is carried out with the resulting 
alignment scored on volume and property overlap. Also FEPOPS is restricted to four point 
representations, whereas here represenations of up to six points are explored in order to 
investigate the optimum level of reduction. The field graph approach described in chapter 3 
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by (Thorner  et al., 1997) is also based on reduced points and although there are similarities 
with the alignment methods used, the representations are completely different. Here all 
atoms are represented whereas the field graph approach is based on extrema, extracted 
from the molecular electrostatic potential.  
4.2 – Overview of method 
 
Initially, the atomic coordinate data for a given molecule are partitioned in 3 dimensions 
using a deterministic K-means algorithm into a user-defined number of K atom clusters 
each represented as a point in 3D space.  Each point defined by the K-means is the 
geometric centroid of the atomic coordinates of the cluster. Each point is represented as a 
sphere with radius determined as the average distance from the centroid to the 
constituent atoms in the given cluster. Each point also has an associated data vector which 
describes the key information about the point including the amount of potential interaction 
behaviour classified by five pharmacophore types which are hydrophobic, aromatic, 
acceptor, donor and hydrophilic. For each point and each pharmacophore type a 
percentage by mass of the atoms present that can exhibit such behaviour is derived using 
the mass of each atom in the cluster. By varying K, different levels of representation are 
possible ranging from a single point and associated vector (K=1) representing a whole 
molecule, up to as many points and associated vectors as there are atoms in the molecule 
so that each point can represent a molecule, a molecular fragment or an atom.   
Any number of target molecules T of interest can be represented in a similar way and then 
pair-wise comparison to a query molecule Q is possible via a suitable alignment approach 
and scoring method. Two pair-wise alignment methods are implemented and investigated. 
One is a systematic exhaustive approach which is based upon iterative triangle and 
tetrahedron matching. The other method, which is potentially more efficient and scalable, 
implements two well established algorithms in Chemoinformatics. A correspondence graph 
is constructed between two reduced point representations (simple graphs) and the Bron-
Kerbosh algorithm (Bron  et al., 1973)  is used to search the correspondence graph and 
identify cliques which represent mappings between the representations. The Kabsch 
algorithm (Kabsch  et al., 1976) is then used to align the representations to a minimal RMSD 
arrangement based on the clique mapped points. In both cases the resulting alignments are 
scored using both a simple geometric volume (sphere overlap) and a volume score that is 
weighted by pharmacophore properties.  
 Figure 4.1 below presents an illustration of the basic representation employed. The more 
alike two molecule objects are in terms of their size, volume (and by
increasing K) and chemical property distribution, at any specified level of description, then 
the higher the similarity score should evaluate to at that level. A fundamental assumption 
is that volume, shape and distribution 
 
 
Figure 4.1 - From random starting 
constructed for the query Q and target T molecule.
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molecular orientation, weighted graph
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 4.3 – Molecular representation
4.3.1 - K-means basic partitioning approach
 
The K-means is a general purpose algorithm used in statistics and machine learning which 
can be used to find the natural
basic set of 3D points to represent a molecule, its heavy atom
partitioned using the basic K
points each of which represents 
3D reduced points molecular representations was implemented by 
order to identify active sites within protein structures. See figure 4.2 below for application 
of K-means to a 3D molecule
retain natural pharmacophore elements such as rings 
possible that atoms that constitute 
reduced points. Single atom clusters are 
figure 4.2 it does a reasonable job depending upon the 
the effects of this phenomenon can be found in 
Figure 4.2 - The molecule 
K-means algorithm (heavy atoms
average cluster distance.
There are two ways in which the K
conditions and these are
approach, K random seed points 




 cluster centres of a given data set. In order to derive the 
ic coordinate
-means algorithm. This effectively defines the molecule as K 
one cluster of atoms. The first use of K
(Glick  et al., 2002)
. The K-means partitioning approach is not 
or chemical functional groups
such substructures can be separated
another possible artefact. In most
judicious choice of K.
the results chapter 5. 
 
“Nevariprine” is partitioned into 4 points using 
 only (non-Hydrogen)). The sphere radi
 
-means algorithm is approached depending upon starting 
 deterministic and non-deterministic. In the non
are generated in the vicinity of the molecule and are 
when random starting points are used a different solution 
s are initially 
-means to generate 
 in 
guaranteed to 
. It is 
 into different 
 cases such as 
 A discussion of 
the deterministic 




(from a possible set of solutions) is possible each time the algorithm is run - one of which 
may be the deterministic solution. The “Lloyds” algorithm (Lloyd  et al., 1982) is a 
deterministic approach that always produces the same solution and so is the more suitable 
option for this method during algorithm development. The set of K points is determined in 
an iterative (deterministic) fashion as follows. In the case where K equals one then a single 
point is simply the geometric centroid of all atoms determined by the average coordinate 
over each of the three dimensions x,y,z as in equation 4.1 below. 
Equation 4.1 
Kx, y, z =$xn

&'
, yn , zn 
Where K is the derived geometric centroid with coordinates, x, y, z	and n is the 
number of atoms in the molecule. x, y and z are the ith atomic coordinates. 
If K>1 an iterative refinement procedure is performed to identify successive points that 
succinctly represent the input molecule in terms of natural data clusters.  
1. The initial seed point (K=1) used in the partitioning is the geometric centroid 
(equation 4.1) determined over all atoms and thus all atoms are members of the 
initial cluster. 
2. Next, the atom is identified that is furthest from its parent centroid point and is 
considered as the next seed point. 
3. All atoms are then re-assigned to the point that they are closest to. In this way new 
cluster membership is defined including assigning atoms to the new seed cluster 
point. 
4. Each point K is then re-positioned to be the geometric centroid of the atoms that it 
now represents  
5. Steps 3 and 4 are then iteratively repeated until the points converge, that is until 
step 4 (above) no longer produces any change in the K point placements. The 
variance is the within-cluster sum of squares and is a minimum as specified in 
equation 4.2. Each cluster point k in K has an exclusive set of atom elements j 
associated with it. Each atom can only belong to a single cluster and sharing is not 
permitted between clusters in the standard algorithm.  For each new level of K the 




The basic K-means approach can naturally lead to fragments in the molecule that are quite 
different in size and thus comparative scores between molecules may become artificially 
low. Suggested extensions to the basic K-means approach are described in chapter 6 as 
such improved annotations are likely to be an immediate next requirement for 
substantially improving the results for this approach. The K means algorithm minimises the 
variation in the set at each point and Equation 4.2 is effectively minimised over all points K 
in order to achieve a global optimum solution. 
Equation 4.2   






Where J is the within-cluster sum of squares, K is the number of cluster points used to 
represent a molecule, S+ is the set of atoms in cluster k and a+ is the ith atom in S+.  
4.3.2 - Fuzzy Pharmacophore point classification vector (characterisation) 
 
Each point k of K is assigned a characteristic vector which describes the pharmacophoric 
character of the point based on the atoms that the point represents. Five categories of 
pharmacophore classification are considered and contributions are derived by summing 
over each atom in the cluster. These are hydrophobic, aromatic, acceptor, donor and 
hydrophilic. In order to model the amount of pharmacophore at a point k, heavy atom 
(non-Hydrogen) atomic masses are used to contribute to a percentage by mass for each 
pharmacophore type classification. This approach is used in the first instance, since it is 
assumed atomic mass is a reasonable method to model the proportional amounts of 
constituent atoms and thus matter composition or density within a sphere. A complexity is 
that atoms can contribute to more than one type in a single point, a typical example being 
aromatic carbon which is both hydrophobic and aromatic. Mappings from atoms to 
classification types are achieved using the SMARTS definitions. In addition the x, y and z 
coordinates for the point and the scalar radius value r are also stored in the vector. The 
latter is the radius of the sphere centred at the point and is evaluated as the average 
distance from the point to each member atom. In the relatively rare case where a point 
represents a single atom then the VDW radius for the atom type is used as default radius. 
This vector of attributes is subsequently required in calculations at both the search, 
alignment and scoring phases which follow in this method. Each pharmacophore type has a 
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value between 0 and 100% which is the mass of the atoms that can match the type divided 
by the mass of all the atoms represented by the point. For example a benzene ring would 
yield 100% in both the aromatic and hydrophobic classes and 0% in the other three classes 
i.e. the values assigned across all classes do not sum to 100%.  There is no “charged” 
pharmacophore type defined, rather it is suggested later that assigned charges should be 
treated separately in order to derive a complementary field based score for each point k 
(see chapter 6 on suggestions for further work). In summary, each point k in a molecule’s 
representation is characterised as shown in figure 4.3 below. A summary of the steps to 
generate the representation is depicted in the flow diagram in figure 4.4.  
Hydrophobic - Carbon in any hybridisation state and any Halogen (Cl,Br,I and F) atoms PHO.  
Aromatic - Aromatic Carbon, Nitrogen, Oxygen or Sulphur atoms ARO. 
Acceptor – Nitrogen, Oxygen or Sulphur atoms with/without implicit H atoms ACC. 
Donor - Nitrogen and Oxygen only with implicit H atoms DON. 
Hydrophilic - Nitrogen and Oxygen atoms PHI. 
	[x, y, z, r, 4%PHO9, 4%ARO9, 4%ACC9, 4%DON9, 4%PHI9] 
Figure 4.3 - Pharmacophore classes and the characteristic vector defined for each point. 
Heavy atoms such as Chlorine and Iodine are included in the hydrophobic pharmacophore 
classification. Inclusion of these atoms could have a significant effect on the % by mass 
value assigned for a point and subsequently the evaluated scores and observed results. The 
occurrence of Iodine in drug-like molecules is relatively low and so it is assumed this effect 
would be relatively rare but Chlorine atoms occur frequently (Corey  et al., 2007). Effects 
relating to Chlorine/Iodine are discussed in the results chapter 5 for data sets containing 





Figure 4.4 - Flow diagram for the assignment of a characteristic vector for each reduced 
point from initial input molecule or existing representation.











aliphatic atoms whereas lower case indicates aromatic 
 
 in the 
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4.4 - Search and alignment approaches employed 
4.4.1 – Two alignment methods are investigated 
 
Two alignment methods are compared in this study. Each alignment method is applied to a 
pair of “Reduced point fuzzy pharmacophore vector” representations in order to identify a 
suitable superposition to score. The first approach can be considered to be an exhaustive 
triangle and tetrahedron alignment which uses the Euclidean origin 0 as well as the 
common axes (+Z) and planes (+YZ) as reference alignments. In order to compare two 
different (potentially scalene, different sides and angles) triangles (3 points) exhaustively 
where one is held static and the other is moved requires consideration of six separate 
alignments with potentially different associated scores. In order to compare two 
tetrahedrons (4 points) exhaustively, each of which contains 4 triangles, requires 4 * 4 * 6 = 
96 discrete alignments.  Above 4 points the number of alignments is too large to consider 
exhaustively and thus the systematic approach only deals with three or four point 
representations in this study. Aligning triangles in this way is significantly faster than the 
clique approach described below hence it provides a useful alternative method with which 
to compare to the clique approach. 
The second method is a combination of applied graph theoretical techniques and the 
Kabsch alignment algorithm. In this method a correspondence graph between two reduced 
representations is processed by the Bron-Kerbosch clique detection algorithm to identify 
cliques. The molecules are aligned by applying the Kabsch algorithm which operates on a 
set of mapped clique points to determine the transformations required in order to 
minimise the RMSD between the points defined by the clique mapping. The transformation 
is applied to the entire representation of one molecule in order to align it with the other 
molecule. The graph based approach is applicable to any number of points in the 
representation and so can align and score representations consisting of more than four 







4.4.2 – Alignment method using clique detection and Kabsch algorithm 
4.4.2.1 - Correspondence graph(s) 
 
In order to generate an alignment for scoring, a correspondence graph is constructed using 
the reduced point representations of two molecules. The two input molecular 
representations can each be thought of as simple graphs. The correspondence graph is a 
representation of all the possible valid mappings between the two input representations at 
a specified parameterisation. The correspondence graph is based upon node and edge 
equivalence rules. Each node in the correspondence graph represents a pair-wise mapping 
of points: one from each input reduced point representation. Edges are placed in the 
correspondence graph if the user-defined distance tolerance is satisfied by the node 
member points.   
4.4.2.2 - Node type equivalence 
 
Each node in one input graph is compared with each node in the other based on the vector 
of properties assigned at each node, which include the pharmacophore properties and the 
sphere radii. Different levels of node equivalence are possible. Figures 4.5 to 4.8 describe 
the equivalence modes. Successfully mapped input graph nodes represent a single node in 
the correspondence graph. The ‘~’ operator used below denotes the specified test, if both 
are equal to zero or both are > 0%. 
Volume mode - No pharmacophore equivalence constraints are enforced for any node 
mapping. This is the least strict setting which will generate many node mappings in the 
correspondence graph. See figure 4.5 below. In order to limit the score to spheres of a 






 Figure 4.5 - Volume mode defined
Radius tolerance - A radius tolerance is used in the node equality test so that the 
difference in radii between the two points is within a certain specified tolerance (figure 
4.6). Thus spheres that have dissimilar radii are not valid mappings and do not result in 
nodes in the correspondence graph. 
Figure 4.6 - Radius tolerance
Partial mode – The node equivalence test treats each pharmacophore type as a Boolean 
value with true indicating that the % by mass for that type is > 0 and false indicating that % 
by mass is 0. The numerical values are used later in scoring. Partial mode then treats two 
nodes A and B as equivalent if the Boolean values for PHO or ARO are the same and 
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 defined. 
ACC, DON or PHI are the same. See figure 4.7 which 





Figure 4.7 - Partial mode defined
Exact mode – The node equivalence test also treats each pharmacophore type as a Boolean 
value (present or absent). Two nodes A and B are considered equivalent if the values for all 
five pharmacophore types are the same. This is the strictest setting which should
the fewest node equivalences and smallest correspondence graphs. S
shows the AND/OR logic implemented














ee figure 4.8 which 







) specified as in 
FAND	PHID~PHIF 
 4.4.2.3 - Edge distance tolerance   
 
Edges are formed between nodes in the correspondence graph based upon distances in the 
input graphs and using a specifie
shows two correspondence graph nodes. Node A1
A1 in molecule A and node B1 in molecule B. Similarly another mapping exists between A2 
in molecule A and B2 in mole
difference in distance between the nodes A1 and A2 in molecule A
between nodes B1 and B2 in molecule B
Figure 4.9 - Edge tolerance defines if an edge is placed in the correspondence graph
It is important at this stage that 
form.  An edge cannot be placed under any circums
either of the input graphs (figure 4.10).
 
Figure 4.10 - Self reference nodes are invalid and are not allowed to form
Figure 4.11 shows a flow diagram of events to generate a correspondence graph.
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d distance tolerance dKL parameter
-B1 represents a mapping between node 
cule B. An edge is formed in the correspondence graph if the 
, 	dD	
, 	dF	, is less than the specified distance tolerance
  dD~dF	if	|dD − dF| 	J 	dKL 
 
edges involving self referencing nodes are not allowed to 
tances for a node back to itself from 
 
. Figure 4.9 







 Figure 4.11 - Flow diagram for
Vertex and edge equality rules are described in 4.4.2.2 and 4.4.2.3.
The construction of a correspondence graph from two input graphs is illustrated in figure 
4.12 below.    
Figure 4.12 - A correspondence graph
specified node and edge tolerance
for mapping with each node in representation B (B1
for distance tolerance 
case are A1-B1,A1-B3,A1
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 correspondence graph node and edge mapping logic
 
 is formulated using both representations 
s. Each node in representation A (A1
-B4). Surviving nodes






-A4) is compared 
 are then tested 
-B1,A4-B2,A4-B4. 
 Finally the correspondence graph is available for input into the Bron
detection algorithm to search and identif
prior to point alignment and overlap scoring.
4.4.2.4 - Bron-Kerbosch clique detection algorithm
 
The set of maximal cliques as identified by the Bron
is then extracted from the correspondence graph for subsequent alignment and scoring.  
The maximal cliques are defined as the set of cliques that 
cliques. The Java implementation for the Bron
(Samudrala  et al., 1998)
algorithms is given by (Johnston  et al., 1976)
identification. 
 
Figure 4.13 - The set of 
correspondence graph.
4.4.2.5 - Kabsch pair-wise
 
The Kabsch algorithm (Kabsch  et al., 1976)
vector that will align two sets of points for which a 1:1 mapping exists so that the RMSD of 
the mapped points is minimised. The translation vector superimposes the geometric 
centroids of the points represented in the extracted clique since the geometric centroids 
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-Kerbosch clique 
y all the maximal connected sub
 
 
-Kerbosch (Bron  et al., 1973)
are not subgraph
-Kerbosch algorithm used is that of
. A further detailed account of Bron-Kerbosch and clique 
. Figure 4.13 aims to demonstrate clique 
maximal cliques is identified and extracted from the 
 In this case, the isolated green triangle shown 
 alignment algorithm 
 identifies both a rotation matrix and translation 
graphs or cliques 
 algorithm 
s of any other 
 
 
is a maximal clique.  
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must be first aligned in order to determine the correct rotation matrix U. The maths 
required to extract this rotation is relatively straightforward and is quite well known in this 
field and is briefly described below. The Kabsch algorithm has been used more extensively 
in Bioinformatics than Chemoinformatics applications and was briefly mentioned in 
Chapter 3 as a component of another 3D alignment method (Baum  et al., 2006). The sets 
of points in each representation that constitute the clique mapping are aligned from their 
respective starting positions so that the RMSD between the mapped points is minimised. 
The Kabsch algorithm is achieved by completion of the following steps: 
1. Let CQ be the n by 3 matrix whose rows are the x,y,z coordinates of the mapped 
points in Q and CT be the n by 3 matrix whose rows are the x,y,z coordinates of the 
mapped points in T, where n is the size of the clique. CQ and CT are placed in the 
same reference frame by translating the centroid of each to the origin 0. 
2. A 3 × 3  covariance matrix M = CP	Q	CQ is formed (NB T   indicates matrix transpose). 
M will capture the extent to which the ordered input data CQ and CT exhibit 
variance. The singular value decomposition theorem (Press  et al., 2007) states that 
M can be written as in equation 4.3.  
Equation 4.3 
M = V. S.WQ 
Where V is the left singular vectors (eigenvectors or MMQ), W is the right singular 
vectors (eigenvectors of MQM). S is the square roots of the eigenvalues of either 
MQM or MMQ. S (or the diagonal of S) is known as the non-zero Singular values. 
3. The sign of the determinant d of M is then extracted. 
Equation 4.4 
d  signdeterminantM 
Where M is the covariance matrix. 
4. Matrices from the singular value decomposition are re-cast to give the required 
matrix U, also called the “rotation vector” U in equation 4.5. The rotation is 
subsequently applied to the target representation to minimise the RMSD with the 
query.   
 
 Equation 4.5  
Where matrix U defines 
Figure 4.14 illustrates the 
 
 
Figure 4.14 - Diagram depicting K
from each four point representation
4.4.2.6 - Overall workflow using Bron
alignment 
 
In summary, in order to generate an alignment for scoring two “Reduced 
pharmacophore vector” objects  the two simple graph representations are input into a 
correspondence graph construction stage, with specified user parameterisation (node 
equivalence and edge distance tolerance). Next, the correspondence graph is
the Bron-Kerbosch clique detection algorithm and the set of maximal cliques which are 
greater than or equal to size 3 are extracted. Finally all sets of paired points in the cliques 
identified above are input into the Kabsch algorithm and the
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the required rotation to align CT with CQ with minimum RMSD
Kabsch alignment as described by the steps above. 
absch alignment of clique contributing nodes
.  
-Kerbosch clique detection followed by Kabsch 






 treated with 
 alignments are scored according to the volume and property scoring functions discussed in 
section 4.5. A summary diagram of the overall workflow is given in figure 4.15. 
Figure 4.15 - Flow diagram for
alignment. 
4.4.3 - Systematic exhaustive alignment
4.4.3.1 – Alignment up to 
 
An exhaustive systematic alignment approach was also developed in order to align two 
representations by points/sphere centroids. This was achiev
origin, axes and planes as common alignment references prior to scoring. In this way an 
alternative search method could act as a comparative benchmark for the graph based 
alignment approach for 3 and 4 point representations.  It i
representations above 4 points would become computationally very difficult indeed since 
the number of combinations of possible alignments soon expands to an untenable number 
of comparisons. For each level of representation the ali
optimisation approach was also implemented and is discussed. 
the alignment of up to 3 or 4 points easily and in this context can be thought of as triangle 
or tetrahedron matching
adopted both historically and in more contemporary methods




 correspondence graph, clique detection and Kabsch 
 
four points 
ed by using the Euclidean 
s clear that to align two 
gnment is described below. An 
Systematic search will allow 
. Three and four point molecular representations have been 




 4.4.3.2 – Single point alignment
 
The query is aligned to the target molecule by placing each point on the universe origin via 
a single translation of each representation to the origin 0 
 
Figure 4.16 - Single point (
4.4.3.3 – Two point alignment
 
Two molecule representations are aligned by placing one point on the universe origin and 
the other point/node projecting along the +Z
required to compare two representations for this level 
can be rotated about its mid
applied by nudging the smaller of the two representations along the +Z
larger of the two representations and then re
a single translation and two
configurations. See figure 4.17.
Figure 4.17 - Two point (
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– see figure 4.16.
 
K=1) alignment.  
 
-axis. There are two possible arrangements 
whereby one of t
-point by pi and re-aligned. Simple optimisation can also be 
-scoring. A two point representation requires 






-axis within the 
 4.4.3.4 – Three point alignment
 
Two molecule representations are aligned by placing one point/node on the universe o
0 with another point/node projecting down the +Z
the +YZ plane. There are 
triangle is scalene (no equal sides or angles) and that each point/node 
follows that if one triangle is held static
to superimpose another 
nudging the smaller of the two representations defined on 
the two representations and then re
translation and two rotations followed by a torsion angle plane rotation in order to initially 
align correctly for each configurati
 
Figure 4.18 - Three point (
4.4.3.5 – Four point alignment using sets of three points
 
Two molecule representations are aligned by placing one point/node on the universe origin 
0 with another point/node projecting dow
plane. Finally the fourth point will exist somewhere else in the 3D Euclidean space. As 
described above, there are 
three point representations.
in nature. In each tetrahedron there are 4 triangles and thus 
compare all combinations of triangles 
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-axis and the third point/node placed in 
six possible ways to place a single triangle, assuming that the 
is different. It 
 then there are six possible combinations 
three point representation. Optimisation can also be applied by 
the +Z-axis within the larger of 
-scoring. A three point representation requires a single 




n the +Z-axis and a third point placed in the +YZ 
six possible arrangements to align and compare two different 
 An assumption is made that all points are potentially different 
4 * 4 * 6 = 
in one tetrahedron with all combinations in another
rigin 
required 
96 possible ways to 
. 
 A four point representation requires a single translation and 
torsion angle plane rotation in order to initially align each triangle correctly within each 
tetrahedron. See figure 4.19.
Figure 4.19 - Four point (
4.4.3.6 – Torsion angle for alignment of two planes
 
In the case of 3 and 4 point representations a torsion angle is required which is defined 
between two planes in order to rotate the plane defined by 3 points into the +YZ plane. 
This requires finding the surfa
the +Z-axis and the point that is to be aligned with the +YZ plane. Both planes share the 
common vector +Z-axis at this stage in the processing and the angle between the planes 
defines the rotation required. See equation 4.
Equation 4.6 
Where ω is the angle defined between two planes
n_F respectively.  
4.4.3.7 – Optimisation along the +Z
 
As mentioned an optional optimi
than 1 i.e. 2, 3 and 4. One set of points that is placed on the +Z







ce normal between the +YZ plane and the plane defined by 
6. 
cosω = 	n_D.		n_F 
 A and B with normal unit vectors 
-axis 
sation step is possible for representation levels greater 
-axis can be nudged along by 
-evaluated. This can actually occur for every triangle 
s followed by a 
n_D and 
 and tetrahedron alignment ensuring the optimisation is attempted for all alignments. The 
default setting for this increment is currently 0.01. Figure 4.20 illustrates this additional 
translation of the representation along the Z
Figure 4.20 - Optimisation along the +Z
increment. 
  
4.5 - Scoring function and similarity 
4.5.1 – Scoring method and alignments
 
Given two aligned representations 
the quality of the alignment. This is achieved by evaluating either a volume
a volume and properties overlap 
clique size is also reported and will be ident
score, since the cliques are extracted prior to scoring. Since three points are needed in 
order to generate an alignment, cliques of size less than three are eliminated with scores 
set to zero. These score se
compared for the given alignment. 
alignments irrespective of how the alignment was achieved. The best score witnessed for 
each of the volume and property objectives is retained and reported hence it is possible 
that the maximal volume and properties scores are obtained from different alignments, 
however all scores will be based on the same clique size. It is important to distinguish 
between the ways the scoring might be employed for the shape and sub
the Clique / Kabsch approach. The sub
scoring whereas the shape mode considers the entire representation. The variation 
possible within the basic scoring model is now elucidated.
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-axis in order to optimise the alignme
-axis by shifting one representation by a small 
coefficient 
 
then the superposition obtained can be scored to assess 
score. For the Clique / Kabsch approach the identified 
ical in size for both the volume and properties 
ts measure the 3D similarity between the two molecules being 
The scoring scheme is applied in an identical way to all 




 overlap score or 
-shape scoring in 
 4.5.2 – Sphere volume overlap function
 
For an alignment of two
derived from two molecules, query Q and target T then a
sphere overlap is defined by equation 4.
Equation 4.7 
Where x,y,z and r are the coordinates and radii of spheres
The radius of each sphere i
atoms in the cluster point. If the two spheres do not overlap then they do not contribute to 
the overlap score and SOV
Equation 4.8 
Where d is the distance between two spheres j and k and
Figure 4.21 - No overlap
If two spheres overlap, then the common overlap volume is based upon the distance
between the two sphere centroids and the radius of each sphere. This volume can be 
thought of as the sum of the two lens cap contributions that define the discus of the sphere 
intersection as illustrated in figure 4.22. 
defined as shown in equation 4.
Equation 4.9  
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 “Reduced point fuzzy pharmacophore vector” 
 simple initial “Boolean” tes
7. 
(xb – x+2 + (yb – y+)2 + (zb – z+)2   < (rb+ r+)2 
 j and k, one from each molecule.
s defined by the average distance between the centroid and the 
b+  0. Equation 4.8 is satisfied and figure 4.21 shows the case.
d   >= rb+ r+ 
 rband r+ are the 
 
 and no score contribution. 
The distance between the centroids 
9. 





radii of j and k 
 
for j and k is 
 Where d is the distance and x,y and z are the coordinates of two spheres j and k
respectively. Two spheres give a volume overlap
4.10 which is derived from a simpler 2D circle
al.). 
Equation 4.10  
SOVb+  πer
Where d is a non-zero distance 
spheres j and k respectively
Figure 4.22 - Sphere overlap geometry
If two spheres overlap, and the sphere centroids are exactly aligned as in figure 4.23, then 
the common overlap volume is the volume of the smaller of the two spheres based upon 




Where rband r+	 are the radii of two spheres j and k respectively
Figure 4.23 - Sphere centroids are exactly aligned
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 SOVb+	according to the following equation 
-circle intersection approach
b  r+  df-d- + 2drb  3rb-  2dr+  6rb  r
12d
as defined in equation 4.9 and rband r+	
. SOVb+ is the volume overlap.  
 
. 
 One of the variants in equation 4.11 below is used.
	expression	r+ 	i 	 rb	is	true	then		SOVb+  43 	π	








 (Weisstein  et 
+  3r+-
 








A molecule overlap volume (MOVPQ) is thus definable as a summation of sphere overlap 
values over all spheres in query (Q) and target (T). as shown in equation 4.12 below. 








Where MOVPQ is the summation over all combinations of points J and K in the query Q and 
target T, respectively. 
4.5.3 – Normalising the volume scores and Tanimoto coefficient 
 
Finally the molecule overlap volume is normalised in order to give a Tanimoto index 
norm_MOVPQ as in equation 4.15, with a value between 0 and 1. The query and target 
volumes (VP,VQ) used in this equation are the summation of sphere volumes as in equation 






Where VPis the total volume, J is the number of spheres defined, for query molecule Q.  





Where VQ is the total volume, K is the number of spheres defined, for target molecule T. 
Equation 4.15  
norm_MOVPQ = MOVPQVP + VQ −MOVPQ 
Where norm_MOVPQ is the Tanimoto or normalised coefficient for overlap of molecules Q 
and T. VP and VQ are described above. norm_MOVPQis referred to as the volume score V, in 
chapter 5.  
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4.5.4 – Percentage pharmacophore type weighted overlap function 
 
In addition to a pure volume overlap score, a properties overlap score can also be derived 
by using the % by mass value for each pharmacophore type in each of the points in the 
“Reduced point fuzzy pharmacophore vector” representations. Thus, the notion of a fuzzy 
property distribution is modelled and scored, by multiplying the volume overlap of two 
spheres using the percentage by mass for each pharmacophore type. If no such interaction 
type exists (% by mass equals zero in either representation) then a score of zero will be 
evaluated for that interaction type. This scoring should give a good indication of the 
overlap of biological property distribution for each alignment. The overlap volume of 
spheres j and k weighted by property is given in equation 4.16. 
Equation 4.16  
PHO_SOVb+ = Qb%massqrs × T+%massqrs × SOVb+ 
Where PHO_SOVb+ is the mass weighted volume overlap using Qb and T+ % by mass for the 
Hydrophobic (PHO) pharmacophore type. 
The overlap of molecules Q and T weighted by pharmacophore property is achieved by 









Where PHO_MOVPQ is the summation over all combinations of points j and k in the query Q 
and target T respectively and PHO_SOVb+ is the mass weighted volume overlap of the j th 
and k th spheres, for the Hydrophobic (PHO) pharmacophore type. 
This score is then normalised to between 0 and 1 by evaluating the identity equivalent of 
the pharmacophore type for the query Q and target T (equation 4.18, 4.19 and 4.20).  
Equation 4.18 






Where PHO_MOVP is the volume of the query molecule Q. 
Equation 4.19 




Where PHO_MOVQ  is the identity volume of the target molecule T. 
Equation 4.20 
norm_PHO_MOVPQ = PHO_MOVPQPHO_MOVP 	+ PHO_MOVQ − PHO_MOVPQ 
Where norm_PHO_MOVPQ is the Tanimoto or normalised coefficient for overlap of 
molecules Q and T, for the Hydrophobic (PHO) pharmacophore type. 
This process is repeated for each of the five pharmacophore types (PHO, ARO, ACC, DON 
and PHI) to give a set of 5 pharmacophore coefficients (each between 0 and 1) which are 
then summed to give a final property score P with value between 0 and 5 (identity = 5). 
Without prior knowledge of the activity class, it is reasonable that no further weighting 
scheme is applied to any particular pharmacophore class. See equation 4.21. 
Equation 4.21  
P = (norm_PHO_MOVPQ + norm_ARO_MOVPQ	 + norm_ACC_MOVPQ + norm_DON_MOVPQ 
+ norm_PHI_MOVPQ) 
Where P is the sum over all pharmacophore types giving a value between 0 and 5. 
4.5.5 – Scoring the systematic alignment 
 
Two representations are aligned exhaustively by attempting all possible superpositions and 
then scored. The best scores evaluated for volume and properties (V and P) over all 
possible alignments are retained and reported for each query and target comparison. The 
best volume and properties scores may in fact be from two different alignments. Both the 
volume V and properties P scoring schemes derived can be applied directly after both 
alignment methods.  
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4.5.6 – Scoring the clique and Kabsch alignment 
 
In the clique and Kabsch alignment approach it is possible to differentiate between shape 
and sub-shape modes. In “Shape” mode, after the alignment all the points in each 
representation are considered in the scoring phase. The best scores evaluated for volume 
and properties (V and P) over all possible alignments are retained and reported for each 
query and target comparison. The volume and properties scores may be from two different 
alignments.  For Sub-shape scoring, only the clique portions of the representations are 
included in scoring irrespective of the rest of either the query or target. In both cases, the 
clique size is also reported.  
Equation 4.22 














Where this example is generalised and PH4 represent all five pharmacophore types. 
 
4.5.7 – Evaluated similarity coefficients 
 
For each alignment method, a set of similarity coefficients for the best volume and 
properties scores observed are reported.  For the systematic alignment, the first element of 
the vector is the maximum volume objective found MAX(V)	and the second element is the 
maximum properties sum is also reported MAX(P). As can be seen from the previous 
equations, the properties score is highly dependent upon the volume scores so in reality 
they are closely related and in many cases they will be from the same alignment.  
Equation 4.23 shows the output for systematic coefficients observed. 
Equation 4.23 
Coef|icients  }2MAXV ,MAXP] 
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Where V is in the range 0 to 1 and P is in the range 0 to 5. 
In the case of Clique/Kabsch alignment in the third element the clique size is also reported. 
This may also help to indicate the extent of the commonality between the structures. 
Equation 4.24 shows the output coefficients. Both Shape and sub-shape correlation vectors 
are identical in structure in that the clique size and identity will be equivalent for these two 
modes. Please see figure 4.24 below for some example alignments and scores.  
 Equation 4.24 
Coef|icients  2MAXV , MAXP,MAX	clique	size] 
























GR query aligned with ZINC active, clique size of 4 and property score P=3.72 
   
 
SAHH query aligned with ZINC active, clique size of 4 and property score P=4.06 
   
 
Figure 4.24 - Several crystal query structures (from DUD) are aligned (clique/Kabsch) and 
scored in shape mode with high scoring actives found for the set. Parameters are K=4, 
distance tolerance=2.0, radius tolerance=2.0, node match mode=EXACT). 
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4.6 - Implementation details 
 
4.6.1 - Data pre-processing steps required 
 
Initially molecules require some pre-processing prior to mapping to the “Reduced point 
fuzzy pharmacophore vector” representation. This pre-processing simply ensures that the 
representation mapping protocol will consistently receive suitable 3D conformation data 
points with the desired protonation state and that each atom is correctly represented by a 
suitable SMARTS encoding which is then used to correctly assign pharmacophore type 
information. Molecules are read in from SDF files and handled using ChemAxon’s basic 
molecule instantiation. Each molecule is aromatized and further de-protonated. Normal 
usage would expect just the heavy atoms since H atoms in isolation map to no 
Pharmacophore type. During enrichment studies the input data might be crystal derived 
data in which case minimal further treatment should be applied. However, if the molecule 
is from a 2D source originally at least one 3D conformation is required and thus should 
need to be generated and this can be achieved initially using an available 3D function to 
map from 2D to 3D coordinates. After this simple treatment, which primarily will aromatize 
and add implicit hydrogen atoms to Heteroatoms and then present heavy atoms for 
partitioning, the data is in a suitable state to map to the internal representation. The basic 
workflow of events that can occur is based upon two simple Boolean input parameters, 
“IsCrystalStructure” and “IncludeHAtoms”, as depicted in figure 4.25. During any 
enrichment studies “IsCrystalStructure” is set to true because the data is experimental 
crystal data and thus should not be treated with any 3D force field. Also “IncludeHAtoms” 
is set to false and this means that H atoms will not be included in the points derivation 
rather just the heavy atoms are included – see figure 4.25 for pre-processing events. 
 
  
Figure 4.25 - Molecule pre
4.6.2 - Software platforms and libraries
 
In the development and testing of this approach the following softwa
been used: Java SE v1.6, Java3D and NetBeans v6.5, jchem.jar molecule file handling 
libraries (ww.chemaxon.com), Jgrapht graph libraries (
Jama Matrix libraries (http://math.nist.gov/javanumerics/jama/
“MAPS3D” (Molecular Alignment and Pharmacophore Search 3D) is the accompanying tool 
which implements the methods described in chapter 4. 
reports V, as well as each of the five 
Diagrams in this document were created 
created using a molecular viewer tool which was created 




-processing flow diagram. 
 
re and libraries have 
http://jgrapht.sourceforge.net/
). The executable jar file  
The associated 
pharmacophore scores as well as the sum value




“MAPS3D” tool also 
 P. 




4.7 – Chapter summary 
 
This chapter has described a new approach to 3D similarity search based upon a reduced 
points representation, two alignment methods and a volume and pharmacophoric 
properties overlap scoring scheme. This new approach pertains to be approaching a logical 
hybrid of shape and pharmacophore search and is able to identify and score both shape 
and sub-shape matches. The next chapter presents and discusses the results of the two 
alignment methods and the scoring functions for several data sets in terms of the rank 
order measures Enrichment Factor (EF), Recall and AUC (area under curve).  
In figure 4.24 several discrete alignments are displayed using the method described in 
chapter 4. The visualisation of the query and target with the associated P scores shows that 
this method provides quite reasonable results in terms of the scores generated and the 
equivalence to the visual alignment of the query and target molecules for these scores. 
Molecules of similar scale and representation can be aligned and scored well with this 
method. Two of the classes (independently identified) in the figure, COX2 and SAHH, were 
noted by the authors of a recent article, as “better suited” to three dimensional 
approaches. They concluded that some sets of actives are chemically or topologically 
similar and probably bind to the same active site via a similar mechanism (Venkatraman  et 














Chapter 5 – Results for rigid search of two alignment methods using 
the DUD data set of actives and decoys 
 
5.1 - Introduction 
 
This chapter presents the results of applying the 3D similarity approaches introduced in 
chapter 4 to some known virtual screening validation data sets, which cover a broad range 
of protein classes. The validation sets contain compounds that are known to be active 
together with decoy compounds which are presumed inactive. The rank ordered lists 
generated by applying the method were evaluated on how well the actives are ranked with 
high order relative to the decoys. Several evaluation measures were used to determine the 
optimum parameters for the method and then enable a direct comparison to other known 
approaches. The methods have been applied to a Thrombin data set (Hendlich  et al., 2003) 
and the DUD data set (Huang  et al., 2006). Use of the latter more comprehensive DUD data 
set, allowed the method’s effectiveness to be determined directly relative to other existing 
methods which have also been validated using this set. In this chapter, we first describe the 
data sets and the experimental details in terms of the parameters and then review the 
generated results of several parameterisations as applied to the Thrombin data set and 
then the DUD data set for each experimental state. 
 
5.2 - Experimental details 
 
5.2.1 – Validation data sets used for virtual screening experiments 
 
Various data sets were used in these virtual screening experiments. The first of these is 
referred to  as the Thrombin set and consists of 18 actives originally obtained from 
Relibase+ and processed using the MOE protonation routine, which adds explicit hydrogen 
atoms (Hendlich  et al., 2003). In the experiments, seven of the active compounds were 
used as queries to search against the rest of the actives and an additional 143 decoy 
molecules from the ZINC database (Irwin  et al., 2005). This set was compiled by Martin 
(Martin  et al., 2010) and comprises handpicked actives known for exhibiting four recurrent 
83 
 
hydrogen bond interactions with the Thrombin protein backbone and which contain a large 
number of potential hydrogen bond donors and acceptors.  
 
The second of these sets is the Directory of Useful Decoys or DUD data as compiled by 
Huang (Huang  et al., 2006). This set consists of 40 query classes each with an associated 
variable number of actives and decoys sourced from the ZINC database (Irwin  et al., 2005). 
The decoys for each activity class were carefully chosen to contain molecules with similar 
physical properties (e.g. molecular weight, calculated LogP) but with dissimilar topology 
(connectivity) to the actives. For each activity class, the primary crystal structure reference 
molecule was used as the query in the conformation extracted from the protein-ligand 
complex. The actives and decoys which were used as target molecules were processed with 
no further conformers generated. A third data set was also employed, which was a reduced 
set of eight of the DUD classes each with a well defined set of queries, actives and eight 
times as many decoys as actives per set. For each of these, the results were averaged over 
the multiple queries, to allow comparison with experiments reported by Martin (Martin  et 
al., 2010). 
 
The tests were rigid search only and the starting orientations which were used to generate 
the representations were directly read in from the SDF files without any initial 
randomisation. In the case of the DUD set it was noted that some minor valence errors 
existed in some of the queries and these required modification by addition of a +1 charge 
to certain N atoms, however the methods under scrutiny here do not consider charge and 
so this had no effect on the results. In the case of the Thrombin set some 1120 distinct 
similarity comparisons were completed for each experimental parameterisation. In the 
case of the DUD set some 106939 distinct similarity comparisons were completed for each 
experimental parameterisation. 
  
5.2.2 – Method variables and parameters 
 
The following aspects of the methodology were considered as variables in these virtual 
screening experiments. Two distinct alignment methods were compared. The first was 
systematic alignment (with incremental optimisation) as discussed in Chapter 4 which 
contains no internal parameters. This method aligns two representations with equal 
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numbers of points where the number of points K was three or four.  The systematic 
alignment optimisation increment was set to 0.01 Å.   
The second alignment method was the clique method discussed in Chapter 4. This 
approach has several associated variables which need to be parameterised. The variables 
associated with a correspondence graph are the edge distance tolerance (D), radius 
tolerance (R) and node equivalence mode (M) all of which are important when defining the 
nodes in the graph. For the clique alignment approach, it is also possible to distinguish 
between shape and sub-shape mode by including all nodes when scoring the superposition 
(shape) or by limiting the scoring to the nodes of the clique (sub-shape).  For these 
experiments the radius tolerance was constant at 2.0 Å. The edge distance tolerance was 
varied with K as indicated in section 5.3.2. The equivalence modes considered in the 
correspondence graph construction were partial and exact. For the clique alignment 
method, K was varied from three to six points inclusively. Each comparison was based on 
the same K level representation for both the query and target molecule in all experiments.  
For both alignment methods, two scoring functions were employed once a superposition 
had been achieved and were used to indicate the numerical quality of the alignment. The 
first of these considered the volume overlap V of the two aligned representations. The 
second included within the volume overlap the concept of weighted pharmacophoric 
properties P (by atom mass) for each point in the representation of the molecule. The 
volume V and properties P scoring functions used are as described in chapter 4 and were 
the same for both alignment methods allowing the direct comparison of the alignment 
methods. 
To summarise, the experimental variables are: systematic or clique based alignment 
method; representation level K; shape or sub-shape mode; volume only, V, or volume and 
property, P, score and the correspondence graph parameters associated with the clique 








5.2.3 – Evaluation measures 
 
Several measures were used to indicate the effectiveness of active retrieval and are 
defined here. The active ratio is defined in equation 5.1 first since it is used as part of other 
definitions.  
Equation 5.1  
Active ratio = 
D
D 
Where “Actives” is the number of known actives and “Decoys” is the number of known 
decoys in the experimental data set. 
The enrichment factor (EF) is defined in equation 5.2 and is based upon the top 10 
positions of the ranked list with the higher number of actives “a” found giving better 
scores. This measure does not consider the entire ranked set and thus is not easily 
comparable if different sized data sets are used (Kirchmair  et al., 2008).  
Equation 5.2  
Enrichment Factor (EF) = (a / 10) / (Active ratio) 
Where “a” is the number of actives found in the top 10 ranked positions and “active ratio” 
is defined in equation 5.1 above. 
The recall is defined in equation 5.3 as the percentage of the total actives found in the top 
X percent of the ranked list (the sum of actives and decoys). Recall values for the 
experiments are reported for the top 5% and 10% of the ranked lists. Recall values are in 
the range of 0 to 100 % inclusive.  
Equation 5.3  
Recall@X% = (a found in top X of ranked list * 100) / Actives 
Where “Actives” is the number of known actives and X is the number of positions defined 
to include by either the top 5% or 10% constraint of the entire ranked list count. 
The final measure is Area Under the Curve (AUC) as defined in equation 5.4 where Se 
denotes selectivity (the true positive rate) and Sp denotes specificity (the false positive 
rate).  The AUC varies from 0.5 to 1.0, with the value of 0.5 indicating that the actives are 
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distributed at random throughout the ranked list. This is a useful property of this measure 
since it can assist in building statistical significance arguments using 0.5 as the null 
hypothesis (random) and values greater than it as the alternative hypothesis (non-random). 
The AUC measure considers the entire ranked list of molecules. 
Equation 5.4  
AUC = ∑ Se'&' )(Sp'	 −	Sp) 
Where n is the total number of items in the ranked list, Selectivity “Se” is the “true positive 
rate” and Specificity “Sp” is the “false positive rate”. 
In virtual screening, it is often the top one or two percent of the list that is of interest 
rather than the whole list. However the AUC is used in the experiments reported here to 
allow comparison of the method developed in chapter 4 with more established methods 
reported in the literature.  
All measures were coded in Java according to the equations defined above except for AUC 
in equation 5.4. A version of the AUC measure is defined in equation 5.4 and is similar to 
the trapezoid rule numerical integration (Kirchmair  et al., 2008). The R software was used 
to calculate the “Wilcoxon” AUC values reported in these results (R Core Team  et al., 













5.3 - Thrombin 
 
5.3.1 – Thrombin data set 
 
The seven different queries (table 5.1) from the Thrombin data set described above were 
processed along with a number of ZINC actives and decoys. In each case 143 decoys were 
present along with the designated query and 17 other actives giving a total of 161 
compounds. No Iodine atoms are found in any of the molecules although a small number 
(5% of total) contain Chlorine.  
 









Table 5.1 – Table of Thrombin active references used 
5.3.2 – Thrombin results and discussion 
 
In total 18 separate experiment parameterisations were completed for each of the 7 
queries in table 5.1. The alignment method was either systematic or clique and for the 
latter both shape and sub-shape matching was included. K is the level of representation 
used for both query and each target molecule. Each experiment yields both a volume V and 
properties P normalised overlap score. The correspondence graph parameter radius R is 
constant at 2.0 Å. D was set at 2.0 Å for K=3,4 and for K=5,6 D of 1.0 Å was used. The 
equivalence modes exact and partial were also examined and these modes differ in the 
logic that is applied at the graph node matching stage with exact implementing a slightly 
stricter matching criterion than partial mode.  
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Results are displayed in table 5.2 below in terms of EF (top 6.25% of rank order), Recall at 
5% and 10% and AUC measures averaged over the seven queries. The raw data for each of 
the 7 queries and for all the experiments can be found in appendix A. A discussion of the 
observed data is given below.  
Alignment 
( Mode)0 













3 n/a 6.32 6.46 36.14 39.50 46.22 41.18 0.57 0.58 




3 2 4.03 4.03 25.21 25.21 25.21 25.21 0.58 0.58 
4 2 6.05 6.05 33.61 32.77 39.5 39.5 0.67 0.67 
5 1 6.05 6.18 33.61 34.45 38.65 38.65 0.64 0.63 




3 2 4.03 4.03 25.21 25.21 25.21 25.21 0.58 0.58 
4 2 5.91 6.05 32.77 31.93 40.34 39.5 0.67 0.67 
5 1 4.57 5.24 24.37 28.57 36.97 37.81 0.63 0.63 




3 2 6.59 6.59 36.98 40.34 44.54 44.54 0.69 0.69 
4 2 7.53 7.26 41.18 40.34 52.94 51.26 0.77 0.75 
5 1 7.93 7.26 42.02 37.82 67.23 53.78 0.89 0.84 




3 2 6.59 6.59 36.98 40.34 44.54 44.54 0.69 0.69 
4 2 3.76 5.78 21.01 30.25 37.82 45.38 0.69 0.7 
5 1 2.55 4.84 14.29 25.21 22.69 36.97 0.67 0.72 
6 1 2.55 3.63 14.28 21.85 17.65 27.73 0.56 0.62 
 
Table 5.2 – Thrombin average results over the seven queries defined in table 5.1. 
Definitions of EXACT and PARTIAL are given in chapter 4, p57 and 58. For K=3, shape and 
sub-shape scores are identical as expected.   
The systematic alignment method gives increasing scores from K=3 to K=4 for all (except 
one) of the observed measures – the four point volume score is very high using the AUC 
measure and might be considered an outlier. Systematic alignment seems to be at least of 
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a comparable order with the clique approaches at K=3 and K=4 (based on partial node 
matching). Only a shape mode is considered since sub-shape is not applicable for this 
method. The data is plotted in the shape mode graphs 5.1 to 5.4 below (V denoted blue 
and P denoted red). The volume V scores appear to be better than the properties P scores.  
For the clique alignment, when K=3, the shape and sub-shape modes should generate the 
same result since the minimum number of nodes necessary to generate an alignment and 
score is three. This is confirmed to be the case and this data is highlighted in yellow in table 
5.2 Further results are plotted in graphs 5.1 to 5.4 for shape mode and 5.5 to 5.8 for sub-
shape mode for this alignment method. The shape mode EF, AUC and Recall measures 
increase from K=3 to 6 (graphs 5.1 to 5.4) and presumably might continue to rise above six 
points, although these experiments were not conducted. Over all parameters and queries, 
AUC is often much greater than 0.5 suggesting this method is significantly better than 
random (at 0.5) with the best AUC score ~0.9 . Some high EF and recall values are also 
witnessed, the best EF being ~8.5 and recall @ 10% being ~69% (all highlighted in green in 
table 5.2).  
The best scores were found, across all measures when using partial match, shape mode 
with K=5 or 6. Conversely, if we examine the sub-shape graphs for partial mode, K=3 is the 
most discriminating and the effect drops with K (sub-shape are graphs 5.5 to 5.8). This 
suggests that extracting and scoring sub-shapes does not work well in this mode. This 
might be rationalised by considering that the decoy sub-shape scoring might actually 
improve here and thus the retrieval measure value decreases as false actives are found and 
scored highly. The clique alignment exact mode will exclude clique sizes of less than three 
and so many actives and decoys may be eliminated during processing with an assigned zero 
score and with an effect on the measures.  For exact sub-shape mode we also see a general 
trend towards increasing values of the retrieval measures with increasing K (graphs 5.5 to 
5.8). The properties scores P have little apparent effect in shape mode but an increased 
effect in sub-shape mode relative to the volume only V score. The number of actives 
retrieved for each query using the exact mode, in the top 10 rank slots is tabulated below 
in table 5.3. The representation of the structure of the three best scoring queries at K=4 
from table 5.3 can be observed in figure 5.1 below. In this instance it appears that natural 
pharmacophores and rings largely remain intact often encompassed within a larger 
fragment (COOH, NH and hydrophobic groups), with an even volume distribution over the 
spheres in the representation. The JKlustor ‘compr’ (ChemAxon  et al., 2012) clustering 
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method from ChemAxon was used to compute a dissimilarity index on these sets. The 
actives and decoys are evaluated dissimilar (0.68), the actives are quite similar (0.55) and 
the decoys are quite dissimilar (0.64) indicating this method is identifying a cluster of 
actives in a diverse target set. Chlorine was present in one query (2bvx) but not in the other 






Figure 5.1 - The queries for four results (highlighted in green in table 5.3) using K=4. The 
sphere size is generated using the computed radius. 
Overall this data set has helped show both alignment methods in a relatively good light, 
since we see good results for both alignment methods at K=4. In the clique case the results 
are then subsequently improved upon by the clique alignment with an increased 
representation level K=5 and 6. Shape /partial mode works well but the sub-shape mode 
shows an oddly converse effect indicating a bias towards shape only search. For Exact 
mode shape and sub-shape mode show more similar behaviours. Behaviour tending 
towards a filtering mechanism with K=4 is feasible to be used with exact search mode to 
pick out true positives in over half of cases (light green Table 5.3 below). Other indications 
suggest a strict clique criterion like Exact mode in conjunction with sub-shape and 
properties scoring can also be used effectively to distinguish actives from decoys (graphs 
5.5 to 5.8).  
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6 9 9 10 
LIMIGN_999_pdb1k21_1 
6 9 9 8 
LIMCDA_201_pdb1mu6_1 
3 3 3 5 
LIMAZL_600_pdb1ae8_1 
1 3 2 6 
LIM162_179_pdb1nzq_1 
6 9 9 9 
LIM34P_1_pdb2feq_1 
6 9 9 9 
LIM5CB_1246-H_pdb2bvx_1 
2 3 4 7 
  
Table 5.3 – Thrombin actives found in top 10 for each of the seven stated queries using 
exact shape mode (D=2,R=2). 2bvx does contain Chlorine atom, 1ae8/1mu6 do not. 
Results for this data set are now placed in context relative to work completed by Martin et 
al at Sheffield (Martin  et al., 2010) discussed in chapter 3. The average AUC results for the 
GRID / wavelet compression approach for this Thrombin set were reported in the range 
0.749 to 0.979 dependent upon probe type selected, as seen in table 4.2 of that thesis 
(Martin  et al., 2010). A value of 0.991 was further evaluated using the ROCS colour 
method.  A similar summary of AUC values for best alignment methods and K level 
(highlighted in green in table 5.2) for the methods presented here is AUC values of 0.65 to 
0.89 indicating that this approach is less effective at retrieving actives than the reported 
method, although there are clearly some parameterisations, where the AUC ranking 










Graph 5.1 – Thrombin set: K vs AVG (EF) – shape 
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Graph 5.3 – Thrombin set: graph of K vs AVG (Recall@5%) – shape 
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Graph 5.5 – Thrombin set: graph of K vs AVG (AUC) sub-shape 
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Graph 5.7 – Thrombin set: graph of K vs sub-shape AVG (Recall@5%) – sub-shape 
 







































5.4 - DUD  
 
5.4.1 – DUD experiments 
Forty different protein active classes exist within the DUD data set. In each class there 
exists a single query for each class (named xtal-lig in all cases). In these experiments this 
single molecule was used as the query and processed against a variable number of ZINC 
actives (DUD lead like set) and decoys (Irwin  et al., 2005). The query molecule was 
compared to all of the available actives and decoys in the set of experiments, hence 
(actives+decoys) comparisons were completed for each experimental parameterisation and 
for each target class and then the results averaged and discussed below. The different 
protein classes and associated numbers are tabulated in the table 5.4 below. 
The JKlustor ‘compr’ clustering method from ChemAxon was used to compute a 
dissimilarity index on these sets. The actives and decoys are evaluated very dissimilar 
(0.74), the actives are also quite dissimilar (0.71) and the decoys are very dissimilar (0.74) 
indicating this method is attempting to identify diverse actives from a diverse target set, 
the most challenging arrangement. This data set was also determined to contain a small 
amount of Iodine atoms (0.67% of all actives and decoys). Specifically the classes ALR2, 
EGFR, COX2 and AMPC showed most significant amounts with ~2% of the molecules in each 
class containing Iodine. Also, 16% of the DUD actives contain Chlorine atoms and 21% of 
the DUD decoys contain Chlorine atoms. 
 
Protein class from DUD Actives Decoys Total 
ACE - Angiotensin-converting enzyme 46 1796 1842 





ADA - Adenosine deaminase 23 927 950 
ALR2 - Aldose reductase 26 986 1012 
AmpC - AmpC beta lactamase 21 786 807 
AR - Androgen receptor 68 2848 2916 
CDK2 - Cyclin dependent kinase 2 47 2070 2117 
COMT - Catechol O-methyltransferase 11 468 479 
COX-1 - Cyclooxygenase 1 23 910 933 
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COX-2 - Cyclooxygenase 2 212 12606 12818 
DHFR - Dihydrofolate reductase 190 8350 8540 
EGFr - Epidermal growth factor receptor kinase 365 15560 15925 
ER_agonist - Estrogen receptor agonist 63 2568 2631 
ER_antagonist - Estrogen receptor antagonist 18 1058 1076 
FGFr1 - Fibroblast growth factor receptor kinase 71 3462 3533 
FXa - Factor Xa 64 2092 2156 
GART - glycinamide ribonucleotide transformylase 8 155 163 
GPB - Glycogen phosphorylase beta 52 2135 2187 
GR - Glutocorticoid receptor 32 2585 2617 
HIVPR - HIV protease 4 9 13 
HIVRT - HIV reverse transcriptase 34 1494 1528 
HMGR - Hydroxymethylglutaryl-CoA reductase 25 1423 1448 
HSP90 - Human heat shock protein 90 kinase 23 975 998 
InhA - Enoyl ACP reductase 57 2707 2764 
MR - Mineralcorticoid receptor 13 636 649 
NA - Neuraminidase 49 1713 1762 
P38 - P38 mitogen activated protein kinase 137 6779 6916 
PARP - Poly(ADP-ribose) polymerase 31 1350 1381 
PDE5 - Phosphodiesterase V 26 1698 1724 
PDGFrb - Platlet derived growth factor receptor kinase 124 5603 5727 
PNP - Purine nucleoside phosphorylase 25 1036 1061 
PPARg - Peroxisome proliferator activated receptor gamma 6 40 46 
PR - Progesterone receptor 22 920 942 
RXRa - Retinoic X receptor alpha 18 575 593 
SAHH - S-adenosyl-homocysteine hydrolase 33 1346 1379 
SRC - Tyrosine kinase SRC 98 5679 5777 
Thrombin - Thrombin 23 1148 1171 
TK - Thymidine kinase 22 891 913 
Trypsin - Trypsin 9 718 727 
VEGFr2 - Vascular endothelial growth factor receptor kinase 48 2712 2760 
 
Table 5.4 – DUD protein class and active, decoys and total counts [Contains Iodine] 
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Each experiment conducted for the DUD data is indicated by a row in the table 5.5 below. 
In total 10 separate parameterisation experiments were completed and averaged over 
each of the 40 queries above. (The sub-shape experiments are omitted). The alignment 
method is either systematic or clique. K is the level of representation used for both query 
and each target molecule. Each experiment yields both a volume V and properties P 
normalised overlap score. The correspondence graph parameter radius R is constant at 2 Å. 
The graph distance parameter D was set to 2.0 Å or 1.0 Å as shown in the table. The 
equivalence modes exact and partial are also examined. Results are displayed in table 5.5 
below in terms of Recall at 5 and 10% and AUC measures averaged over the 40 queries and 
sets in table 5.4.  
 
5.4.2 – DUD results and discussion 
The results for the set of experiments in terms of the Recall and AUC measures are defined 
in table 5.5 below. The raw data for each of the 40 queries and for all the experiments can 
be found in appendix B. A discussion of the observed data is given below the table.  
Alignment 
(mode) 




















3 n/a 20.14 20.55 26.36 28.2 0.63 0.65 




3 2 14.96 14.51 15.75 15.77 0.56 0.56 
4 2 20.21 20.92 24.84 25.98 0.59 0.59 
5 1 23.21 24.03 28.84 29.89 0.61 0.61 




3 2 19.16 20.4 24.4 25.72 0.64 0.64 
4 2 16.74 19.91 23.16 24.86 0.61 0.62 
5 1 17.9 18.84 23.42 25.13 0.60 0.62 
6 1 17.62 17.23 23.78 23.92 0.60 0.61 
 
Table 5.5 – DUD average results over the 40 stated queries for ten experimental 
parameterisations. The best observed values are highlighted in green. 
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From graph 5.9 we observe, the systematic alignment shape method gives approximately 
equivalent AUC values for K=3 and K=4 which are comparable with the best clique result 
observed at K=6, ~0.65. The best observed AUC scores were seen with this approach and 
the properties are superior to the volume scores. Exact mode shows significantly different 
behaviour than partial mode. In graph 5.9 we can see that in partial shape mode as K 
increases, then the AUC value appears to steadily decrease which is perhaps contrary to 
expectation and is inconsistent when compared to the single class Thrombin result. Exact 
mode shows a steady almost linear increase with K in line with what was observed for 
Thrombin. Graphs 5.10 and 5.11 similarly show that the recall values decline slightly with 
increasing K for partial mode. Exact mode shows a steady almost linear increase with K in 
line with what was observed for Thrombin and exact mode from graph 5.9, indicating this 
mode becoming more effective as K increases. Properties scores are better than the 
volume equivalents. By extrapolation for this parameterisation K=7 or 8 could be a better 
level of representation with exact mode. The recall values for systematic alignment, 
increase from K=3 to K=4 can be seen in graphs 5.10 and 5.11. For the exact clique 
alignment method, the recall values also increase for increasing K and at K=5 and 6 they 
exceed the values seen for the systematic alignment reaching 25% and 35% for @5% and 
@10% respectively. This is most likely due to an increase in the discrimination of the 
representation applied to each molecule. Again, properties scores are often superior to the 
volume scores indicating pharacophore weighting is a useful paradigm.  
There is a lot of variation over the 40 classes and it may be that we witness some of the 
effects of the diversity of the actives and decoys in each class. We can see from graphs 5.12 
that a large spread of results is seen for any given parameterisation. Other methods 
applied to the DUD set can similarly show much variation in results as discussed recently 
(Venkatraman  et al., 2010). Overall the magnitude of the best results is AUC ~0.65 to 2 
decimal places which is witnessed for three parameterisations, two of which were the 
systematic alignment method. These AUC results are on average better than random (0.5). 
Contributing to this spread of AUC values observed from 0.5 to 0.9 will be artefacts of the 
partition algorithm applied which can give non-ideal, uneven sized cluster points for some 
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Graph 5.10 – K vs AVG (Recall@5%) for DUD results 
 
 










































Graphs 5.12 –Spread of AUC results for 40 DUD classes, K=4, Volume and Properties 
scores for both Parital/Clique/Shape and Systematic alignments 
 
 
In table 5.6 below the K representation for several of the DUD reference queries: RXR, 
SAHH and AR can be viewed.  In the case of RXR we observe both the AUC decrease with 
increasing K, from 0.75 to 0.69 and 0.54. It seems that K=3 is the best shape representation 
here, with K=4 and 5 not capturing the shape particularly well, with two “incorrectly” 
placed points retained between K=4 and 5 which disrupt the natural ring pharmacophores. 




































the clique method from 0.7 to 0.75 and 0.79. It seems the K-means is behaving relatively 
well for this query in that it captures the shape and internal heteroatom functionality to 
some extent despite not representing rings perfectly. In the case of AR we see AUC 
decrease from 0.78 to 0.71 and then 0.67 with increasing K. The shape is perhaps slightly 
more correctly captured for K=4. We might also be witnessing the effects of an uneven 
volume distribution and again points offset from the ring centres. In all cases we can see 
some tendency for the points not to sit inside rings and this undoubtedly will decrease the 
effectiveness of our representation. The representation could be modified to share bridge 
atoms, as suggested in chapter 6 which should give a more accurate representation. These 
examples reflect the general observation in graph 5.9 for partial match mode. 














Table 5.6 – Selected DUD query RXR, SAHH and AR representation for K=3,4,5. AUC values 
for (V score, Clique/Partial Mode) are shown in bottom centre of each cell. The best 
observed AUC values are highlighted in green.  
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In table 5.7 below, for the PDGFRB query we see the P score recall @10% values increase 
with K from 11.29% to 12.90% and 21.77%. One might say the K=5 is the best 
representation because it defines the rings well with points placed fairly neatly in the ring 
centres and the amide linker.  The scale is captured well using even sized spheres 
distributed over the whole molecule. In the case of PARP query, the P score recall @10% is 
equivalent for K= 3 and 4 at 19.35% and rises for K=5 to 32.36%. In this case the rings and 
pharmacophore groups are being captured more correctly and there is a relatively even 
volume distribution over the entire molecule. In the case of Trypsin query, we notice the P 
score recall @10% rise from K=3 at 44.44% to K=4 at 66.67% followed by a sudden drop off 
at K=5 to 11.11%. This might be rationalised by the rings and linkers being quite well 
represented at K=3 and 4. At K=5 there are too many small cluster points which will reduce 
the possible overlap scores. One of the ring points is also not well represented, breaking up 
a natural pharmacophore and placing the points the “wrong way round”. 
Any apparent effects of a potential bias in the scoring due to large Iodine mass can be 
deduced by considering the classes COX2, EGFR, ALR2 and AMPC all of which contain high 
levels of Iodine in the decoy sets as well as having the two highest actives and decoy counts 
over the entire DUD set. COX2 gave good AUC scores over most of the parameterisations 
whereas the other three did not exhibit good AUC values. Hence, a logical deduction that 
Iodine is not a major factor that affects the observed results can be concluded. Please see 
5.4.1 which discussed Iodine composition in the DUD set. Ten percent of the forty classes 
contain Iodine with each of the four cases containing ~2%, predominantly (99%) are seen in 
the decoys set.  
The conclusion for this data set is complex, considering the amount of variability in the 
observed result of a single parameterisation and over all K. Scale and ideal K representation 
which captures correctly the whole molecule, without splitting pharmacophores and that 
of comparing molecules of different “ideal K” should assist in better retrieval and 
distinguish of actives. The number of points in a representation is less important than the 
fact that we should only use a single point per ring system, with the points placed in the 
ring centroids. Small cluster points will have a detrimental effect on volume overlap. For 
example PDGFRB at K=5 is a good representation and one might imagine a better 
representation of Trypsin for K=4 and above. The sharing of bridge atoms will help towards 

































Table 5.7 – Selected DUD query PDGFRB, PARP and Trypsin representation for K=3,4,. 
Percentage recall @10% values for (P score, Clique/Partial Mode) are shown in bottom 






5.5 – Results of eight targets from DUD 
5.5.1 – Further eight DUD experiments 
The results from the DUD set showed a large amount of variability and thus a reduced 
subset of eight targets as seen in Table 5.8 below, were chosen to apply the method to, in 
order to help further understand the behaviour for selected targets. Each of these target 
sets contained seven different queries, all of which are active for that target. For each of 
the seven queries a number of additional actives were used as well as eight times that 
number of decoys. A total of 7 * (actives + decoys) comparisons were completed for each 
experimental parameterisation and for each target class and then the results averaged for 
each class and discussed in each section below. 
The JKlustor ‘compr’ clustering method from ChemAxon was used to compute a 
dissimilarity index on these sets. The actives, decoys and actives vs decoys are evaluated 
and the numerical values displayed in brackets in table 5.8 for convenience. Relatively high 
diversity is shown, particularly for actives vs decoys with the latter also being more diverse. 
Four of the DUD classes contain moleciules with Iodine atoms: the percentage of molecules 
that contain Iodine within each of these classes is as follows: COX2 (1.5%), EGFR (1%), SRC 
(1.6%) and VEGFR2 (0.4%). All of the DUD classes contain Chlorine atoms: the percentages 
of molecules within a class range from 6 to 42 %. This will be considered during the 
discussion 5.5.2. 
Protein class from DUD 
Actives 
(a vs a) 
Decoys 
(d vs d) 
Total 
(a vs d) 
COX-2 - Cyclooxygenase 2 44(0.65) 352(0.69) 396(0.74) 
EGFr - Epidermal growth factor receptor kinase 40(0.61) 320(0.70) 360(0.75) 
InhA - Enoyl ACP reductase 23(0.59) 182(0.66) 205(0.72) 
P38 - P38 mitogen activated protein kinase 20(0.45) 160(0.67) 180(0.71) 
PDE5 - Phosphodiesterase V 22(0.64) 174(0.64) 196(0.70) 
PDGFrb - Platlet derived growth factor receptor kinase 22(0.56) 174(0.67) 196(0.70) 
SRC - Tyrosine kinase SRC 21(0.61) 168(0.67) 189(0.72) 
VEGFr2- Vascular endothelial growth factor receptor kinase 31(0.64) 248(0.68) 279(0.70) 
 
Table 5.8 –DUD reduced sets used for these experiments [Contains Iodine] 
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5.5.2 – Discussion of eight experiments 
For these eight DUD classes this discussion now aims to assess the method retrieval rates in 
terms of two simple indicators: Does any single data point actually represent a good 
retrieval in terms of any of the measures or parameterisations and do any of the protein 
classes exhibit the overall behaviour witnessed for the well behaved Thrombin set in terms 
of K. Full results are shown in graphs 5.13 to 5.20 and the best AUC value for each data set 
is shown in table 5.9 alongside the best results reported by Martin for the wavelet method 













Comparable to method? 
COX2 (5.13) 0.74 
(C@K=3,4,5,P) 




(S@K=4 V & 
C@K=6,P) 
0.60 0.81 Wavelet 
INHA (5.15) 0.74 
(S@K=3,P) 
0.73 0.59 Wavelet 
P38 (5.16) 0.77 
(C@K=5,V) 
0.83 0.79 ROCS 
PDE5 (5.17) 0.79 
(S@K=3,V & 
C@K=3,V) 





0.85 0.76 x 
SRC  (5.19) 0.80 
(S@K=3,V) 





0.84 0.80 x 
 
Table 5.9 – Assessment of 8 DUD classes in graph sets 5.13 to 5.20.  Data from Martin 
thesis tables 8.4 and 8.10 are re-produced in table 5.9 alongside the best noted scores 
from this approach with the associated parameterisation.  
KEY : Clique/Systematic@K=n,Volume/Properties. AUC >0.7, 0.69>=AUC> 0.6 and 
AUC=<0.6. Error of 0.05 AUC units is assumed. 
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The classes that show the best response are INHA, P38, PDE5, COX2 and SRC (green in table 
5.9) and to some extent PDGFRB and VEGFR2 (yellow in table 5.9). The one that showed 
poorest response is EGFR (red in table 5.9). The COX2 and P38 are also useful in that they 
show that the five point representation can outperform the systematic alignment at K=3,4 
even without an optimisation step. There are also examples of properties scores that are 
better than the volume scores and associated retrieval of actives. Logically, the presence of 
Iodine has little or no detrimental effects if we consider that PDGFRB (no Iodine) and 
EGFR/VEGFR2 (small amounts) and the fact that COX2 (good result) has the most at 1.5%. 
Similarly COX2 (42%) and PDE5 (6%) contain the extrema of Chlorine content yet are both 
relatively close and have reasonably good scores.  
Many of the observed results are significantly better than random (0.5) and the colour 
coding explained in table 5.9 attempts to qualitatively assess how good each score can be 
categorised. The best observed ‘COX2’ AUC result is 0.74, obtained using Clique alignment 
and with K=3,4 or 5 and  is directly comparable to ROCS colour 0.75 but the best wavelet 
result is significantly better than either at 0.89. The best observed ‘EGFR’ AUC result is 0.60 
obtained using either alignment method and is comparable with the wavelet result 0.60 
but the best ROCS colour result is significantly better than either at 0.81. The best observed 
‘INHA’ AUC result is 0.74 obtained using the systematic alignment K=3 and shows an 
improvement on ROCS colour 0.59 and is similar to the wavelet result 0.73. The best 
observed ‘P38’ AUC result is 0.77 obtained using parameters Clique alignment K=5 which is 
the same order as the best ROCS colour result 0.79 but the wavelet result is slightly better 
still at 0.83. The best observed PDE5 result is 0.79 obtained using either alignment method 
at K=3 and is the same order of magnitude as the ROCS colour and wavelet result. ROCS 
colour is best at 0.88 and the wavelet score is 0.75. The best observed ‘PDGFRB’ result is 
0.67 obtained using systematic alignment parameters K=4 which is less than ROCS colour 
0.76 with the wavelet approach significantly better 0.85.  The best observed ‘SRC’ result is 
0.80 obtained using the systematic alignment K=3. This result is good but does not improve 
upon either the ROCS colour 0.88 or wavelet approaches 0.91. The best observed ‘VEGFR2’ 
result is 0.64 obtained using the systematic alignment parameters K=3. This result is 
significantly worse than either ROCS colour 0.80 or the wavelet approach 0.84 which show 
good results here. The JKlustor values do not assist in any rational argument in this case 
since we can see relatively close dissimilarity conditions for (COX2, SRC) and (EGFR, 




We now should consider the parameterisations observed that led to the best scores for this 
method reported in table 5.9 and summarise any observed trends. The systematic 
alignment is equal to or better than the clique detection method for six of the eight activity 
classes and the K level of 3 occurs as the best level more frequently than 4 or 5. Volume 
and properties appear almost equally in the best results – these observations concur with 
the larger DUD set with properties only slightly more prevalent. The best parameterisation 
overall could be concluded to be systematic triangle matching (3 point representation) with 
either volume or properties scores used – further to this another useful configuration is 
Clique shape mode with K=3 or 5 with either volume or properties – these 
parameterisation ‘templates’, appear to give the best results for these data sets and with 
the K-means representation, which as noted previously can give less than ideal 
representations, depending upon K.  
The Wilcoxon signed-rank (paired) test was completed using the R tool (R Core Team  et al., 
2012) implementation ("wilcox.test(vec1,vec2,paired=TRUE)"). The input to this test is two 
vectors of values that are paired by vector index. In this case the pairing order is based on 
the protein class (column 1) in table 5.9. In this test, the p-value can be used to determine 
if one should accept the null hypothesis H0 and conclude the numbers are from the same 
populations or if not, to invoke the alternative hypothesis H1, that they are from different 
populations. If the p-value evaluated is greater than 0.05 then the sets of paired inputs are 
considered to come from the same population (H0) with 0.05 significance level else p-value 
is less than  0.05 the alternative hypothesis (H1) is the logical conclusion. This test was 
completed three times, once for each of the combinations of AUC columns found in table 
5.9. The method described in chapter 4 MAPS3D, was compared with the wavelet method 
(column 2, column 3 in table 5.9) and gave p-value=0.1069 and compared with ROCS colour 
(column 2, column 4 in table 5.9), p-value=0.07593. Both comparisons conclude that the 
null hypothesis is accepted, indicating that values generated by this method (for certain 
parameters) are statistically considered to be from the same population as the other two 
methods within the 0.05 significance level. For completeness, the final test wavelet vs 
ROCS colour (column 3, column 4 in table 5.9) evaluated a p-value=0.5276, indicating a 
significantly higher probability that the values are from the same population than any other 
comparison. The table 5.10 below displays and suggests how slight differences in 3D 
coordinates can significantly affect the outcome, for this method. 
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It should be stated that one of the other two approaches always produced an actual better 
result, with one exception class ‘INHA’. In many cases this method was very close to the 
other results, for example P38, PDE5 and to a lesser extent COX2, SRC, PDGFRB and 
VEGFR2. EGFR which scored relatively poorly compared to ROCS colour. Three point 
representations feature a lot, as do four and five but these are not as prominent as 
compared to Thrombin which shows a smooth rise for increasing K. Properties scores 
feature slightly more than volume but for the best noted scores however one might 
conclude that volume and properties are synonymous. Trends are less comparable to the 
Thrombin set but are consistent with the average DUD observations. Two queries from the 
INHA set are aligned and scored for K=3 points as explained in table 5.10. The 
representations generated are dependent upon the specific input coordinates, with a single 
atom having a large effect on the outcome. This phenomenon is suggested to be an 
artefact of the K-means. 
 
Bad – ring split Good - rings and linkers 
Reasonable – alignment and 
score 
 
Table 5.10 – Example of two INHA queries aligned and scored using K=3, scoring V=0.67 
and P=2.89. The Volume and internal functionality is aligned reasonably well with three 
points. However, one can see with the red spheres the rings and linkers are captured well 
however with the white spheres this is not the case and a ring is disrupted. The subtle 
difference is an extra atom in the linker in the case of red and for white one of the rings is 
not aromatic and is “more 3D” as a result. Hence even in this case with very small atomic 
differences, volume overlap will be unnecessarily lost for this alignment and this is 
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5.6 – Conclusion of overall method effectiveness over these data sets 
The Thrombin results show improving results for increasing levels of representation, which 
might be considered the intuitive behaviour for an apparently well behaved homogeneous 
data set. The magnitude of the results and the trends are generally encouraging compared 
to other methods reported in the literature indicating that for this data set this method can 
work well. All the stated measures for shape comparison show an increase for increasing 
levels of representation K, with the partial matching mode giving the best results. The 
clique/partial alignment method outperforms the systematic alignment method with 5 
points and above but the systematic alignment also gives good results for 3 and 4 points. 
The volume scores V more often outperform the properties P and perhaps the converse is 
closer to expectation, since the inclusion of properties attempts to improve the chemical 
representation. The sub-shape scores are less conclusive and show the behaviour of 
decrease with K, thus indicating that whole molecule matching is preferable. 
The whole DUD set exhibits a lot of variation across the 40 protein classes with some 
showing good response and others showing little or no response and this seems to be no 
different to other 3D methods applied to this data set which can also show a large spread 
of AUC values. For the systematic alignment we see K=3,4 gave approximately the same 
AUC values but both recall measures increase from K=3 to 4. Exact mode results increase 
almost linearly with K for AUC and recall. Partial mode shows a drop off with increasing K. 
The properties scores are always better than the volume scores which is a more 
encouraging conclusion, assuming pharmacophore properties are exerting an effect. The 
systematic alignment gives the better results than clique alignment (K=3 to 6).  
All data reported initially are averaged and hence it is not as clear cut as the Thrombin case 
which is for a single activity class. The partitioning algorithm yielding non-perfect 
representations at certain K levels and the possible need for a clique optimisation might 
contribute to the difference. The recall data does tend to portray a slightly better picture of 
the average results than AUC showing generally increasing values over increasing K, similar 
to Thrombin.  
Examining eight of the DUD protein classes in detail we find that several of the classes 
show some good results. The method performed best on P38, PDE5, PDGFRB and to some 
extent COX2, INHA and SRC. VEGFR2 and EGFR show relatively poor response. This method 
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has been directly compared to Sheffield wavelet thumbnail and ROCS colour in this chapter 
and the compared results showed no significant difference within a 0.05 significance level.  
It was observed that the clique alignment method with K=5 can outperform the systematic 
alignment K=3,4 for some of these sets but not often. This might lead to the conclusion that 
basic three point representation and ‘Triangle matching’, scoring using either volume or 
properties is actually on average the most effective method. Example of other triangle or 
three point representation based methods are defined in the literature (Bonachera  et al., 
2006; Kinnings  et al., 2009).  The presence of Iodine or Chlorine was shown not to have any 
detrimental or bias effects on the results. The results were not as good as those exhibited 
by ROCS colour or the wavelet method, however triangle alignment can be very fast and so 
there is some utility as a faster pre-screening step. 
Both alignment methods have some utility and of course the systematic alignment is only 
able to deal with three or four points, so for larger molecules based on scale, the clique 
alignment method should be the dominant option. One of the major over-sights of this 
approach was not considering scale appropriately and always matching similar levels of 
representation without considering, the three internal principal moments which help to 
identify the relative sizes of molecules. The shape mode seems to be more effective in 
resolving actives and decoys which makes sense also since in the entire representation 
(more information) is being considered (sub-shape can give false actives).  
A limitation of the K-means algorithm was identified, it was shown that the K-means can 
naturally produce artificially small points that contain only 1 or 2 atoms and this can also be 
detrimental to performance, since the available overlap volume can reduce sharply. Also 
non-ideal “ring breaker” representations are possible.  It appears that the level of K used 
will only be beneficial to the scoring if the number of points represents the major rings and 
fragments correctly and it is clear that comparing molecules with the same K is incorrect if 
scale is not considered suitably. Suggestions for improvement of the partition algorithm are 







Chapter 6 – Conclusions and future work 
 
6.1 – Conclusions 
 
This thesis has included a literature search in the areas of virtual screening, rational drug 
design and 3D similarity search. The development of a novel three dimensional similarity 
searching method is then described. A set of Java programs has been developed that 
executes the method workflows described in Chapter 4.   This method has been applied to 
some industry standard test data sets and the results observed and discussed in Chapter 5. 
The rest of this chapter describes suggested ways to improve on the basic methods and 
approaches defined in chapter 4. 
The previous chapter 5 described three sets of experiments that have aimed to validate the 
method described in chapter 4. The first experimental set was the single target class of 
Thrombin actives and showed that the method behaves largely as might be presumed for a 
homogeneous set of actives. As the number of points increased then the retrieval 
increased however perhaps more surprising was the properties scores often did not 
outperform the volume scores. The sub-shape scores were also less discriminating.  
The second experimental set examined was the forty DUD targets. This data set showed a 
lot of variation with this method in that some classes showed promise with actives scoring 
well with the queries and with visual alignments and associated scores that seem quite 
reasonable to analysis and visual inspection (Figure 4.24). The trends on the whole show 
properties scores to be more discriminating than volume but it is much less clear about the 
best level of representation for the entire set. Some of the classes showed very little 
propensity to be resolved via this method at all and so at best it would appear it could be 
used for only some of the protein classes in this set. The alignment methods proved to be 
largely comparable with some cases where the clique approach with K>4 gave better 
results than the systematic approach, particularly with the exact mode. 
The final set of experiments concentrated on eight of the DUD classes which were also 
used in validation experiments of other 3D similarity methods reported in the literature. In 
some cases, the method compared well with the established methods with the values 
showing some clear overlap and also a fairly normal distribution of response was observed 
over the eight targets with several relatively good, several average and some poor results 
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observed. In most cases, this method does not perform to the same standard as the bench 
mark ROCS colour method but in most cases it is of the same order of magnitude. In one of 
the eight cases it did outperform ROCS colour in terms of AUC scores (INHA). Looking in 
more detail at the components of the method we can describe potential improvements 
that could be investigated.  
• The K-means representation used proved to be useful to some extent in some 
cases and parameterisations. The concept of scale was not well implemented in 
that identical levels of representation K, were always compared irrelevant of 
molecular size. Using a standard unit size sphere, for example using the radius of a 
six member ring as standard, could be used to place points in a new 
representation. The K-means can give representations with non-ideal point 
placements as Table 5.10 shows in the simplest of cases with minor structural 
modifications a detrimental effect is seen using K-means (rings split). Comparing 
molecules represented by different numbers of “ring units” is likely to give 
markedly improved results and in particular the sub-shape results should also 
improve with a better implementation of scale.  
• Both alignment methods and scoring approaches seem perfectly reasonable to 
investigate further with a possible improved representation. Assuming that some 
larger molecules will certainly have to be represented with more than four points 
then the clique method would certainly be required in the alignment step.  
• The scoring functions used could be tuned further to include more atom or 
chemical information or extended with alternative scoring such as simple counts of 
pharmacophore typed atoms rather than using atomic masses. 
• Flexible search was not investigated here and indeed would be unlikely to improve 
the picture until such a time as the representation or partitioning approach is 
improved upon. Representative (extrema and average) conformers are a 
reasonable input for this.  
• Alignment of three point representations just using the Kabsch algorithm is another 








There is evidence to suggest the method is working as intended with trends being observed 
which are reasonable with some data sets. Does the method identify biologically similar 
molecules as was the original intention? Yes, there is evidence to suggest this is occurring 
in some cases with visual and numerical evidence to support this. Does the method 
discriminate sufficiently between different molecules? To some extent the retrieval rates 
show some good discrimination for some classes but this method by no means out 
performs other established similarity methods. Is there any correlation with the scores and 
biological activity? The method shows some correlation with biological activity but certainly 
with open questions. Is the method fast enough for real sized searches? For a real 
environment with very large data sets this method as currently implemented would 
struggle to perform to an acceptable standard. Fingerprinting the representation does help 
speed up method execution. Processing of the cliques was noted in particular as the rate 
determining step for that alignment method and the systematic alignment method did 
perform significantly faster (matching triangles with this method is rapid). Overall, it can be 
said that this approach is novel relative to its peers and does show some initial promise. 
The next sections describe ways in which the method and performance may be improved 
to achieve better results. From the author’s perspective it has certainly been a considerable 















6.2 – Suggestions for future work 
 
6.2.1 – Extending the partitioning approach 
Alternative reduced graphs in two dimensions have been applied to 2D similarity search 
where the performance is comparable to Daylight fingerprints (Gillet  et al., 2003). The 
reduction schemas applied are based on ring systems and functional groups defined using 
SMARTS strings. It should be possible to extend the 2D graph representation to 3D, which 
could then form the input to the alignment methods developed here. The K-means 
algorithm does not always result in the partitioning of molecules into fragments of similar 
sizes and can in some cases give less than ideal centroid placements. Spheres that are of 
different sizes have a detrimental effect on similarity comparison (in some cases the K-
means assigns a single atom to a point). The K-means is potentially good to identify an 
initial set of well distributed seed starting points that can then be used as initial conditions.  
Such extension schemes could include rules to allow the sharing of atoms across clusters 
(bridge atoms), ensuring ring systems are always retained intact where possible with ring 
centred points and also smarter ways to identify successive points in the representation 
generation. Further to this the points are derived geometrically to start with but could be 
weighted so as to reflect the centre of mass of the atoms. Figure 6.1 below shows an 
example of a point that is not aligned with the ring centroid since the points cannot share 
the bridge atoms. 
 
Figure 6.1 - The K-means does not accommodate bridge sharing of atoms (the group 
membership is currently mutually exclusive). 
6.2.2 – Use of smart search algorithm and non-deterministic representation set 
The K-means can be non-deterministic if seeded with K random coordinate starting points. 
This in turn leads to a set of solutions, one of which was always observed as equal to the 
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deterministic solution. Speculation on the nature of the deterministic solution always 
appearing in the solution set for non-deterministic algorithm is not analysed further here. 
Clearly there could be scope to investigate a set of non-deterministic representations 
generated in conjunction with a smarter search algorithm which might be used to 
determine representations that approach ideal.  The ideal value for the number of points 
required to represent a (drug-like) molecule is also part of the research question, however 
other approaches suggest 3, 4 and possibly 5 point pharmacophores are assumed to give 
an adequate level of description. However one must consider that pharmacophores are 
normally considered a substructure and thus these heuristics might not apply to 
partitioned whole molecules but might apply to portions of active “sub-shapes”. The 
representation is essentially molecular fragments which are not discrete classical chemical 
functional groups that are identified by a SMARTS.  
6.2.3 - Comparing molecules of different K representations 
The current method is restricted to comparing molecules that are reduced to the same 
number of K points. While this may be a reasonable approach for molecules that are of 
similar sizes it is unlikely to be optimal where the query and target molecules are 
significantly different in size. A more effective approach may be to choose K so that each 
node represents a different structural feature such as a ring or aliphatic fragment or so that 
each K represents a fixed number of atoms. Thus the level of reduction would be molecule 
dependent. Since the clique alignment approach can accept any number of points for query 
and target this could be used directly with any new representation of any number of points 
for either. An example of where the K-means does a provide a reasonable representation is 
the molecule Gleevec shown in Figure 6.2 below. 
 
 
Figure 6.2 - The molecule Gleevec represented (relatively well) by the K-means at K=5. 
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6.2.4 – Flexible search 
 
A suggested way to include flexible search in this approach is to build information about 
inherent molecular flexibility into the representation so that there is still only a single 
representation object to handle for each molecule within any given search context.  This 
could potentially reduce the search time for flexible search relative to employing the 
ensemble approach or exhaustively searching through rotational bonds, both of which 
become less tractable as the inherent flexibility increases. As such, flexible search as 
described here should add little or no additional over-head since the radius r value is the 
only term modified. The approach requires that some representative conformers are 
generated similar to the ensemble approach. Two important criteria regarding any 
molecule’s flexibility are the number of rotational bonds present and the associated RMSD 
for an ensemble of conformations. The latter is derived experimentally.  
For each sphere, k a flexibility weighting could be applied to the radius according to the 
number of rotatable bonds present in its constituent atoms. A suggested function is 
defined below in equation 6.1 which shows a function that should return a simple number 
that slightly increases the size of the local sphere representation based upon the fractional 
number of rotational bonds present and thus provides a basis for investigation. 
Equation 6.1 
k. |lexible	r = f k. r	 ∗ 1 +	k.Rotatable	bond	countk. Total	bond	count 	
Where “k.r” is the kth sphere radius and the other terms are the sums of rotatable and 
non-rotatable bond counts defined in the kth sphere 
A common way of handling conformational flexibility is the ensemble approach where a 
representative set of conformations is used to represent a flexible molecule. Within any 
ensemble set there is usually an RMSD value associated with each conformer relative to 
some reference lowest energy conformation for that molecule.  Thus a useful numerical 
index for flexibility is defined by the average RMSD or average internal strain energy value 
of the range of conformers from the minimal or lowest energy instance and helps indicate 
the amount of variability over the set of atoms in the molecule.  
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Each conformation is a query in its own right however, the interest is mainly how similar 
molecules behave irrespective of the ensemble of conformations. In order to derive a single 
representation object for search, we should still need to generate a small number of 
representative conformers with the ensemble approach and then use the RMSD 
information in the construction of the flexible representation.  Given an ensemble of 
conformers and an associated maximal RMSD for a set of conformers we can build the 
global flexibility into each member sphere radii as well as incorporating the local flexibility 
as defined above. A simple function to combine both “local” and “global” flexibility is 
suggested in equation 6.2 below. 
Equation 6.2 
k. |lexible	r
= 	f k. r	 ∗ 1 +	k. Rotatable	bond	countk. Total	bond	count  + 1 + k. Heavy	Atom	Count ∗ 	RMSDHeavy	Atom	Count 2 	
Where “k.r” is the kth sphere radius and the other terms are the sums of rotatable and 
non-rotatable bond counts and the heavy atom count defined in the kth sphere, the global 
heavy atom count and the RMSD defined for the ensemble, if it exists. 
The issue is then where to position the centroid of the sphere and one option would be to 
use the group centroid. This is of course a speculative research question and it has been 
noted in chapter 3 that flexible search often adds absolutely no observed value to similarity 
type approaches. 
6.2.5 - Gaussian function to model rigid or flexible fragment  
During group level scoring exactly when hard or soft sphere should be employed is likely to 
be related to the distance between two points during any given overlap comparison (Grant  
et al., 1995).The original Grant/Pickup work suggested that a choice between the two 
representations was actually based upon the distance between two points. It is also 
pertinent to consider the use of soft sphere representations to model flexible groups. Since 
it is difficult to parameterise a non-spherical Gaussian to represent a fragment perhaps a 
spherical Gaussian can be used to model flexibility at the fragment level i.e. the spherical 
Gaussian parameterisation for a fragment is derived in conjunction with the modified 
flexible index above so that the effects of matter over the flexible space decays in some 
fashion and is not uniform. This seems a more realistic way to model a fragment that is 
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mobile and rapidly moving or rotating in space and thus exerts some form of centripetal 
force. One might expect more mass to be found closer to the source of rotation rather than 
further away, to some extent.  The Gaussian function parameterisation can be extracted by 
using the hard sphere rigid or flexible radius in order to give a spherical Gaussian 
representation in 3D with a density component. This representation may be integrated 
quickest in conjunction with a look up table which stores the parameterisation and 
evaluated integrals. See equation 6.3 below. 
Equation 6.3  
 = 2.7 ∗  	
 - ∗  sin 	 ∗  -  
Where r is the sphere radius and b is the required Gaussian pre-factor and Vhs is the hard 
sphere volume. 
6.2.6 - Use of radial distribution functions at atom level for superposition query 
generation 
Use of an active series alignment, to derive pharmacophore hypotheses is a well known 
technique, the original being termed the active analogue approach (Marshall  et al., 1979) 
with many other similar approaches such as GASP, GALAHAD, CATALYST and DISCO (Patel  
et al., 2002), which are all well established methods of deriving accurate query data for any 
given search problem domain. Many molecules are geometrically aligned, compared and 
scored in order to compile a dense object for logical hypotheses extraction. Ultimately, the 
reduced point representation of a molecule is run to “completion” we end up dealing with 
an all atom representation. Query derivation or elucidation might yield a denser “super 
molecule” object for input into the database search process. This data object sourced from 
a set of coordinates and might be the result of an active series alignment perhaps based 
upon a similar overlap scoring function and alignment approach to the database search. An 
all atom comparison and score during an elucidation phase followed by a reduced points 
extraction method to derive a query object clearly exists using this approach. In the past 
atoms have been represented as hard spheres and soft spheres and any discussion of the 
merits of using a soft sphere approach primarily include a more accurate depiction of 
electron density decay with distance from a specific atomic nucleus. At the group or 
fragment level the use of spherical or non-spherical Gaussians electron density might be 
difficult to parameterise correctly and at the atomic level a simple Gaussian may not reflect 
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more complex higher atomic number atoms very well which also contain non-spherical 
atomic orbitals. Characteristic single atom density decay can be more accurately 
approximated by use of radial distribution functions which are higher forms of the Gaussian 
function which include power series in with an additional  term. The alignment and 
comparison of two or more molecules in order to maximise the volume and properties 
overlap of an active series might be based upon the use of radial distribution functions to 
represent atoms. Clearly, in this approach atoms and fragments will require different 
functional forms and parameterisations. This could provide a super molecule object which 
could be used for subsequent combinatorial extraction of speculative hypothesis source for 
“Reduced point fuzzy pharmacophore vectors”. Once an alignment is complete one will 
have a dense set of points to which we can apply our representation approaches in order to 
derive a set of objects as query. Use of the all atom density overlap criterion to generate 
the dense point set which is then used to derive the representation source will require 
scoring of all representative conformers in an active series. Figure 6.3 shows the use of an 
exponential function to model an S orbital.  




















Figure 6.3 - Radial distribution function  =  ∗  
¡ 	can be used to model a 
Hydrogen 1s orbital and for use as higher orbital representation. The overlap of these 
functions could be used to score an elucidation / alignment method. 
Please see equation 6.4 for associated integral. 
Equation 6.4  
¢fx, y, z	dv =	
  fr, θ, ω	dv


 =  Ae
¤ rdr ∗  sinθ	dθ¥ ∗  dω-¥  
Where n is an integer and A and b are characteristic exponential factors.  This is the 
spherical coordinates form of the integral. 
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6.2.7 - Use of a field graph at the fragment level 
Since it is a difficult task to correctly parameterise and construct a (non-spherical) Gaussian 
function that correctly represents an arbitrary fragment as a field then it might be 
pertinent to employ an icosahedral field graph approximation for each point (k)  in order to 
simulate a local scalar or vector field. It is assumed that this sort of treatment might be a 
way to extend the scoring for molecules that exhibit high volume and property overlap. The 
VDW and electrostatic contribution of each fragment could be determined at each vertex 
and a scalar (VDW) or vector (electrostatic) field defined using a [+1,0,-1] probe. It is 
suggested that this platonic solid is scaled such that each vertex sits upon a sphere that is 
slightly larger (1 Å) than the maximal distance between the centroid and furthest atom 
member in each cluster point and in fact an alternative radius such as in equation 6.1 could 
be used here. Clearly such an approach could use existing formal charge or would require 
the use of a partial charge assignment algorithm for the heavy atoms. Alignment of a net 
dipole vector for each fragment is also another possible avenue to explore. Heavy atom 
partial charge could be assigned using the orbital electronegativity plug-in, for example 
from ChemAxon. Please see equation 6.5 below which describes a possible scoring 
approach. 







Where ©ª is kth point charge, ª¨  is distance between kth point and j th probe evaluation 
point and ¬ is a vacuum permittivity constant. 
 
6.2.8 – Using Structural and active site data for included or excluded volume 
If a protein structure is available, an active site shape could be extracted by taking a “cast” 
of the active site and mapping this point set to an “inverse object” or “pseudo ligand” that 
is contained with the convex hull of what is effectively a 3D graph of the active site. 
Inversion of these characteristics in the space defines an ideal complementary set of points 
in terms of required interactions. It seems that one way this could be achieved is by taking 
the geometric mid-points between all atom combinations and then applying a slightly 
 modified version of the representation generation approach in order to define the effective 
inverse. This could then be included in an active series alignment as 
template prior to active series overlay in rotational bond or biological 
example. This could be thought of as a simple kind 
docking approach whereby
template for further alignments
structure based 3D similarity approach 
subsequently extracted 
active series alignment and elucidation stage such as described in 6.2.1 above. Complex 
crystal water molecules can be treated as discrete points also in
and used in mass weighting in the H
 
Figure 6.4 - Extracting an active site negative image
between all active site atoms can be used as the dense data set to be partitioned and 












the starting point 
activity order, for 
of pharmacophore or fragment level 
 an active site inverse template is derived and used as a 
 (Ebalunode  et al., 2008). This would then become a 
with the aim to enhance the accuracy of the queries 
(Goto  et al., 2004). Such data could also be incorporated into an 
 this approach and treated 
-bond donor/acceptor categories. 




6.3 – Conclusion 
 
Some ways to extend the methods in chapter 4 are suggested here. Partitioning scheme 
modifications are suggested as the primary change, in order to create a more accurate or 
effective representation that does not split up natural ring pharmacophoric ring systems. 
Modified representations generated and compared at different K levels are almost 
certainly a crucial next step for the existing representation. Alternatively, another reduced 
point representation can be used with the alignment and scoring methods discussed in 
Chapter 4. In addition the non-deterministic K-means could be investigated in conjunction 
with a genetic algorithm. A flexible search approach can be defined using rotational bond 
and RMSD data but it was noted in the literature that often this will yield no improvements. 
The use of a look up table to pre-compute each representation prior to alignment will yield 
a performance increase.  A field based approach could be annotated using icosahedral 
approximations and an electrostatic scoring function to model charge distribution which is 
not included in the current model. The negative image of a protein active site could be 
extracted and built into the query. Some simple data fusion rules might be used with 
different alignments and scores to derive indexes that correlate better with observed 
biological activity. Deriving an accurate query using multiple molecule overlay and accurate 
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Appendix A – Thrombin results data 
EF & AUC LIMNA9_501_pdb2a2x_1 
K D R M SHAPE EF(V) EF(P) R_AUC(V) R_AUC(P) ACTIVES DECOYS TOTAL 
3 2 2 1 shape 7.53 7.53 0.77 0.77 17 143 160 
3 2 2 1 sub-shape 7.53 7.53 0.77 0.77 17 143 160 
3 2 2 2 shape 5.65 5.65 0.62 0.62 17 143 160 
3 2 2 2 sub-shape 5.65 5.65 0.62 0.62 17 143 160 
3 4 2 1 shape 7.53 7.53 0.81 0.83 17 143 160 
3 4 2 1 sub-shape 7.53 7.53 0.81 0.83 17 143 160 
3 0 0 0 shape 7.53 7.53 0.56 0.60 17 143 160 
4 2 2 1 shape 8.47 8.47 0.77 0.78 17 143 160 
4 2 2 1 sub-shape 2.82 7.53 0.69 0.72 17 143 160 
4 2 2 2 shape 8.47 8.47 0.77 0.77 17 143 160 
4 2 2 2 sub-shape 8.47 8.47 0.77 0.77 17 143 160 
4 0 0 0 shape 8.47 8.47 0.93 0.78 17 143 160 
5 1 2 1 shape 9.41 8.47 0.95 0.92 17 143 160 
5 1 2 1 sub-shape 1.88 5.65 0.69 0.80 17 143 160 
5 1 2 2 shape 8.47 8.47 0.72 0.72 17 143 160 
5 1 2 2 sub-shape 7.53 8.47 0.72 0.72 17 143 160 
6 1 2 1 shape 9.41 8.47 0.95 0.92 17 143 160 
6 1 2 1 sub-shape 3.76 6.59 0.64 0.69 17 143 160 
6 1 2 2 shape 9.41 7.53 0.78 0.77 17 143 160 







EF &AUC LIMIGN_999_pdb1k21_1 
K D R M SHAPE EF(V) EF(P) R_AUC(V) R_AUC(P) ACTIVES DECOYS TOTAL 
3 2 2 1 shape 7.53 7.53 0.74 0.74 17 143 160 
3 2 2 1 sub-shape 7.53 7.53 0.74 0.74 17 143 160 
3 2 2 2 shape 5.65 5.65 0.61 0.61 17 143 160 
3 2 2 2 sub-shape 5.65 5.65 0.61 0.61 17 143 160 
3 4 2 1 shape 7.53 7.53 0.80 0.82 17 143 160 
3 4 2 1 sub-shape 7.53 7.53 0.80 0.82 17 143 160 
3 0 0 0 shape 6.59 7.53 0.58 0.63 17 143 160 
4 2 2 1 shape 8.47 8.47 0.73 0.72 17 143 160 
4 2 2 1 sub-shape 3.76 7.53 0.66 0.67 17 143 160 
4 2 2 2 shape 8.47 8.47 0.77 0.77 17 143 160 
4 2 2 2 sub-shape 8.47 9.41 0.77 0.77 17 143 160 
4 0 0 0 shape 7.53 8.47 0.87 0.76 17 143 160 
5 1 2 1 shape 8.47 9.41 0.88 0.87 17 143 160 
5 1 2 1 sub-shape 2.82 6.59 0.67 0.75 17 143 160 
5 1 2 2 shape 8.47 8.47 0.72 0.72 17 143 160 
5 1 2 2 sub-shape 8.47 8.47 0.72 0.72 17 143 160 
6 1 2 1 shape 8.47 9.41 0.90 0.86 17 143 160 
6 1 2 1 sub-shape 1.88 3.76 0.55 0.66 17 143 160 
6 1 2 2 shape 7.53 9.41 0.84 0.85 17 143 160 








E & AUC LIMCDA_201_pdb1mu6_1 
K D R M SHAPE EF(V) EF(P) R_AUC(V) R_AUC(P) ACTIVES DECOYS TOTAL 
3 2 2 1 shape 6.59 6.59 0.61 0.61 17 143 160 
3 2 2 1 sub-shape 6.59 6.59 0.61 0.61 17 143 160 
3 2 2 2 shape 2.82 2.82 0.54 0.54 17 143 160 
3 2 2 2 sub-shape 2.82 2.82 0.54 0.54 17 143 160 
3 4 2 1 shape 6.59 6.59 0.60 0.59 17 143 160 
3 4 2 1 sub-shape 6.59 6.59 0.60 0.59 17 143 160 
3 0 0 0 shape 6.59 6.59 0.60 0.52 17 143 160 
4 2 2 1 shape 4.71 4.71 0.54 0.50 17 143 160 
4 2 2 1 sub-shape 3.76 3.76 0.56 0.57 17 143 160 
4 2 2 2 shape 2.82 2.82 0.60 0.60 17 143 160 
4 2 2 2 sub-shape 2.82 2.82 0.60 0.60 17 143 160 
4 0 0 0 shape 5.65 5.65 0.89 0.69 17 143 160 
5 1 2 1 shape 7.53 6.59 0.91 0.83 17 143 160 
5 1 2 1 sub-shape 3.76 5.65 0.67 0.63 17 143 160 
5 1 2 2 shape 2.82 3.76 0.51 0.51 17 143 160 
5 1 2 2 sub-shape 1.88 2.82 0.53 0.51 17 143 160 
6 1 2 1 shape 5.65 4.71 0.75 0.68 17 143 160 
6 1 2 1 sub-shape 3.76 2.82 0.55 0.53 17 143 160 
6 1 2 2 shape 4.71 3.76 0.66 0.64 17 143 160 








EF & AUC LIMAZL_600_pdb1ae8_1 
K D R M SHAPE EF(V) EF(P) R_AUC(V) R_AUC(P) ACTIVES DECOYS TOTAL 
3 2 2 1 shape 3.76 4.71 0.76 0.77 17 143 160 
3 2 2 1 sub-shape 3.76 4.71 0.76 0.77 17 143 160 
3 2 2 2 shape 0.94 0.94 0.50 0.50 17 143 160 
3 2 2 2 sub-shape 0.94 0.94 0.50 0.50 17 143 160 
3 4 2 1 shape 3.76 4.71 0.76 0.77 17 143 160 
3 4 2 1 sub-shape 3.76 4.71 0.76 0.77 17 143 160 
3 0 0 0 shape 3.76 5.65 0.55 0.55 17 143 160 
4 2 2 1 shape 6.59 7.53 0.78 0.79 17 143 160 
4 2 2 1 sub-shape 1.88 3.76 0.61 0.63 17 143 160 
4 2 2 2 shape 2.82 2.82 0.54 0.54 17 143 160 
4 2 2 2 sub-shape 1.88 2.82 0.54 0.54 17 143 160 
4 0 0 0 shape 7.53 3.76 0.91 0.74 17 143 160 
5 1 2 1 shape 5.65 4.71 0.77 0.74 17 143 160 
5 1 2 1 sub-shape 1.88 2.82 0.64 0.66 17 143 160 
5 1 2 2 shape 1.88 1.88 0.51 0.51 17 143 160 
5 1 2 2 sub-shape 1.88 1.88 0.51 0.51 17 143 160 
6 1 2 1 shape 8.47 9.41 0.93 0.93 17 143 160 
6 1 2 1 sub-shape 0.94 0.94 0.52 0.53 17 143 160 
6 1 2 2 shape 5.65 4.71 0.76 0.76 17 143 160 








EF & AUC LIM162_179_pdb1nzq_1 
K D R M SHAPE EF(V) EF(P) R_AUC(V) R_AUC(P) ACTIVES DECOYS TOTAL 
3 2 2 1 shape 7.53 7.53 0.65 0.65 17 143 160 
3 2 2 1 sub-shape 7.53 7.53 0.65 0.65 17 143 160 
3 2 2 2 shape 5.65 5.65 0.62 0.62 17 143 160 
3 2 2 2 sub-shape 5.65 5.65 0.62 0.62 17 143 160 
3 4 2 1 shape 7.53 7.53 0.80 0.81 17 143 160 
3 4 2 1 sub-shape 7.53 7.53 0.80 0.81 17 143 160 
3 0 0 0 shape 7.53 7.53 0.58 0.56 17 143 160 
4 2 2 1 shape 8.47 8.47 0.83 0.81 17 143 160 
4 2 2 1 sub-shape 4.71 6.59 0.77 0.78 17 143 160 
4 2 2 2 shape 8.47 8.47 0.77 0.77 17 143 160 
4 2 2 2 sub-shape 8.47 7.53 0.77 0.77 17 143 160 
4 0 0 0 shape 9.41 8.47 0.92 0.78 17 143 160 
5 1 2 1 shape 9.41 9.41 0.96 0.96 17 143 160 
5 1 2 1 sub-shape 3.76 7.53 0.82 0.92 17 143 160 
5 1 2 2 shape 8.47 8.47 0.77 0.76 17 143 160 
5 1 2 2 sub-shape 5.65 7.53 0.75 0.76 17 143 160 
6 1 2 1 shape 9.41 9.41 0.93 0.91 17 143 160 
6 1 2 1 sub-shape 2.82 4.71 0.52 0.65 17 143 160 
6 1 2 2 shape 8.47 7.53 0.82 0.81 17 143 160 








EF & AUC LIM34P_1_pdb2feq_1 
K D R M SHAPE EF(V) EF(P) R_AUC(V) R_AUC(P) ACTIVES DECOYS TOTAL 
3 2 2 1 shape 6.59 6.59 0.65 0.65 17 143 160 
3 2 2 1 sub-shape 6.59 6.59 0.65 0.65 17 143 160 
3 2 2 2 shape 5.65 5.65 0.61 0.61 17 143 160 
3 2 2 2 sub-shape 5.65 5.65 0.61 0.61 17 143 160 
3 4 2 1 shape 6.59 6.59 0.82 0.82 17 143 160 
3 4 2 1 sub-shape 6.59 6.59 0.82 0.82 17 143 160 
3 0 0 0 shape 5.65 4.71 0.57 0.54 17 143 160 
4 2 2 1 shape 8.47 8.47 0.84 0.82 17 143 160 
4 2 2 1 sub-shape 5.65 7.53 0.78 0.80 17 143 160 
4 2 2 2 shape 8.47 8.47 0.72 0.72 17 143 160 
4 2 2 2 sub-shape 8.47 8.47 0.72 0.72 17 143 160 
4 0 0 0 shape 8.47 8.47 0.91 0.76 17 143 160 
5 1 2 1 shape 9.41 8.47 0.98 0.88 17 143 160 
5 1 2 1 sub-shape 0.94 3.76 0.56 0.67 17 143 160 
5 1 2 2 shape 8.47 8.47 0.73 0.72 17 143 160 
5 1 2 2 sub-shape 4.71 5.65 0.71 0.71 17 143 160 
6 1 2 1 shape 9.41 8.47 0.84 0.81 17 143 160 
6 1 2 1 sub-shape 1.88 2.82 0.56 0.62 17 143 160 
6 1 2 2 shape 8.47 8.47 0.73 0.73 17 143 160 








EF & AUC LIM5CB_1246-H_pdb2bvx_1 
K D R M SHAPE EF(V) EF(P) R_AUC(V) R_AUC(P) ACTIVES DECOYS TOTAL 
3 2 2 1 shape 6.59 5.65 0.63 0.64 17 143 160 
3 2 2 1 sub-shape 6.59 5.65 0.63 0.64 17 143 160 
3 2 2 2 shape 1.88 1.88 0.53 0.53 17 143 160 
3 2 2 2 sub-shape 1.88 1.88 0.53 0.53 17 143 160 
3 4 2 1 shape 6.59 5.65 0.65 0.65 17 143 160 
3 4 2 1 sub-shape 6.59 5.65 0.65 0.65 17 143 160 
3 0 0 0 shape 6.59 5.65 0.56 0.63 17 143 160 
4 2 2 1 shape 7.53 4.71 0.87 0.81 17 143 160 
4 2 2 1 sub-shape 3.76 3.76 0.74 0.73 17 143 160 
4 2 2 2 shape 2.82 2.82 0.51 0.51 17 143 160 
4 2 2 2 sub-shape 2.82 2.82 0.51 0.51 17 143 160 
4 0 0 0 shape 4.71 2.82 0.92 0.80 17 143 160 
5 1 2 1 shape 5.65 3.76 0.76 0.66 17 143 160 
5 1 2 1 sub-shape 2.82 1.88 0.61 0.61 17 143 160 
5 1 2 2 shape 3.76 3.76 0.50 0.50 17 143 160 
5 1 2 2 sub-shape 1.88 1.88 0.50 0.50 17 143 160 
6 1 2 1 shape 8.47 7.53 0.86 0.85 17 143 160 
6 1 2 1 sub-shape 2.82 3.76 0.61 0.64 17 143 160 
6 1 2 2 shape 6.59 4.71 0.69 0.68 17 143 160 








Thrombin 7 datasets, Recall@5% 
K D R M SHAPE RECALL(V) RECALL(P) ACTIVES DECOYS TOTAL 
3 2 2 1 shape 41.18 41.18 17 143 160 
3 2 2 1 
sub-
shape 
41.18 41.18 17 143 160 
3 2 2 2 shape 35.29 35.29 17 143 160 
3 2 2 2 
sub-
shape 
35.29 35.29 17 143 160 
3 4 2 1 shape 41.18 41.18 17 143 160 
3 4 2 1 
sub-
shape 
41.18 41.18 17 143 160 
3 0 0 0 shape 41.18 41.18 17 143 160 
4 2 2 1 shape 47.06 47.06 17 143 160 
4 2 2 1 
sub-
shape 
17.65 41.18 17 143 160 
4 2 2 2 shape 47.06 47.06 17 143 160 
4 2 2 2 
sub-
shape 
47.06 47.06 17 143 160 
4 0 0 0 shape 47.06 47.06 17 143 160 
5 1 2 1 shape 47.06 47.06 17 143 160 
5 1 2 1 
sub-
shape 
5.88 35.29 17 143 160 
5 1 2 2 shape 47.06 47.06 17 143 160 
5 1 2 2 
sub-
shape 
35.29 41.18 17 143 160 
6 1 2 1 shape 47.06 47.06 17 143 160 
6 1 2 1 
sub-
shape 
11.76 35.29 17 143 160 
6 1 2 2 shape 47.06 47.06 17 143 160 
6 1 2 2 
sub-
shape 
35.29 35.29 17 143 160 
3 2 2 1 shape 41.18 47.06 17 143 160 
3 2 2 1 
sub-
shape 
41.18 47.06 17 143 160 
3 2 2 2 shape 35.29 35.29 17 143 160 
3 2 2 2 
sub-
shape 
35.29 35.29 17 143 160 
3 4 2 1 shape 41.18 47.06 17 143 160 
3 4 2 1 
sub-
shape 
41.18 47.06 17 143 160 
3 0 0 0 shape 41.18 47.06 17 143 160 
4 2 2 1 shape 47.06 47.06 17 143 160 
4 2 2 1 
sub-
shape 
23.53 35.29 17 143 160 
4 2 2 2 shape 47.06 47.06 17 143 160 
4 2 2 2 
sub-
shape 
47.06 47.06 17 143 160 
4 0 0 0 shape 41.18 47.06 17 143 160 
5 1 2 1 shape 47.06 47.06 17 143 160 
149 
 
5 1 2 1 
sub-
shape 
17.65 29.41 17 143 160 
5 1 2 2 shape 47.06 47.06 17 143 160 
5 1 2 2 
sub-
shape 
47.06 47.06 17 143 160 
6 1 2 1 shape 47.06 47.06 17 143 160 
6 1 2 1 
sub-
shape 
11.76 23.53 17 143 160 
6 1 2 2 shape 47.06 47.06 17 143 160 
6 1 2 2 
sub-
shape 
41.18 47.06 17 143 160 
3 2 2 1 shape 41.18 41.18 17 143 160 
3 2 2 1 
sub-
shape 
41.18 41.18 17 143 160 
3 2 2 2 shape 17.65 17.65 17 143 160 
3 2 2 2 
sub-
shape 
17.65 17.65 17 143 160 
3 4 2 1 shape 41.18 41.18 17 143 160 
3 4 2 1 
sub-
shape 
41.18 41.18 17 143 160 
3 0 0 0 shape 41.18 41.18 17 143 160 
4 2 2 1 shape 29.41 29.41 17 143 160 
4 2 2 1 
sub-
shape 
23.53 23.53 17 143 160 
4 2 2 2 shape 17.65 17.65 17 143 160 
4 2 2 2 
sub-
shape 
17.65 17.65 17 143 160 
4 0 0 0 shape 35.29 35.29 17 143 160 
5 1 2 1 shape 41.18 29.41 17 143 160 
5 1 2 1 
sub-
shape 
23.53 29.41 17 143 160 
5 1 2 2 shape 17.65 23.53 17 143 160 
5 1 2 2 
sub-
shape 
11.76 17.65 17 143 160 
6 1 2 1 shape 29.41 29.41 17 143 160 
6 1 2 1 
sub-
shape 
23.53 17.65 17 143 160 
6 1 2 2 shape 23.53 17.65 17 143 160 
6 1 2 2 
sub-
shape 
29.41 29.41 17 143 160 
3 2 2 1 shape 11.76 29.41 17 143 160 
3 2 2 1 
sub-
shape 
11.76 29.41 17 143 160 
3 2 2 2 shape 5.88 5.88 17 143 160 
3 2 2 2 
sub-
shape 
5.88 5.88 17 143 160 
3 4 2 1 shape 11.76 29.41 17 143 160 
3 4 2 1 
sub-
shape 
11.76 29.41 17 143 160 
3 0 0 0 shape 11.76 35.29 17 143 160 
150 
 
4 2 2 1 shape 35.29 41.18 17 143 160 
4 2 2 1 
sub-
shape 
11.76 17.65 17 143 160 
4 2 2 2 shape 11.76 11.76 17 143 160 
4 2 2 2 
sub-
shape 
11.76 11.76 17 143 160 
4 0 0 0 shape 41.18 23.53 17 143 160 
5 1 2 1 shape 29.41 23.53 17 143 160 
5 1 2 1 
sub-
shape 
11.76 11.76 17 143 160 
5 1 2 2 shape 11.76 11.76 17 143 160 
5 1 2 2 
sub-
shape 
11.76 11.76 17 143 160 
6 1 2 1 shape 41.18 47.06 17 143 160 
6 1 2 1 
sub-
shape 
5.88 5.88 17 143 160 
6 1 2 2 shape 23.53 29.41 17 143 160 
6 1 2 2 
sub-
shape 
29.41 35.29 17 143 160 
3 2 2 1 shape 41.18 47.06 17 143 160 
3 2 2 1 
sub-
shape 
41.18 47.06 17 143 160 
3 2 2 2 shape 35.29 35.29 17 143 160 
3 2 2 2 
sub-
shape 
35.29 35.29 17 143 160 
3 4 2 1 shape 41.18 47.06 17 143 160 
3 4 2 1 
sub-
shape 
41.18 47.06 17 143 160 
3 0 0 0 shape 41.18 47.06 17 143 160 
4 2 2 1 shape 47.06 47.06 17 143 160 
4 2 2 1 
sub-
shape 
29.41 35.29 17 143 160 
4 2 2 2 shape 47.06 47.06 17 143 160 
4 2 2 2 
sub-
shape 
41.18 41.18 17 143 160 
4 0 0 0 shape 47.06 47.06 17 143 160 
5 1 2 1 shape 47.06 47.06 17 143 160 
5 1 2 1 
sub-
shape 
17.65 41.18 17 143 160 
5 1 2 2 shape 47.06 47.06 17 143 160 
5 1 2 2 
sub-
shape 
23.53 35.29 17 143 160 
6 1 2 1 shape 47.06 47.06 17 143 160 
6 1 2 1 
sub-
shape 
17.65 29.41 17 143 160 
6 1 2 2 shape 47.06 47.06 17 143 160 
6 1 2 2 
sub-
shape 
29.41 41.18 17 143 160 
3 2 2 1 shape 41.18 41.18 17 143 160 




3 2 2 2 shape 35.29 35.29 17 143 160 
3 2 2 2 
sub-
shape 
35.29 35.29 17 143 160 
3 4 2 1 shape 41.18 41.18 17 143 160 
3 4 2 1 
sub-
shape 
41.18 41.18 17 143 160 
3 0 0 0 shape 35.29 29.41 17 143 160 
4 2 2 1 shape 47.06 47.06 17 143 160 
4 2 2 1 
sub-
shape 
29.41 41.18 17 143 160 
4 2 2 2 shape 47.06 47.06 17 143 160 
4 2 2 2 
sub-
shape 
47.06 41.18 17 143 160 
4 0 0 0 shape 47.06 47.06 17 143 160 
5 1 2 1 shape 47.06 47.06 17 143 160 
5 1 2 1 
sub-
shape 
5.88 17.65 17 143 160 
5 1 2 2 shape 47.06 47.06 17 143 160 
5 1 2 2 
sub-
shape 
29.41 35.29 17 143 160 
6 1 2 1 shape 47.06 47.06 17 143 160 
6 1 2 1 
sub-
shape 
11.76 17.65 17 143 160 
6 1 2 2 shape 47.06 47.06 17 143 160 
6 1 2 2 
sub-
shape 
35.29 35.29 17 143 160 
3 2 2 1 shape 41.18 35.29 17 143 160 
3 2 2 1 
sub-
shape 
41.18 35.29 17 143 160 
3 2 2 2 shape 11.76 11.76 17 143 160 
3 2 2 2 
sub-
shape 
11.76 11.76 17 143 160 
3 4 2 1 shape 41.18 35.29 17 143 160 
3 4 2 1 
sub-
shape 
41.18 35.29 17 143 160 
3 0 0 0 shape 41.18 35.29 17 143 160 
4 2 2 1 shape 35.29 23.53 17 143 160 
4 2 2 1 
sub-
shape 
11.76 17.65 17 143 160 
4 2 2 2 shape 17.65 11.76 17 143 160 
4 2 2 2 
sub-
shape 
17.65 17.65 17 143 160 
4 0 0 0 shape 23.53 11.76 17 143 160 
5 1 2 1 shape 35.29 23.53 17 143 160 
5 1 2 1 
sub-
shape 
17.65 11.76 17 143 160 
5 1 2 2 shape 17.65 17.65 17 143 160 
5 1 2 2 
sub-
shape 
11.76 11.76 17 143 160 
152 
 
6 1 2 1 shape 41.18 35.29 17 143 160 
6 1 2 1 
sub-
shape 
17.65 23.53 17 143 160 
6 1 2 2 shape 35.29 29.41 17 143 160 
6 1 2 2 
sub-
shape 



























Thrombin 7 datasets, Recall@10% 
K D R M SHAPE RECALL(V) RECALL(P) ACTIVES DECOYS TOTAL 
3 2 2 1 shape 47.06 47.06 17 143 160 
3 2 2 1 
sub-
shape 
47.06 47.06 17 143 160 
3 2 2 2 shape 35.29 35.29 17 143 160 
3 2 2 2 
sub-
shape 
35.29 35.29 17 143 160 
3 4 2 1 shape 47.06 47.06 17 143 160 
3 4 2 1 
sub-
shape 
47.06 47.06 17 143 160 
3 0 0 0 shape 47.06 47.06 17 143 160 
4 2 2 1 shape 58.82 52.94 17 143 160 
4 2 2 1 
sub-
shape 
41.18 52.94 17 143 160 
4 2 2 2 shape 58.82 58.82 17 143 160 
4 2 2 2 
sub-
shape 
58.82 52.94 17 143 160 
4 0 0 0 shape 58.82 52.94 17 143 160 
5 1 2 1 shape 76.47 58.82 17 143 160 
5 1 2 1 
sub-
shape 
17.65 52.94 17 143 160 
5 1 2 2 shape 52.94 52.94 17 143 160 
5 1 2 2 
sub-
shape 
52.94 52.94 17 143 160 
6 1 2 1 shape 76.47 76.47 17 143 160 
6 1 2 1 
sub-
shape 
23.53 52.94 17 143 160 
6 1 2 2 shape 58.82 52.94 17 143 160 
6 1 2 2 
sub-
shape 
58.82 52.94 17 143 160 
3 2 2 1 shape 47.06 47.06 17 143 160 
3 2 2 1 
sub-
shape 
47.06 47.06 17 143 160 
3 2 2 2 shape 35.29 35.29 17 143 160 
3 2 2 2 
sub-
shape 
35.29 35.29 17 143 160 
3 4 2 1 shape 47.06 47.06 17 143 160 
3 4 2 1 
sub-
shape 
47.06 47.06 17 143 160 
3 0 0 0 shape 52.94 47.06 17 143 160 
4 2 2 1 shape 52.94 52.94 17 143 160 
4 2 2 1 
sub-
shape 
41.18 52.94 17 143 160 
4 2 2 2 shape 58.82 58.82 17 143 160 
4 2 2 2 
sub-
shape 
58.82 58.82 17 143 160 
4 0 0 0 shape 52.94 58.82 17 143 160 
5 1 2 1 shape 58.82 58.82 17 143 160 
154 
 
5 1 2 1 
sub-
shape 
17.65 47.06 17 143 160 
5 1 2 2 shape 52.94 52.94 17 143 160 
5 1 2 2 
sub-
shape 
52.94 52.94 17 143 160 
6 1 2 1 shape 70.59 58.82 17 143 160 
6 1 2 1 
sub-
shape 
11.76 29.41 17 143 160 
6 1 2 2 shape 58.82 58.82 17 143 160 
6 1 2 2 
sub-
shape 
58.82 64.71 17 143 160 
3 2 2 1 shape 41.18 41.18 17 143 160 
3 2 2 1 
sub-
shape 
41.18 41.18 17 143 160 
3 2 2 2 shape 17.65 17.65 17 143 160 
3 2 2 2 
sub-
shape 
17.65 17.65 17 143 160 
3 4 2 1 shape 41.18 41.18 17 143 160 
3 4 2 1 
sub-
shape 
41.18 41.18 17 143 160 
3 0 0 0 shape 47.06 41.18 17 143 160 
4 2 2 1 shape 29.41 35.29 17 143 160 
4 2 2 1 
sub-
shape 
23.53 23.53 17 143 160 
4 2 2 2 shape 17.65 17.65 17 143 160 
4 2 2 2 
sub-
shape 
17.65 17.65 17 143 160 
4 0 0 0 shape 41.18 35.29 17 143 160 
5 1 2 1 shape 70.59 58.82 17 143 160 
5 1 2 1 
sub-
shape 
29.41 35.29 17 143 160 
5 1 2 2 shape 23.53 23.53 17 143 160 
5 1 2 2 
sub-
shape 
17.65 23.53 17 143 160 
6 1 2 1 shape 52.94 35.29 17 143 160 
6 1 2 1 
sub-
shape 
23.53 17.65 17 143 160 
6 1 2 2 shape 47.06 29.41 17 143 160 
6 1 2 2 
sub-
shape 
35.29 41.18 17 143 160 
3 2 2 1 shape 41.18 41.18 17 143 160 
3 2 2 1 
sub-
shape 
41.18 41.18 17 143 160 
3 2 2 2 shape 5.88 5.88 17 143 160 
3 2 2 2 
sub-
shape 
5.88 5.88 17 143 160 
3 4 2 1 shape 41.18 41.18 17 143 160 
3 4 2 1 
sub-
shape 
41.18 41.18 17 143 160 
3 0 0 0 shape 41.18 35.29 17 143 160 
155 
 
4 2 2 1 shape 52.94 47.06 17 143 160 
4 2 2 1 
sub-
shape 
23.53 29.41 17 143 160 
4 2 2 2 shape 17.65 17.65 17 143 160 
4 2 2 2 
sub-
shape 
23.53 23.53 17 143 160 
4 0 0 0 shape 58.82 41.18 17 143 160 
5 1 2 1 shape 58.82 41.18 17 143 160 
5 1 2 1 
sub-
shape 
17.65 17.65 17 143 160 
5 1 2 2 shape 11.76 11.76 17 143 160 
5 1 2 2 
sub-
shape 
11.76 11.76 17 143 160 
6 1 2 1 shape 58.82 64.71 17 143 160 
6 1 2 1 
sub-
shape 
5.88 5.88 17 143 160 
6 1 2 2 shape 47.06 41.18 17 143 160 
6 1 2 2 
sub-
shape 
47.06 52.94 17 143 160 
3 2 2 1 shape 47.06 47.06 17 143 160 
3 2 2 1 
sub-
shape 
47.06 47.06 17 143 160 
3 2 2 2 shape 35.29 35.29 17 143 160 
3 2 2 2 
sub-
shape 
35.29 35.29 17 143 160 
3 4 2 1 shape 47.06 47.06 17 143 160 
3 4 2 1 
sub-
shape 
47.06 47.06 17 143 160 
3 0 0 0 shape 47.06 47.06 17 143 160 
4 2 2 1 shape 58.82 64.71 17 143 160 
4 2 2 1 
sub-
shape 
41.18 52.94 17 143 160 
4 2 2 2 shape 52.94 52.94 17 143 160 
4 2 2 2 
sub-
shape 
52.94 52.94 17 143 160 
4 0 0 0 shape 64.71 64.71 17 143 160 
5 1 2 1 shape 82.35 82.35 17 143 160 
5 1 2 1 
sub-
shape 
35.29 52.94 17 143 160 
5 1 2 2 shape 52.94 52.94 17 143 160 
5 1 2 2 
sub-
shape 
52.94 52.94 17 143 160 
6 1 2 1 shape 76.47 70.59 17 143 160 
6 1 2 1 
sub-
shape 
17.65 41.18 17 143 160 
6 1 2 2 shape 52.94 52.94 17 143 160 
6 1 2 2 
sub-
shape 
47.06 58.82 17 143 160 
3 2 2 1 shape 47.06 47.06 17 143 160 




3 2 2 2 shape 35.29 35.29 17 143 160 
3 2 2 2 
sub-
shape 
35.29 35.29 17 143 160 
3 4 2 1 shape 47.06 41.18 17 143 160 
3 4 2 1 
sub-
shape 
47.06 41.18 17 143 160 
3 0 0 0 shape 47.06 35.29 17 143 160 
4 2 2 1 shape 64.71 58.82 17 143 160 
4 2 2 1 
sub-
shape 
52.94 58.82 17 143 160 
4 2 2 2 shape 52.94 52.94 17 143 160 
4 2 2 2 
sub-
shape 
52.94 52.94 17 143 160 
4 0 0 0 shape 64.71 58.82 17 143 160 
5 1 2 1 shape 82.35 52.94 17 143 160 
5 1 2 1 
sub-
shape 
5.88 29.41 17 143 160 
5 1 2 2 shape 52.94 52.94 17 143 160 
5 1 2 2 
sub-
shape 
47.06 47.06 17 143 160 
6 1 2 1 shape 70.59 52.94 17 143 160 
6 1 2 1 
sub-
shape 
17.65 17.65 17 143 160 
6 1 2 2 shape 58.82 52.94 17 143 160 
6 1 2 2 
sub-
shape 
52.94 52.94 17 143 160 
3 2 2 1 shape 41.18 41.18 17 143 160 
3 2 2 1 
sub-
shape 
41.18 41.18 17 143 160 
3 2 2 2 shape 11.76 11.76 17 143 160 
3 2 2 2 
sub-
shape 
11.76 11.76 17 143 160 
3 4 2 1 shape 41.18 41.18 17 143 160 
3 4 2 1 
sub-
shape 
41.18 41.18 17 143 160 
3 0 0 0 shape 41.18 35.29 17 143 160 
4 2 2 1 shape 52.94 47.06 17 143 160 
4 2 2 1 
sub-
shape 
41.18 47.06 17 143 160 
4 2 2 2 shape 17.65 17.65 17 143 160 
4 2 2 2 
sub-
shape 
17.65 17.65 17 143 160 
4 0 0 0 shape 52.94 29.41 17 143 160 
5 1 2 1 shape 41.18 23.53 17 143 160 
5 1 2 1 
sub-
shape 
35.29 23.53 17 143 160 
5 1 2 2 shape 23.53 23.53 17 143 160 
5 1 2 2 
sub-
shape 
23.53 23.53 17 143 160 
157 
 
6 1 2 1 shape 76.47 58.82 17 143 160 
6 1 2 1 
sub-
shape 
23.53 29.41 17 143 160 
6 1 2 2 shape 47.06 35.29 17 143 160 
6 1 2 2 
sub-
shape 



























Appendix B - 40 DUD queries  
Shape AUC Volume and Properties values 
QUERY/CLASS K D R M AUC (V) AUC (P) 
ACE 3 4 2 1 0.691438 0.67427 
ACE 3 4 2 2 0.501393 0.501393 
ACE 3 0 0 0 0.605165 0.630822 
ACE 4 2 2 1 0.603076 0.611184 
ACE 4 2 2 2 0.562947 0.562014 
ACE 4 0 0 0 0.616604 0.590838 
ACE 5 1 2 1 0.585927 0.601072 
ACE 5 1 2 2 0.502368 0.504311 
ACE 6 1 2 1 0.578697 0.568669 
ACE 6 1 2 2 0.629181 0.614909 
ACHE 3 4 2 1 0.657332 0.6433 
ACHE 3 4 2 2 0.579045 0.579683 
ACHE 3 0 0 0 0.528525 0.516175 
ACHE 4 2 2 1 0.609302 0.660629 
ACHE 4 2 2 2 0.767535 0.77029 
ACHE 4 0 0 0 0.585356 0.657022 
ACHE 5 1 2 1 0.590435 0.664471 
ACHE 5 1 2 2 0.693503 0.691404 
ACHE 6 1 2 1 0.565997 0.651821 
ACHE 6 1 2 2 0.769726 0.766984 
ADA 3 4 2 1 0.633275 0.676621 
ADA 3 4 2 2 0.531857 0.531857 
ADA 3 0 0 0 0.567894 0.613563 
ADA 4 2 2 1 0.5241 0.560851 
ADA 4 2 2 2 0.509439 0.509807 
ADA 4 0 0 0 0.622664 0.544989 
ADA 5 1 2 1 0.53714 0.556038 
ADA 5 1 2 2 0.52627 0.524603 
ADA 6 1 2 1 0.607217 0.510118 
ADA 6 1 2 2 0.639285 0.629191 
ALR2 3 4 2 1 0.654998 0.597189 
ALR2 3 4 2 2 0.581988 0.581927 
ALR2 3 0 0 0 0.648165 0.622843 
ALR2 4 2 2 1 0.525244 0.55205 
ALR2 4 2 2 2 0.66066 0.659098 
ALR2 4 0 0 0 0.578212 0.525166 
ALR2 5 1 2 1 0.546701 0.527763 
ALR2 5 1 2 2 0.619249 0.626904 
ALR2 6 1 2 1 0.57294 0.625693 
ALR2 6 1 2 2 0.661927 0.68116 
AMPC 3 4 2 1 0.578721 0.572328 
AMPC 3 4 2 2 0.500637 0.500637 
AMPC 3 0 0 0 0.518734 0.651431 
AMPC 4 2 2 1 0.603094 0.59906 
AMPC 4 2 2 2 0.503185 0.503185 
159 
 
AMPC 4 0 0 0 0.594359 0.574841 
AMPC 5 1 2 1 0.537701 0.616894 
AMPC 5 1 2 2 0.503817 0.503817 
AMPC 6 1 2 1 0.516257 0.514377 
AMPC 6 1 2 2 0.511355 0.511673 
ANP/SRC 3 4 2 1 0.551336 0.53794 
ANP/SRC 3 4 2 2 0.53375 0.53394 
ANP/SRC 3 0 0 0 0.761952 0.773009 
ANP/SRC 4 2 2 1 0.51885 0.510868 
ANP/SRC 4 2 2 2 0.576967 0.581592 
ANP/SRC 4 0 0 0 0.533148 0.576627 
ANP/SRC 5 1 2 1 0.583679 0.527182 
ANP/SRC 5 1 2 2 0.544151 0.544716 
ANP/SRC 6 1 2 1 0.546624 0.528962 
ANP/SRC 6 1 2 2 0.500588 0.503071 
AR 3 4 2 1 0.778106 0.798138 
AR 3 4 2 2 0.541983 0.541682 
AR 3 0 0 0 0.587236 0.727583 
AR 4 2 2 1 0.705887 0.678413 
AR 4 2 2 2 0.622237 0.616597 
AR 4 0 0 0 0.618334 0.686496 
AR 5 1 2 1 0.668255 0.597872 
AR 5 1 2 2 0.638696 0.638626 
AR 6 1 2 1 0.668699 0.526848 
AR 6 1 2 2 0.763704 0.737192 
CDK2 3 4 2 1 0.65707 0.686538 
CDK2 3 4 2 2 0.530048 0.529601 
CDK2 3 0 0 0 0.553197 0.550122 
CDK2 4 2 2 1 0.513322 0.52012 
CDK2 4 2 2 2 0.538615 0.538872 
CDK2 4 0 0 0 0.563136 0.617145 
CDK2 5 1 2 1 0.527755 0.533406 
CDK2 5 1 2 2 0.50925 0.509307 
CDK2 6 1 2 1 0.511754 0.522541 
CDK2 6 1 2 2 0.501327 0.507522 
COMT 3 4 2 1 0.502141 0.502141 
COMT 3 4 2 2 0.5 0.5 
COMT 3 0 0 0 0.698184 0.64308 
COMT 4 2 2 1 0.62663 0.656706 
COMT 4 2 2 2 0.531633 0.528908 
COMT 4 0 0 0 0.736218 0.68795 
COMT 5 1 2 1 0.612906 0.623613 
COMT 5 1 2 2 0.550029 0.550905 
COMT 6 1 2 1 0.626436 0.513724 
COMT 6 1 2 2 0.539031 0.538544 
COX1 3 4 2 1 0.504545 0.519181 
COX1 3 4 2 2 0.5 0.5 
COX1 3 0 0 0 0.592383 0.61506 
COX1 4 2 2 1 0.547253 0.645904 
COX1 4 2 2 2 0.518917 0.518917 
160 
 
COX1 4 0 0 0 0.556668 0.542108 
COX1 5 1 2 1 0.503707 0.549376 
COX1 5 1 2 2 0.567907 0.567308 
COX1 6 1 2 1 0.55522 0.678971 
COX1 6 1 2 2 0.682594 0.660165 
COX2 3 4 2 1 0.924634 0.931038 
COX2 3 4 2 2 0.508479 0.509295 
COX2 3 0 0 0 0.821387 0.716973 
COX2 4 2 2 1 0.809729 0.775932 
COX2 4 2 2 2 0.62008 0.620236 
COX2 4 0 0 0 0.742389 0.724361 
COX2 5 1 2 1 0.757596 0.746411 
COX2 5 1 2 2 0.63666 0.636043 
COX2 6 1 2 1 0.708154 0.688295 
COX2 6 1 2 2 0.72855 0.734075 
DHFR 3 4 2 1 0.52287 0.582374 
DHFR 3 4 2 2 0.53302 0.532434 
DHFR 3 0 0 0 0.509206 0.660208 
DHFR 4 2 2 1 0.509937 0.526579 
DHFR 4 2 2 2 0.515597 0.517504 
DHFR 4 0 0 0 0.589048 0.620461 
DHFR 5 1 2 1 0.551585 0.575491 
DHFR 5 1 2 2 0.560594 0.559536 
DHFR 6 1 2 1 0.519995 0.598663 
DHFR 6 1 2 2 0.680004 0.700721 
EGFR 3 4 2 1 0.641054 0.666528 
EGFR 3 4 2 2 0.501779 0.501779 
EGFR 3 0 0 0 0.666681 0.695826 
EGFR 4 2 2 1 0.524347 0.536231 
EGFR 4 2 2 2 0.512528 0.503661 
EGFR 4 0 0 0 0.573495 0.546496 
EGFR 5 1 2 1 0.517974 0.571867 
EGFR 5 1 2 2 0.572179 0.573304 
EGFR 6 1 2 1 0.523503 0.543195 
EGFR 6 1 2 2 0.509905 0.502631 
ER_AGONIST 3 4 2 1 0.850975 0.874055 
ER_AGONIST 3 4 2 2 0.511851 0.512617 
ER_AGONIST 3 0 0 0 0.758148 0.891465 
ER_AGONIST 4 2 2 1 0.761314 0.850777 
ER_AGONIST 4 2 2 2 0.586957 0.596799 
ER_AGONIST 4 0 0 0 0.642662 0.844804 
ER_AGONIST 5 1 2 1 0.821767 0.851704 
ER_AGONIST 5 1 2 2 0.775301 0.779092 
ER_AGONIST 6 1 2 1 0.8228 0.851852 
ER_AGONIST 6 1 2 2 0.812296 0.822876 
ER_ANTAGONIST 3 4 2 1 0.581536 0.550373 
ER_ANTAGONIST 3 4 2 2 0.570777 0.570916 
ER_ANTAGONIST 3 0 0 0 0.699238 0.640387 
ER_ANTAGONIST 4 2 2 1 0.697376 0.694512 
ER_ANTAGONIST 4 2 2 2 0.686367 0.687034 
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ER_ANTAGONIST 4 0 0 0 0.777744 0.632242 
ER_ANTAGONIST 5 1 2 1 0.724647 0.684838 
ER_ANTAGONIST 5 1 2 2 0.621066 0.621595 
ER_ANTAGONIST 6 1 2 1 0.534249 0.588485 
ER_ANTAGONIST 6 1 2 2 0.67155 0.670355 
FGFR 3 4 2 1 0.514371 0.508928 
FGFR 3 4 2 2 0.504334 0.504334 
FGFR 3 0 0 0 0.638749 0.559067 
FGFR 4 2 2 1 0.54649 0.506072 
FGFR 4 2 2 2 0.547015 0.546992 
FGFR 4 0 0 0 0.506566 0.549654 
FGFR 5 1 2 1 0.552429 0.552033 
FGFR 5 1 2 2 0.54102 0.540691 
FGFR 6 1 2 1 0.534941 0.520803 
FGFR 6 1 2 2 0.536552 0.537331 
FXA 3 4 2 1 0.632921 0.650212 
FXA 3 4 2 2 0.531198 0.531758 
FXA 3 0 0 0 0.507715 0.568689 
FXA 4 2 2 1 0.540744 0.565047 
FXA 4 2 2 2 0.5519 0.545696 
FXA 4 0 0 0 0.5481 0.543674 
FXA 5 1 2 1 0.573578 0.650085 
FXA 5 1 2 2 0.640685 0.639242 
FXA 6 1 2 1 0.542096 0.529128 
FXA 6 1 2 2 0.66079 0.664033 
GART 3 4 2 1 0.671672 0.630682 
GART 3 4 2 2 0.581169 0.581169 
GART 3 0 0 0 0.677354 0.524351 
GART 4 2 2 1 0.63474 0.627029 
GART 4 2 2 2 0.536932 0.525346 
GART 4 0 0 0 0.549919 0.670049 
GART 5 1 2 1 0.655438 0.719562 
GART 5 1 2 2 0.6447 0.656221 
GART 6 1 2 1 0.700893 0.659497 
GART 6 1 2 2 0.752995 0.760829 
GPB 3 4 2 1 0.711016 0.723428 
GPB 3 4 2 2 0.683166 0.68194 
GPB 3 0 0 0 0.506159 0.575414 
GPB 4 2 2 1 0.593013 0.536533 
GPB 4 2 2 2 0.744469 0.759408 
GPB 4 0 0 0 0.564604 0.781207 
GPB 5 1 2 1 0.522799 0.533528 
GPB 5 1 2 2 0.854163 0.849024 
GPB 6 1 2 1 0.733621 0.766149 
GPB 6 1 2 2 0.776945 0.758146 
GR 3 4 2 1 0.581107 0.557228 
GR 3 4 2 2 0.536913 0.537019 
GR 3 0 0 0 0.705965 0.542148 
GR 4 2 2 1 0.620291 0.627279 
GR 4 2 2 2 0.526287 0.526287 
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GR 4 0 0 0 0.679928 0.675959 
GR 5 1 2 1 0.519411 0.510464 
GR 5 1 2 2 0.595838 0.595801 
GR 6 1 2 1 0.589742 0.582935 
GR 6 1 2 2 0.579148 0.578942 
HIV-PR 3 4 2 1 0.6875 0.59375 
HIV-PR 3 4 2 2 0.75 0.75 
HIV-PR 3 0 0 0 0.65625 0.5625 
HIV-PR 4 2 2 1 0.609375 0.59375 
HIV-PR 4 2 2 2 0.5 0.5 
HIV-PR 4 0 0 0 0.555556 0.8125 
HIV-PR 5 1 2 1 0.84375 0.96875 
HIV-PR 5 1 2 2 0.765625 0.765625 
HIV-PR 6 1 2 1 0.796875 0.6875 
HIV-PR 6 1 2 2 0.5 0.5 
HIVRT 3 4 2 1 0.739638 0.708531 
HIVRT 3 4 2 2 0.586896 0.604732 
HIVRT 3 0 0 0 0.642223 0.555627 
HIVRT 4 2 2 1 0.518813 0.55117 
HIVRT 4 2 2 2 0.505486 0.504078 
HIVRT 4 0 0 0 0.665104 0.535135 
HIVRT 5 1 2 1 0.573395 0.508481 
HIVRT 5 1 2 2 0.527708 0.525757 
HIVRT 6 1 2 1 0.615372 0.574936 
HIVRT 6 1 2 2 0.551884 0.550855 
HMGA 3 4 2 1 0.577243 0.63384 
HMGA 3 4 2 2 0.658263 0.671533 
HMGA 3 0 0 0 0.563924 0.637131 
HMGA 4 2 2 1 0.67305 0.673313 
HMGA 4 2 2 2 0.539072 0.522588 
HMGA 4 0 0 0 0.581294 0.698158 
HMGA 5 1 2 1 0.548833 0.523066 
HMGA 5 1 2 2 0.732519 0.73948 
HMGA 6 1 2 1 0.529395 0.512855 
HMGA 6 1 2 2 0.799831 0.784346 
HSP90 3 4 2 1 0.887319 0.865967 
HSP90 3 4 2 2 0.630793 0.630956 
HSP90 3 0 0 0 0.778135 0.719674 
HSP90 4 2 2 1 0.674583 0.612657 
HSP90 4 2 2 2 0.641096 0.642587 
HSP90 4 0 0 0 0.708345 0.636993 
HSP90 5 1 2 1 0.523681 0.618555 
HSP90 5 1 2 2 0.592358 0.570932 
HSP90 6 1 2 1 0.701701 0.642005 
HSP90 6 1 2 2 0.702504 0.693978 
INHA 3 4 2 1 0.603571 0.52949 
INHA 3 4 2 2 0.50567 0.505696 
INHA 3 0 0 0 0.542994 0.534355 
INHA 4 2 2 1 0.679805 0.708181 
INHA 4 2 2 2 0.553275 0.555105 
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INHA 4 0 0 0 0.619173 0.629354 
INHA 5 1 2 1 0.512768 0.589243 
INHA 5 1 2 2 0.570841 0.571854 
INHA 6 1 2 1 0.512682 0.562193 
INHA 6 1 2 2 0.601015 0.601163 
MR 3 4 2 1 0.565657 0.606787 
MR 3 4 2 2 0.503937 0.503937 
MR 3 0 0 0 0.947184 0.824292 
MR 4 2 2 1 0.912417 0.829468 
MR 4 2 2 2 0.651992 0.656184 
MR 4 0 0 0 0.921563 0.688221 
MR 5 1 2 1 0.829921 0.730346 
MR 5 1 2 2 0.725694 0.722746 
MR 6 1 2 1 0.685403 0.574358 
MR 6 1 2 2 0.825136 0.795008 
NA 3 4 2 1 0.74373 0.745561 
NA 3 4 2 2 0.528157 0.539405 
NA 3 0 0 0 0.573837 0.600214 
NA 4 2 2 1 0.62292 0.597909 
NA 4 2 2 2 0.542743 0.548787 
NA 4 0 0 0 0.670644 0.642154 
NA 5 1 2 1 0.589488 0.61853 
NA 5 1 2 2 0.504743 0.505746 
NA 6 1 2 1 0.655839 0.628192 
NA 6 1 2 2 0.504932 0.50768 
P38 3 4 2 1 0.538847 0.546829 
P38 3 4 2 2 0.548656 0.549127 
P38 3 0 0 0 0.502848 0.509631 
P38 4 2 2 1 0.579719 0.547261 
P38 4 2 2 2 0.503503 0.507317 
P38 4 0 0 0 0.527243 0.617622 
P38 5 1 2 1 0.641622 0.617147 
P38 5 1 2 2 0.58436 0.57924 
P38 6 1 2 1 0.540136 0.524044 
P38 6 1 2 2 0.588735 0.584344 
PARP 3 4 2 1 0.575588 0.504113 
PARP 3 4 2 2 0.539324 0.538272 
PARP 3 0 0 0 0.599034 0.502702 
PARP 4 2 2 1 0.601306 0.543533 
PARP 4 2 2 2 0.586575 0.587102 
PARP 4 0 0 0 0.500813 0.663239 
PARP 5 1 2 1 0.538284 0.67737 
PARP 5 1 2 2 0.639284 0.646148 
PARP 6 1 2 1 0.620017 0.755566 
PARP 6 1 2 2 0.73371 0.810194 
PDE5 3 4 2 1 0.727914 0.729738 
PDE5 3 4 2 2 0.518268 0.518268 
PDE5 3 0 0 0 0.518574 0.6213 
PDE5 4 2 2 1 0.532761 0.594012 
PDE5 4 2 2 2 0.505496 0.505462 
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PDE5 4 0 0 0 0.534779 0.61671 
PDE5 5 1 2 1 0.586963 0.542111 
PDE5 5 1 2 2 0.536082 0.536161 
PDE5 6 1 2 1 0.568141 0.555687 
PDE5 6 1 2 2 0.586555 0.591576 
PDGFRB 3 4 2 1 0.619564 0.611092 
PDGFRB 3 4 2 2 0.535893 0.536109 
PDGFRB 3 0 0 0 0.704699 0.644979 
PDGFRB 4 2 2 1 0.534314 0.50517 
PDGFRB 4 2 2 2 0.535737 0.541592 
PDGFRB 4 0 0 0 0.666894 0.608104 
PDGFRB 5 1 2 1 0.504985 0.523412 
PDGFRB 5 1 2 2 0.50664 0.501216 
PDGFRB 6 1 2 1 0.566537 0.566671 
PDGFRB 6 1 2 2 0.508154 0.500961 
PNP 3 4 2 1 0.567769 0.581256 
PNP 3 4 2 2 0.539111 0.539111 
PNP 3 0 0 0 0.527852 0.50742 
PNP 4 2 2 1 0.516174 0.523382 
PNP 4 2 2 2 0.553431 0.572 
PNP 4 0 0 0 0.598106 0.5297 
PNP 5 1 2 1 0.70858 0.624678 
PNP 5 1 2 2 0.738647 0.746976 
PNP 6 1 2 1 0.556618 0.569565 
PNP 6 1 2 2 0.745952 0.755053 
PPAR 3 4 2 1 0.602564 0.561966 
PPAR 3 4 2 2 0.508547 0.510684 
PPAR 3 0 0 0 0.903846 0.965812 
PPAR 4 2 2 1 0.651709 0.65812 
PPAR 4 2 2 2 0.512821 0.512821 
PPAR 4 0 0 0 0.944444 0.878205 
PPAR 5 1 2 1 0.606838 0.551282 
PPAR 5 1 2 2 0.538462 0.538462 
PPAR 6 1 2 1 0.564103 0.606838 
PPAR 6 1 2 2 0.594017 0.619658 
PR 3 4 2 1 0.533139 0.593753 
PR 3 4 2 2 0.50596 0.505911 
PR 3 0 0 0 0.589376 0.566995 
PR 4 2 2 1 0.512291 0.751632 
PR 4 2 2 2 0.542391 0.542391 
PR 4 0 0 0 0.631319 0.625155 
PR 5 1 2 1 0.500346 0.635844 
PR 5 1 2 2 0.524457 0.524457 
PR 6 1 2 1 0.637773 0.635548 
PR 6 1 2 2 0.54837 0.523939 
RXR 3 4 2 1 0.745403 0.77555 
RXR 3 4 2 2 0.807673 0.806547 
RXR 3 0 0 0 0.724303 0.855038 
RXR 4 2 2 1 0.691444 0.690718 
RXR 4 2 2 2 0.802711 0.813964 
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RXR 4 0 0 0 0.667212 0.709565 
RXR 5 1 2 1 0.540505 0.601045 
RXR 5 1 2 2 0.78794 0.800329 
RXR 6 1 2 1 0.725319 0.774729 
RXR 6 1 2 2 0.894406 0.911973 
SAHH 3 4 2 1 0.702382 0.646615 
SAHH 3 4 2 2 0.596211 0.596211 
SAHH 3 0 0 0 0.762874 0.830087 
SAHH 4 2 2 1 0.754492 0.77829 
SAHH 4 2 2 2 0.616224 0.616735 
SAHH 4 0 0 0 0.766403 0.799115 
SAHH 5 1 2 1 0.790014 0.809784 
SAHH 5 1 2 2 0.74105 0.742988 
SAHH 6 1 2 1 0.586982 0.740539 
SAHH 6 1 2 2 0.802076 0.815124 
Thrombin 3 4 2 1 0.591865 0.598328 
Thrombin 3 4 2 2 0.502161 0.502502 
Thrombin 3 0 0 0 0.684091 0.721732 
Thrombin 4 2 2 1 0.612714 0.655794 
Thrombin 4 2 2 2 0.663148 0.663394 
Thrombin 4 0 0 0 0.623157 0.716993 
Thrombin 5 1 2 1 0.595391 0.596206 
Thrombin 5 1 2 2 0.525321 0.525549 
Thrombin 6 1 2 1 0.574713 0.508472 
Thrombin 6 1 2 2 0.540673 0.54327 
TK 3 4 2 1 0.593871 0.624438 
TK 3 4 2 2 0.640679 0.640577 
TK 3 0 0 0 0.530005 0.641599 
TK 4 2 2 1 0.591905 0.602656 
TK 4 2 2 2 0.732083 0.762436 
TK 4 0 0 0 0.560981 0.547651 
TK 5 1 2 1 0.530746 0.669842 
TK 5 1 2 2 0.722957 0.742467 
TK 6 1 2 1 0.533657 0.669178 
TK 6 1 2 2 0.770761 0.783631 
Trypsin 3 4 2 1 0.619092 0.636913 
Trypsin 3 4 2 2 0.545328 0.545328 
Trypsin 3 0 0 0 0.574384 0.833023 
Trypsin 4 2 2 1 0.595665 0.666822 
Trypsin 4 2 2 2 0.712847 0.718116 
Trypsin 4 0 0 0 0.611266 0.648845 
Trypsin 5 1 2 1 0.648381 0.634976 
Trypsin 5 1 2 2 0.562529 0.562064 
Trypsin 6 1 2 1 0.556563 0.599179 
Trypsin 6 1 2 2 0.622579 0.611731 
VEGFR2 3 4 2 1 0.570511 0.562969 
VEGFR2 3 4 2 2 0.500434 0.501226 
VEGFR2 3 0 0 0 0.517245 0.506374 
VEGFR2 4 2 2 1 0.582649 0.564206 
VEGFR2 4 2 2 2 0.584113 0.582807 
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VEGFR2 4 0 0 0 0.597612 0.623463 
VEGFR2 5 1 2 1 0.593434 0.529801 
VEGFR2 5 1 2 2 0.537413 0.534504 
VEGFR2 6 1 2 1 0.530966 0.57224 




























DUD 40 Shape Volume/Properties and Recall@5% and 10% 













ACTIVES DECOYS TOTAL 
3 4 2 1 4.35 4.35 4.35 4.35 46 1796 1842 
3 4 2 2 2.17 2.17 2.17 2.17 46 1796 1842 
3 0 0 0 17.39 10.87 19.57 15.22 46 1796 1842 
4 2 2 1 8.7 6.52 8.7 8.7 46 1796 1842 
4 2 2 2 15.22 15.22 23.91 23.91 46 1796 1842 
4 0 0 0 10.87 13.04 13.04 15.22 46 1796 1842 
5 1 2 1 4.35 6.52 10.87 6.52 46 1796 1842 
5 1 2 2 8.7 13.04 15.22 15.22 46 1796 1842 
6 1 2 1 6.52 13.04 13.04 15.22 46 1796 1842 
6 1 2 2 15.22 10.87 34.78 26.09 46 1796 1842 
3 4 2 1 22.22 17.17 33.33 23.23 99 3859 3958 
3 4 2 2 21.21 21.21 21.21 21.21 99 3859 3958 
3 0 0 0 19.19 18.18 26.26 22.22 99 3859 3958 
4 2 2 1 17.17 26.26 30.3 35.35 99 3859 3958 
4 2 2 2 41.41 40.4 54.55 55.56 99 3859 3958 
4 0 0 0 19.19 28.28 26.26 38.38 99 3859 3958 
5 1 2 1 15.15 21.21 21.21 30.3 99 3859 3958 
5 1 2 2 35.35 35.35 43.43 45.45 99 3859 3958 
6 1 2 1 14.14 19.19 24.24 31.31 99 3859 3958 
6 1 2 2 30.3 31.31 51.52 39.39 99 3859 3958 
3 4 2 1 17.39 13.04 21.74 21.74 23 927 950 
3 4 2 2 4.35 4.35 4.35 4.35 23 927 950 
3 0 0 0 8.7 13.04 13.04 17.39 23 927 950 
4 2 2 1 13.04 13.04 17.39 17.39 23 927 950 
4 2 2 2 13.04 13.04 17.39 17.39 23 927 950 
4 0 0 0 13.04 13.04 13.04 17.39 23 927 950 
5 1 2 1 4.35 4.35 13.04 4.35 23 927 950 
5 1 2 2 4.35 4.35 4.35 8.7 23 927 950 
6 1 2 1 4.35 8.7 26.09 8.7 23 927 950 
6 1 2 2 39.13 13.04 43.48 39.13 23 927 950 
3 4 2 1 15.38 7.69 19.23 11.54 26 986 1012 
3 4 2 2 26.92 26.92 26.92 26.92 26 986 1012 
3 0 0 0 11.54 7.69 11.54 11.54 26 986 1012 
4 2 2 1 11.54 3.85 19.23 7.69 26 986 1012 
4 2 2 2 23.08 19.23 42.31 42.31 26 986 1012 
4 0 0 0 7.69 3.85 11.54 11.54 26 986 1012 
5 1 2 1 15.38 11.54 19.23 19.23 26 986 1012 
5 1 2 2 23.08 23.08 26.92 23.08 26 986 1012 
6 1 2 1 11.54 7.69 11.54 11.54 26 986 1012 
6 1 2 2 11.54 11.54 30.77 34.62 26 986 1012 
3 4 2 1 9.52 9.52 9.52 9.52 21 786 807 
3 4 2 2 4.76 4.76 4.76 4.76 21 786 807 
3 0 0 0 9.52 9.52 9.52 9.52 21 786 807 
4 2 2 1 9.52 9.52 9.52 14.29 21 786 807 
4 2 2 2 4.76 4.76 4.76 4.76 21 786 807 
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4 0 0 0 9.52 14.29 9.52 19.05 21 786 807 
5 1 2 1 4.76 4.76 9.52 9.52 21 786 807 
5 1 2 2 9.52 9.52 9.52 9.52 21 786 807 
6 1 2 1 4.76 4.76 14.29 14.29 21 786 807 
6 1 2 2 9.52 9.52 14.29 14.29 21 786 807 
3 4 2 1 32.35 38.24 38.24 45.59 68 2848 2916 
3 4 2 2 10.29 10.29 10.29 10.29 68 2848 2916 
3 0 0 0 26.47 38.24 30.88 45.59 68 2848 2916 
4 2 2 1 36.76 42.65 42.65 50 68 2848 2916 
4 2 2 2 29.41 29.41 29.41 29.41 68 2848 2916 
4 0 0 0 30.88 41.18 35.29 52.94 68 2848 2916 
5 1 2 1 30.88 33.82 41.18 33.82 68 2848 2916 
5 1 2 2 33.82 33.82 33.82 33.82 68 2848 2916 
6 1 2 1 32.35 10.29 47.06 14.71 68 2848 2916 
6 1 2 2 33.82 25 52.94 35.29 68 2848 2916 
3 4 2 1 8.51 6.38 14.89 8.51 47 2070 2117 
3 4 2 2 4.26 4.26 6.38 6.38 47 2070 2117 
3 0 0 0 14.89 8.51 17.02 19.15 47 2070 2117 
4 2 2 1 8.51 4.26 12.77 8.51 47 2070 2117 
4 2 2 2 4.26 4.26 6.38 6.38 47 2070 2117 
4 0 0 0 4.26 6.38 14.89 8.51 47 2070 2117 
5 1 2 1 6.38 6.38 6.38 10.64 47 2070 2117 
5 1 2 2 6.38 6.38 6.38 6.38 47 2070 2117 
6 1 2 1 4.26 4.26 10.64 6.38 47 2070 2117 
6 1 2 2 10.64 8.51 12.77 17.02 47 2070 2117 
3 4 2 1 9.09 9.09 9.09 9.09 11 468 479 
3 4 2 2 9.09 9.09 9.09 9.09 11 468 479 
3 0 0 0 36.36 18.18 36.36 27.27 11 468 479 
4 2 2 1 9.09 9.09 9.09 9.09 11 468 479 
4 2 2 2 9.09 9.09 18.18 18.18 11 468 479 
4 0 0 0 36.36 9.09 36.36 9.09 11 468 479 
5 1 2 1 9.09 9.09 9.09 18.18 11 468 479 
5 1 2 2 27.27 18.18 27.27 27.27 11 468 479 
6 1 2 1 9.09 18.18 9.09 18.18 11 468 479 
6 1 2 2 27.27 27.27 27.27 27.27 11 468 479 
3 4 2 1 21.74 21.74 21.74 26.09 23 910 933 
3 4 2 2 4.35 4.35 4.35 4.35 23 910 933 
3 0 0 0 21.74 30.43 21.74 30.43 23 910 933 
4 2 2 1 21.74 17.39 21.74 17.39 23 910 933 
4 2 2 2 8.7 8.7 8.7 8.7 23 910 933 
4 0 0 0 21.74 26.09 30.43 30.43 23 910 933 
5 1 2 1 21.74 26.09 26.09 26.09 23 910 933 
5 1 2 2 26.09 21.74 26.09 26.09 23 910 933 
6 1 2 1 21.74 26.09 21.74 34.78 23 910 933 
6 1 2 2 26.09 13.04 34.78 26.09 23 910 933 
3 4 2 1 59.91 67.45 75.47 76.42 212 12606 12818 
3 4 2 2 24.53 24.53 25.47 25.94 212 12606 12818 
3 0 0 0 58.49 42.45 62.74 50 212 12606 12818 
4 2 2 1 31.6 30.66 44.34 45.75 212 12606 12818 
4 2 2 2 27.36 27.36 27.36 27.36 212 12606 12818 
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4 0 0 0 34.43 24.06 46.7 36.32 212 12606 12818 
5 1 2 1 26.42 31.6 36.32 43.4 212 12606 12818 
5 1 2 2 30.66 30.66 32.55 32.55 212 12606 12818 
6 1 2 1 39.15 39.15 43.87 44.34 212 12606 12818 
6 1 2 2 34.91 34.91 43.87 41.51 212 12606 12818 
3 4 2 1 4.74 10 9.47 21.58 190 8350 8540 
3 4 2 2 2.63 2.63 7.89 8.42 190 8350 8540 
3 0 0 0 4.21 17.37 7.89 30.53 190 8350 8540 
4 2 2 1 8.42 16.32 12.63 18.42 190 8350 8540 
4 2 2 2 2.63 3.68 7.89 8.42 190 8350 8540 
4 0 0 0 11.05 14.21 20 22.11 190 8350 8540 
5 1 2 1 11.58 14.21 18.42 27.37 190 8350 8540 
5 1 2 2 13.16 13.68 21.58 21.58 190 8350 8540 
6 1 2 1 10 20.53 16.32 30.53 190 8350 8540 
6 1 2 2 16.32 34.21 35.26 43.68 190 8350 8540 
3 4 2 1 4.93 1.92 8.77 3.56 365 15560 15925 
3 4 2 2 0.82 0.82 0.82 0.82 365 15560 15925 
3 0 0 0 5.75 4.11 8.22 6.85 365 15560 15925 
4 2 2 1 5.21 8.77 10.68 13.15 365 15560 15925 
4 2 2 2 8.22 10.96 13.42 18.63 365 15560 15925 
4 0 0 0 4.93 3.01 9.04 10.96 365 15560 15925 
5 1 2 1 4.66 8.22 9.59 17.81 365 15560 15925 
5 1 2 2 18.63 17.81 24.66 23.29 365 15560 15925 
6 1 2 1 5.75 5.48 9.59 8.49 365 15560 15925 
6 1 2 2 9.04 8.49 17.26 14.79 365 15560 15925 
3 4 2 1 46.03 60.32 68.25 74.6 63 2568 2631 
3 4 2 2 12.7 12.7 12.7 12.7 63 2568 2631 
3 0 0 0 25.4 58.73 44.44 71.43 63 2568 2631 
4 2 2 1 36.51 55.56 52.38 63.49 63 2568 2631 
4 2 2 2 22.22 26.98 26.98 30.16 63 2568 2631 
4 0 0 0 23.81 63.49 38.1 74.6 63 2568 2631 
5 1 2 1 34.92 36.51 47.62 60.32 63 2568 2631 
5 1 2 2 44.44 46.03 63.49 60.32 63 2568 2631 
6 1 2 1 38.1 60.32 52.38 69.84 63 2568 2631 
6 1 2 2 41.27 63.49 71.43 71.43 63 2568 2631 
3 4 2 2 1.41 1.41 33.33 33.33 71 3462 3533 
3 0 0 0 19.72 5.63 27.78 27.78 71 3462 3533 
4 2 2 1 11.27 4.23 44.44 55.56 71 3462 3533 
4 2 2 2 1.41 1.41 44.44 44.44 71 3462 3533 
4 0 0 0 9.86 7.04 50 50 71 3462 3533 
5 1 2 1 16.9 14.08 61.11 44.44 71 3462 3533 
5 1 2 2 1.41 2.82 55.56 38.89 71 3462 3533 
6 1 2 1 12.68 1.41 38.89 38.89 71 3462 3533 
3 4 2 1 33.33 33.33 33.33 33.33 18 1058 1076 
3 4 2 2 27.78 27.78 50 50 18 1058 1076 
3 0 0 0 33.33 44.44 15.49 11.27 18 1058 1076 
4 2 2 1 38.89 38.89 1.41 1.41 18 1058 1076 
4 2 2 2 50 50 19.72 14.08 18 1058 1076 
4 0 0 0 33.33 33.33 19.72 7.04 18 1058 1076 
5 1 2 1 44.44 33.33 1.41 1.41 18 1058 1076 
170 
 
5 1 2 2 38.89 38.89 21.13 8.45 18 1058 1076 
6 1 2 1 33.33 22.22 25.35 32.39 18 1058 1076 
6 1 2 2 44.44 44.44 2.82 2.82 18 1058 1076 
3 4 2 1 12.68 9.86 15.49 8.45 71 3462 3533 
6 1 2 2 5.63 4.23 8.45 12.68 71 3462 3533 
3 4 2 1 12.5 12.5 25 26.56 64 2092 2156 
3 4 2 2 12.5 12.5 12.5 12.5 64 2092 2156 
3 0 0 0 15.63 14.06 20.31 21.88 64 2092 2156 
4 2 2 1 4.69 7.81 9.38 10.94 64 2092 2156 
4 2 2 2 10.94 15.63 20.31 20.31 64 2092 2156 
4 0 0 0 7.81 10.94 14.06 17.19 64 2092 2156 
5 1 2 1 6.25 25 10.94 32.81 64 2092 2156 
5 1 2 2 31.25 29.69 35.94 35.94 64 2092 2156 
6 1 2 1 6.25 10.94 9.38 12.5 64 2092 2156 
6 1 2 2 37.5 37.5 37.5 37.5 64 2092 2156 
3 4 2 1 12.5 12.5 12.5 12.5 8 155 163 
3 4 2 2 12.5 12.5 12.5 12.5 8 155 163 
3 0 0 0 12.5 12.5 25 12.5 8 155 163 
4 2 2 1 25 37.5 37.5 37.5 8 155 163 
4 2 2 2 25 25 25 37.5 8 155 163 
4 0 0 0 25 37.5 37.5 50 8 155 163 
5 1 2 1 25 37.5 37.5 37.5 8 155 163 
5 1 2 2 37.5 50 50 62.5 8 155 163 
6 1 2 1 25 12.5 37.5 12.5 8 155 163 
6 1 2 2 37.5 37.5 50 37.5 8 155 163 
3 4 2 1 13.46 9.62 17.31 25 52 2135 2187 
3 4 2 2 44.23 44.23 48.08 48.08 52 2135 2187 
3 0 0 0 9.62 13.46 11.54 17.31 52 2135 2187 
4 2 2 1 1.92 9.62 5.77 15.38 52 2135 2187 
4 2 2 2 36.54 44.23 51.92 55.77 52 2135 2187 
4 0 0 0 11.54 34.62 21.15 51.92 52 2135 2187 
5 1 2 1 7.69 15.38 9.62 19.23 52 2135 2187 
5 1 2 2 38.46 36.54 55.77 53.85 52 2135 2187 
6 1 2 1 15.38 25 26.92 40.38 52 2135 2187 
6 1 2 2 17.31 13.46 40.38 30.77 52 2135 2187 
3 4 2 1 18.75 21.88 21.88 21.88 32 2585 2617 
3 4 2 2 15.63 15.63 15.63 15.63 32 2585 2617 
3 0 0 0 43.75 18.75 43.75 28.13 32 2585 2617 
4 2 2 1 25 21.88 28.13 25 32 2585 2617 
4 2 2 2 12.5 12.5 12.5 12.5 32 2585 2617 
4 0 0 0 40.63 25 43.75 28.13 32 2585 2617 
5 1 2 1 28.13 25 31.25 28.13 32 2585 2617 
5 1 2 2 25 25 25 25 32 2585 2617 
6 1 2 1 31.25 25 31.25 28.13 32 2585 2617 
6 1 2 2 25 25 25 25 32 2585 2617 
3 4 2 1 25 25 25 25 4 9 13 
3 4 2 2 25 25 25 25 4 9 13 
3 0 0 0 25 25 25 25 4 9 13 
4 2 2 1 25 25 25 25 4 9 13 
4 2 2 2 25 25 25 25 4 9 13 
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4 0 0 0 25 25 25 25 4 9 13 
5 1 2 1 25 25 25 25 4 9 13 
5 1 2 2 25 25 25 25 4 9 13 
6 1 2 1 25 25 25 25 4 9 13 
6 1 2 2 25 25 25 25 4 9 13 
3 4 2 1 14.71 17.65 29.41 23.53 34 1494 1528 
3 4 2 2 5.88 5.88 8.82 8.82 34 1494 1528 
3 0 0 0 11.76 8.82 26.47 14.71 34 1494 1528 
4 2 2 1 11.76 8.82 20.59 14.71 34 1494 1528 
4 2 2 2 14.71 11.76 17.65 20.59 34 1494 1528 
4 0 0 0 23.53 14.71 32.35 17.65 34 1494 1528 
5 1 2 1 26.47 14.71 29.41 20.59 34 1494 1528 
5 1 2 2 17.65 17.65 20.59 17.65 34 1494 1528 
6 1 2 1 32.35 11.76 32.35 23.53 34 1494 1528 
6 1 2 2 14.71 8.82 26.47 14.71 34 1494 1528 
3 4 2 1 20 32 28 36 25 1423 1448 
3 4 2 2 40 40 44 44 25 1423 1448 
3 0 0 0 16 8 28 32 25 1423 1448 
4 2 2 2 44 40 48 48 25 1423 1448 
4 4 2 1 4 12 16 24 25 1423 1448 
4 0 0 0 4 28 12 44 25 1423 1448 
5 1 2 1 12 32 16 32 25 1423 1448 
5 1 2 2 52 48 56 56 25 1423 1448 
6 1 2 1 8 8 8 12 25 1423 1448 
6 1 2 2 60 48 68 64 25 1423 1448 
3 4 2 1 52.17 52.17 60.87 56.52 23 975 998 
3 4 2 2 34.78 34.78 34.78 34.78 23 975 998 
3 0 0 0 26.09 47.83 34.78 52.17 23 975 998 
4 2 2 1 17.39 30.43 30.43 30.43 23 975 998 
4 2 2 2 39.13 43.48 43.48 43.48 23 975 998 
4 0 0 0 17.39 26.09 30.43 30.43 23 975 998 
5 1 2 1 21.74 17.39 26.09 17.39 23 975 998 
5 1 2 2 21.74 21.74 30.43 30.43 23 975 998 
6 1 2 1 26.09 13.04 30.43 13.04 23 975 998 
6 1 2 2 26.09 17.39 43.48 30.43 23 975 998 
3 4 2 1 10.53 15.79 15.79 28.07 57 2707 2764 
3 4 2 2 8.77 8.77 8.77 8.77 57 2707 2764 
3 0 0 0 5.26 21.05 15.79 21.05 57 2707 2764 
4 2 2 1 5.26 8.77 5.26 10.53 57 2707 2764 
4 2 2 2 19.3 21.05 22.81 22.81 57 2707 2764 
4 0 0 0 8.77 14.04 10.53 21.05 57 2707 2764 
5 1 2 1 22.81 21.05 26.32 29.82 57 2707 2764 
5 1 2 2 22.81 22.81 22.81 22.81 57 2707 2764 
6 1 2 1 19.3 17.54 24.56 26.32 57 2707 2764 
6 1 2 2 26.32 28.07 29.82 29.82 57 2707 2764 
3 4 2 1 38.46 38.46 38.46 46.15 13 636 649 
3 4 2 2 7.69 7.69 7.69 7.69 13 636 649 
3 0 0 0 53.85 38.46 92.31 69.23 13 636 649 
4 2 2 1 46.15 46.15 84.62 61.54 13 636 649 
4 2 2 2 46.15 46.15 46.15 46.15 13 636 649 
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4 0 0 0 76.92 53.85 100 53.85 13 636 649 
5 1 2 1 53.85 46.15 61.54 53.85 13 636 649 
5 1 2 2 61.54 53.85 61.54 61.54 13 636 649 
6 1 2 1 38.46 23.08 53.85 30.77 13 636 649 
6 1 2 2 38.46 38.46 76.92 61.54 13 636 649 
3 4 2 1 24.49 26.53 40.82 40.82 49 1713 1762 
3 4 2 2 4.08 4.08 4.08 4.08 49 1713 1762 
3 0 0 0 20.41 20.41 28.57 30.61 49 1713 1762 
4 2 2 1 14.29 18.37 26.53 28.57 49 1713 1762 
4 2 2 2 6.12 6.12 8.16 8.16 49 1713 1762 
4 0 0 0 14.29 24.49 32.65 34.69 49 1713 1762 
5 1 2 1 16.33 12.24 22.45 18.37 49 1713 1762 
5 1 2 2 4.08 6.12 12.24 12.24 49 1713 1762 
6 1 2 1 22.45 20.41 32.65 22.45 49 1713 1762 
6 1 2 2 10.2 8.16 14.29 16.33 49 1713 1762 
3 4 2 1 25.55 28.47 28.47 32.85 137 6779 6916 
3 4 2 2 16.06 16.79 18.25 18.25 137 6779 6916 
3 0 0 0 28.47 24.09 32.85 28.47 137 6779 6916 
4 2 2 1 10.22 5.11 16.79 11.68 137 6779 6916 
4 2 2 2 4.38 4.38 4.38 4.38 137 6779 6916 
4 0 0 0 11.68 5.11 17.52 8.76 137 6779 6916 
5 1 2 1 17.52 14.6 38.69 29.93 137 6779 6916 
5 1 2 2 32.12 22.63 32.12 31.39 137 6779 6916 
6 1 2 1 13.14 7.3 27.74 19.71 137 6779 6916 
6 1 2 2 18.25 8.03 23.36 21.9 137 6779 6916 
3 4 2 1 16.13 19.35 19.35 19.35 31 1350 1381 
3 4 2 2 9.68 9.68 12.9 12.9 31 1350 1381 
3 0 0 0 6.45 16.13 9.68 19.35 31 1350 1381 
4 2 2 1 6.45 9.68 9.68 19.35 31 1350 1381 
4 2 2 2 22.58 22.58 29.03 29.03 31 1350 1381 
4 0 0 0 32.26 32.26 35.48 45.16 31 1350 1381 
5 1 2 1 22.58 25.81 29.03 32.26 31 1350 1381 
5 1 2 2 35.48 35.48 38.71 38.71 31 1350 1381 
6 1 2 1 32.26 48.39 35.48 51.61 31 1350 1381 
6 1 2 2 32.26 22.58 38.71 51.61 31 1350 1381 
3 4 2 1 15.38 7.69 19.23 19.23 26 1698 1724 
3 4 2 2 3.85 3.85 3.85 3.85 26 1698 1724 
3 0 0 0 15.38 7.69 15.38 7.69 26 1698 1724 
4 2 2 1 7.69 11.54 7.69 11.54 26 1698 1724 
4 2 2 2 3.85 3.85 11.54 11.54 26 1698 1724 
4 0 0 0 3.85 15.38 11.54 15.38 26 1698 1724 
5 1 2 1 19.23 7.69 23.08 15.38 26 1698 1724 
5 1 2 2 7.69 11.54 19.23 19.23 26 1698 1724 
6 1 2 1 7.69 11.54 11.54 15.38 26 1698 1724 
6 1 2 2 11.54 19.23 26.92 26.92 26 1698 1724 
3 4 2 1 8.87 8.87 8.87 11.29 124 5603 5727 
3 4 2 2 12.1 12.9 14.52 14.52 124 5603 5727 
3 0 0 0 8.87 9.68 10.48 12.1 124 5603 5727 
4 2 2 1 3.23 8.87 7.26 12.9 124 5603 5727 
4 2 2 2 11.29 18.55 17.74 24.19 124 5603 5727 
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4 0 0 0 6.45 8.06 8.87 12.9 124 5603 5727 
5 1 2 1 4.03 15.32 15.32 21.77 124 5603 5727 
5 1 2 2 10.48 16.13 16.13 18.55 124 5603 5727 
6 1 2 1 2.42 4.84 4.03 12.1 124 5603 5727 
6 1 2 2 9.68 9.68 16.94 15.32 124 5603 5727 
3 4 2 1 8 8 12 12 25 1036 1061 
3 4 2 2 12 12 12 12 25 1036 1061 
3 0 0 0 16 16 20 28 25 1036 1061 
4 2 2 1 12 12 12 20 25 1036 1061 
4 2 2 2 20 20 20 20 25 1036 1061 
4 0 0 0 28 20 44 20 25 1036 1061 
5 1 2 1 8 8 8 16 25 1036 1061 
5 1 2 2 44 56 60 60 25 1036 1061 
6 1 2 1 16 12 24 24 25 1036 1061 
6 1 2 2 56 60 60 64 25 1036 1061 
3 4 2 1 16.67 16.67 16.67 16.67 6 40 46 
3 4 2 2 16.67 16.67 16.67 16.67 6 40 46 
3 0 0 0 16.67 16.67 16.67 16.67 6 40 46 
4 2 2 1 16.67 16.67 16.67 16.67 6 40 46 
4 2 2 2 16.67 16.67 16.67 16.67 6 40 46 
4 0 0 0 16.67 16.67 16.67 16.67 6 40 46 
5 1 2 1 16.67 16.67 16.67 16.67 6 40 46 
5 1 2 2 16.67 16.67 16.67 16.67 6 40 46 
6 1 2 1 16.67 16.67 16.67 16.67 6 40 46 
6 1 2 2 16.67 16.67 33.33 16.67 6 40 46 
3 4 2 1 18.18 13.64 18.18 18.18 22 920 942 
3 4 2 2 9.09 9.09 9.09 9.09 22 920 942 
3 0 0 0 18.18 9.09 27.27 22.73 22 920 942 
4 2 2 1 13.64 13.64 22.73 13.64 22 920 942 
4 2 2 2 9.09 9.09 9.09 9.09 22 920 942 
4 0 0 0 13.64 13.64 31.82 13.64 22 920 942 
5 1 2 1 18.18 9.09 27.27 9.09 22 920 942 
5 1 2 2 9.09 9.09 9.09 9.09 22 920 942 
6 1 2 1 9.09 4.55 18.18 4.55 22 920 942 
6 1 2 2 9.09 9.09 9.09 9.09 22 920 942 
3 4 2 1 22.22 38.89 33.33 50 18 575 593 
3 4 2 2 72.22 61.11 72.22 72.22 18 575 593 
3 0 0 0 16.67 50 22.22 72.22 18 575 593 
4 2 2 1 5.56 22.22 5.56 33.33 18 575 593 
4 2 2 2 33.33 27.78 55.56 50 18 575 593 
4 0 0 0 22.22 50 50 55.56 18 575 593 
5 1 2 1 16.67 16.67 16.67 27.78 18 575 593 
5 1 2 2 11.11 22.22 27.78 44.44 18 575 593 
6 1 2 1 22.22 33.33 33.33 55.56 18 575 593 
6 1 2 2 38.89 44.44 66.67 66.67 18 575 593 
3 4 2 1 27.27 24.24 30.3 30.3 33 1346 1379 
3 4 2 2 6.06 6.06 6.06 6.06 33 1346 1379 
3 0 0 0 33.33 33.33 51.52 42.42 33 1346 1379 
4 2 2 1 30.3 48.48 60.61 60.61 33 1346 1379 
4 2 2 2 36.36 39.39 39.39 39.39 33 1346 1379 
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4 0 0 0 36.36 54.55 51.52 60.61 33 1346 1379 
5 1 2 1 57.58 51.52 60.61 60.61 33 1346 1379 
5 1 2 2 57.58 60.61 60.61 60.61 33 1346 1379 
6 1 2 1 39.39 48.48 42.42 66.67 33 1346 1379 
6 1 2 2 60.61 63.64 72.73 78.79 33 1346 1379 
3 4 2 1 6.12 5.1 8.16 8.16 98 5679 5777 
3 4 2 2 10.2 10.2 10.2 10.2 98 5679 5777 
3 0 0 0 7.14 4.08 7.14 8.16 98 5679 5777 
4 2 2 1 16.33 13.27 17.35 20.41 98 5679 5777 
4 2 2 2 17.35 19.39 25.51 25.51 98 5679 5777 
4 0 0 0 10.2 12.24 16.33 16.33 98 5679 5777 
5 1 2 1 4.08 4.08 8.16 15.31 98 5679 5777 
5 1 2 2 14.29 14.29 16.33 16.33 98 5679 5777 
6 1 2 1 2.04 8.16 9.18 11.22 98 5679 5777 
6 1 2 2 12.24 10.2 17.35 15.31 98 5679 5777 
3 4 2 1 4.35 4.35 8.7 4.35 23 1148 1171 
3 4 2 2 4.35 4.35 4.35 4.35 23 1148 1171 
3 0 0 0 4.35 4.35 17.39 13.04 23 1148 1171 
4 2 2 1 8.7 8.7 8.7 8.7 23 1148 1171 
4 2 2 2 4.35 4.35 4.35 4.35 23 1148 1171 
4 0 0 0 13.04 4.35 17.39 4.35 23 1148 1171 
5 1 2 1 4.35 4.35 4.35 4.35 23 1148 1171 
5 1 2 2 4.35 4.35 8.7 8.7 23 1148 1171 
6 1 2 1 4.35 4.35 8.7 13.04 23 1148 1171 
6 1 2 2 13.04 4.35 17.39 17.39 23 1148 1171 
3 4 2 1 9.09 13.64 13.64 22.73 22 891 913 
3 4 2 2 36.36 31.82 40.91 40.91 22 891 913 
3 0 0 0 18.18 18.18 27.27 27.27 22 891 913 
4 2 2 1 18.18 27.27 18.18 31.82 22 891 913 
4 2 2 2 31.82 36.36 45.45 50 22 891 913 
4 0 0 0 18.18 18.18 22.73 27.27 22 891 913 
5 1 2 1 13.64 27.27 13.64 40.91 22 891 913 
5 1 2 2 13.64 27.27 36.36 50 22 891 913 
6 1 2 1 13.64 22.73 13.64 40.91 22 891 913 
6 1 2 2 40.91 31.82 45.45 63.64 22 891 913 
3 4 2 1 33.33 44.44 44.44 44.44 9 718 727 
3 4 2 2 11.11 11.11 11.11 11.11 9 718 727 
3 0 0 0 44.44 44.44 44.44 55.56 9 718 727 
4 2 2 1 55.56 66.67 55.56 66.67 9 718 727 
4 2 2 2 44.44 44.44 44.44 55.56 9 718 727 
4 0 0 0 55.56 44.44 55.56 55.56 9 718 727 
5 1 2 1 11.11 11.11 11.11 11.11 9 718 727 
5 1 2 2 11.11 11.11 33.33 33.33 9 718 727 
6 1 2 1 22.22 11.11 33.33 22.22 9 718 727 
6 1 2 2 11.11 11.11 44.44 22.22 9 718 727 
3 4 2 1 10.42 8.33 16.67 16.67 48 2712 2760 
3 4 2 2 10.42 6.25 10.42 10.42 48 2712 2760 
3 0 0 0 18.75 12.5 27.08 22.92 48 2712 2760 
4 2 2 1 16.67 18.75 22.92 22.92 48 2712 2760 
4 2 2 2 12.5 14.58 16.67 16.67 48 2712 2760 
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4 0 0 0 12.5 12.5 25 22.92 48 2712 2760 
5 1 2 1 6.25 8.33 18.75 10.42 48 2712 2760 
5 1 2 2 2.08 2.08 6.25 10.42 48 2712 2760 
6 1 2 1 6.25 2.08 12.5 6.25 48 2712 2760 




























Appendix C - DUD 8 reduced sets – averages EF, AUC and Recall @10%  
COX2 EF, AUC 
shape K D R M EF(V) EF(P) ACTIVE DECOY TOTAL AUC(V) AUC(P) 
 
3 0 0 0 2.83 4.5 44 352 396 0.58 0.63 
 
3 4 2 0 3.09 4.11 44 352 396 0.76 0.69 
 
3 4 2 1 3.34 4.5 44 352 396 0.71 0.74 
 
3 4 2 2 3.09 3.34 44 352 396 0.55 0.55 
 
4 0 0 0 4.11 5.91 44 352 396 0.62 0.69 
 
4 2 2 0 4.24 6.04 44 352 396 0.63 0.74 
 
4 2 2 1 5.01 5.66 44 352 396 0.72 0.74 
 
4 2 2 2 6.17 6.3 44 352 396 0.68 0.68 
 
5 1 2 0 4.24 5.53 44 352 396 0.6 0.72 
 
5 1 2 1 5.4 5.53 44 352 396 0.71 0.74 
 
5 1 2 2 6.56 6.3 44 352 396 0.66 0.66 
 
6 1 2 0 3.73 5.27 44 352 396 0.64 0.68 
 
6 1 2 1 4.11 5.01 44 352 396 0.67 0.67 
 
6 1 2 2 5.91 6.17 44 352 396 0.67 0.67 
sub-
shape 
K D R M EF(V) EF(P) ACTIVE DECOY TOTAL AUC(V) AUC(P) 
 
4 2 2 0 2.7 5.79 44 352 396 0.63 0.74 
 
4 2 2 1 4.5 4.89 44 352 396 0.69 0.73 
 
4 2 2 2 6.56 6.3 44 352 396 0.68 0.68 
 
5 1 2 2 6.43 5.79 44 352 396 0.66 0.65 
 
6 1 2 2 4.5 4.11 44 352 396 0.66 0.65 
 
Recall@10% 
K D R M EF(V) EF(P) RECALL(V) RECALL(P) ACTIVES DECOYS TOTAL 
3 0 0 0 2.83 4.5 12.66 20.78 44 352 396 
3 4 2 0 3.08 4.11 14.61 21.75 44 352 396 
3 4 2 1 3.34 4.49 18.51 24.03 44 352 396 
3 4 2 2 3.08 3.33 12.99 13.64 44 352 396 
4 0 0 0 4.11 5.91 22.73 30.52 44 352 396 
4 2 2 0 4.23 6.03 24.03 36.04 44 352 396 
4 2 2 1 5 5.64 28.9 34.42 44 352 396 
4 2 2 2 6.16 6.29 34.41 36.36 44 352 396 
5 1 2 0 4.23 5.51 20.13 33.44 44 352 396 
5 1 2 1 5.39 5.52 25.65 33.44 44 352 396 
5 1 2 2 6.54 6.29 34.74 35.06 44 352 396 
6 1 2 0 3.72 5.26 22.73 30.52 44 352 396 
6 1 2 1 4.1 5 25.65 30.2 44 352 396 





EGFR EF, AUC 
shape K D R M EF(V) EF(P) ACTIVE DECOY TOTAL AUC(V) AUC(P) 
 
3 0 0 0 4.11 4.24 40 320 360 0.58 0.53 
 
3 4 2 0 4.37 3.6 40 320 360 0.63 0.58 
 
3 4 2 1 3.21 3.09 40 320 360 0.53 0.54 
 
3 4 2 2 2.57 2.06 40 320 360 0.55 0.54 
 
4 0 0 0 3.6 2.7 40 320 360 0.6 0.56 
 
4 2 2 0 3.09 2.06 40 320 360 0.6 0.57 
 
4 2 2 1 2.57 2.06 40 320 360 0.59 0.57 
 
4 2 2 2 2.83 3.09 40 320 360 0.57 0.57 
 
5 1 2 0 2.19 3.09 40 320 360 0.54 0.54 
 
5 1 2 1 2.57 3.09 40 320 360 0.55 0.57 
 
5 1 2 2 3.21 3.73 40 320 360 0.53 0.53 
 
6 1 2 0 2.7 3.34 40 320 360 0.54 0.54 
 
6 1 2 1 3.6 3.34 40 320 360 0.55 0.6 
 
6 1 2 2 2.96 3.34 40 320 360 0.54 0.54 
sub-
shape 
K D R M EF(V) EF(P) ACTIVE DECOY TOTAL AUC(V) AUC(P) 
 
4 2 2 0 1.29 1.54 40 320 360 0.56 0.55 
 
4 2 2 1 1.03 1.8 40 320 360 0.57 0.57 
 
4 2 2 2 1.93 2.06 40 320 360 0.57 0.57 
 
5 1 2 2 2.31 2.7 40 320 360 0.53 0.53 
 
6 1 2 2 2.57 2.19 40 320 360 0.55 0.54 
 
Recall@10% 
K D R M EF(V) EF(P) RECALL(V) RECALL(P) ACTIVES DECOYS TOTAL 
3 0 0 0 4.11 4.24 27.14 18.93 40 320 360 
3 4 2 0 4.36 3.59 26.07 20.36 40 320 360 
3 4 2 1 3.21 3.08 18.21 15 40 320 360 
3 4 2 2 2.57 2.05 12.86 12.5 40 320 360 
4 0 0 0 3.6 2.7 21.07 18.21 40 320 360 
4 2 2 0 3.08 2.05 17.5 18.93 40 320 360 
4 2 2 1 2.56 2.05 15 15.71 40 320 360 
4 2 2 2 2.82 3.08 16.07 16.43 40 320 360 
5 1 2 0 2.18 3.08 11.79 16.43 40 320 360 
5 1 2 1 2.57 3.08 14.29 18.93 40 320 360 
5 1 2 2 3.21 3.72 16.07 17.14 40 320 360 
6 1 2 0 2.69 3.33 13.21 16.07 40 320 360 
6 1 2 1 3.59 3.33 16.07 16.43 40 320 360 






INHA EF, AUC 
shape K D R M EF(V) EF(P) ACTIVE DECOY TOTAL AUC(V) AUC(P) 
 
3 0 0 0 5.6 4.71 23 182 205 0.72 0.74 
 
3 4 2 0 5.22 3.82 23 182 205 0.72 0.74 
 
3 4 2 1 4.2 3.31 23 182 205 0.59 0.61 
 
3 4 2 2 2.16 2.16 23 182 205 0.54 0.54 
 
4 0 0 0 4.71 4.46 23 182 205 0.66 0.64 
 
4 2 2 0 4.2 3.57 23 182 205 0.62 0.59 
 
4 2 2 1 3.57 3.44 23 182 205 0.61 0.59 
 
4 2 2 2 2.8 2.93 23 182 205 0.56 0.56 
 
5 1 2 0 3.18 3.82 23 182 205 0.62 0.58 
 
5 1 2 1 3.82 3.44 23 182 205 0.64 0.63 
 
5 1 2 2 2.93 2.93 23 182 205 0.54 0.54 
 
6 1 2 0 4.71 3.18 23 182 205 0.67 0.59 
 
6 1 2 1 3.82 3.06 23 182 205 0.61 0.54 
 
6 1 2 2 3.31 3.31 23 182 205 0.56 0.55 
sub-
shape 
K D R M EF(V) EF(P) ACTIVE DECOY TOTAL AUC(V) AUC(P) 
 
4 2 2 0 2.42 2.93 23 182 205 0.58 0.59 
 
4 2 2 1 3.31 3.31 23 182 205 0.6 0.61 
 
4 2 2 2 2.93 3.05 23 182 205 0.56 0.56 
 
5 1 2 2 3.06 3.18 23 182 205 0.54 0.54 
 
6 1 2 2 3.18 3.44 23 182 205 0.55 0.55 
 
Recall@10% 
K D R M EF(V) EF(P) RECALL(V) RECALL(P) ACTIVES DECOYS TOTAL 
3 0 0 0 5.6 4.71 39.75 36.02 23 182 205 
3 4 2 0 5.19 3.8 34.16 32.92 23 182 205 
3 4 2 1 4.18 3.29 30.43 26.71 23 182 205 
3 4 2 2 2.15 2.15 11.18 11.18 23 182 205 
4 0 0 0 4.71 4.46 32.92 26.71 23 182 205 
4 2 2 0 4.18 3.55 27.95 20.5 23 182 205 
4 2 2 1 3.55 3.42 25.47 21.12 23 182 205 
4 2 2 2 2.79 2.91 15.53 15.53 23 182 205 
5 1 2 0 3.17 3.8 22.98 21.74 23 182 205 
5 1 2 1 3.8 3.42 24.84 25.47 23 182 205 
5 1 2 2 2.91 2.91 16.77 18.01 23 182 205 
6 1 2 0 4.69 3.17 30.43 19.88 23 182 205 
6 1 2 1 3.8 3.04 25.47 17.39 23 182 205 






P38 EF, AUC 
shape K D R M EF(V) EF(P) ACTIVE DECOY TOTAL AUC(V) AUC(P) 
 
3 0 0 0 4.63 4.11 20 160 180 0.56 0.62 
 
3 4 2 0 4.37 3.86 20 160 180 0.7 0.7 
 
3 4 2 1 3.86 3.47 20 160 180 0.68 0.68 
 
3 4 2 2 2.57 2.44 20 160 180 0.53 0.53 
 
4 0 0 0 4.5 5.27 20 160 180 0.71 0.72 
 
4 2 2 0 3.47 3.86 20 160 180 0.62 0.58 
 
4 2 2 1 4.24 4.63 20 160 180 0.66 0.64 
 
4 2 2 2 3.6 3.34 20 160 180 0.59 0.59 
 
5 1 2 0 5.4 5.27 20 160 180 0.72 0.73 
 
5 1 2 1 5.14 5.27 20 160 180 0.77 0.75 
 
5 1 2 2 5.79 5.27 20 160 180 0.66 0.65 
 
6 1 2 0 4.76 4.63 20 160 180 0.7 0.71 
 
6 1 2 1 4.89 4.63 20 160 180 0.71 0.67 
 
6 1 2 2 5.27 4.63 20 160 180 0.68 0.67 
sub-
shape 
K D R M EF(V) EF(P) ACTIVE DECOY TOTAL AUC(V) AUC(P) 
 
4 2 2 0 3.21 3.34 20 160 180 0.59 0.56 
 
4 2 2 1 4.11 4.24 20 160 180 0.64 0.63 
 
4 2 2 2 3.47 3.47 20 160 180 0.59 0.59 
 
5 1 2 2 5.14 5.79 20 160 180 0.66 0.66 
 
6 1 2 2 4.5 4.24 20 160 180 0.67 0.66 
 
Recall@10% 
K D R M EF(V) EF(P) RECALL(V) RECALL(P) ACTIVES DECOYS TOTAL 
3 0 0 0 4.63 4.11 31.43 24.29 20 160 180 
3 4 2 0 4.35 3.84 29.29 27.86 20 160 180 
3 4 2 1 3.84 3.45 23.57 23.57 20 160 180 
3 4 2 2 2.56 2.43 15 14.29 20 160 180 
4 0 0 0 4.5 5.27 35 35 20 160 180 
4 2 2 0 3.45 3.84 23.57 26.43 20 160 180 
4 2 2 1 4.22 4.61 27.86 30.71 20 160 180 
4 2 2 2 3.58 3.33 26.43 24.29 20 160 180 
5 1 2 0 5.37 5.24 36.43 35.71 20 160 180 
5 1 2 1 5.12 5.25 38.57 36.43 20 160 180 
5 1 2 2 5.76 5.24 38.57 35 20 160 180 
6 1 2 0 4.73 4.61 34.29 32.14 20 160 180 
6 1 2 1 4.86 4.61 33.57 31.43 20 160 180 





PDE5 EF, AUC 
shape K D R M EF(V) EF(P) ACTIVE DECOY TOTAL AUC(V) AUC(P) 
 
3 0 0 0 6.37 3.82 22 174 196 0.79 0.68 
 
3 4 2 0 5.35 4.2 22 174 196 0.82 0.79 
 
3 4 2 1 4.84 3.94 22 174 196 0.79 0.76 
 
3 4 2 2 1.65 1.65 22 174 196 0.52 0.52 
 
4 0 0 0 3.82 3.69 22 174 196 0.75 0.72 
 
4 2 2 0 3.43 3.44 22 174 196 0.63 0.63 
 
4 2 2 1 3.94 3.44 22 174 196 0.67 0.65 
 
4 2 2 2 3.18 3.18 22 174 196 0.57 0.57 
 
5 1 2 0 3.18 3.56 22 174 196 0.68 0.65 
 
5 1 2 1 3.69 3.94 22 174 196 0.71 0.66 
 
5 1 2 2 2.67 2.67 22 174 196 0.55 0.55 
 
6 1 2 0 3.18 2.92 22 174 196 0.63 0.59 
 
6 1 2 1 3.31 3.31 22 174 196 0.64 0.6 
 
6 1 2 2 3.05 3.05 22 174 196 0.57 0.56 
sub-
shape 
K D R M EF(V) EF(P) ACTIVE DECOY TOTAL AUC(V) AUC(P) 
 
4 2 2 0 3.05 2.92 22 174 196 0.59 0.57 
 
4 2 2 1 3.44 3.18 22 174 196 0.59 0.58 
 
4 2 2 2 2.8 2.92 22 174 196 0.57 0.56 
 
5 1 2 2 2.54 2.54 22 174 196 0.55 0.55 
 
6 1 2 2 2.67 2.67 22 174 196 0.57 0.57 
 
Recall@10% 
K D R M EF(V) EF(P) RECALL(V) RECALL(P) ACTIVES DECOYS TOTAL 
3 0 0 0 6.37 3.82 48.7 27.92 22 174 196 
3 4 2 0 5.32 4.18 38.96 33.12 22 174 196 
3 4 2 1 4.81 3.93 37.66 28.57 22 174 196 
3 4 2 2 1.65 1.65 8.44 9.09 22 174 196 
4 0 0 0 3.82 3.69 28.57 25.97 22 174 196 
4 2 2 0 3.42 3.42 28.57 25.97 22 174 196 
4 2 2 1 3.93 3.42 29.87 25.97 22 174 196 
4 2 2 2 3.17 3.17 20.13 19.48 22 174 196 
5 1 2 0 3.17 3.54 22.08 21.43 22 174 196 
5 1 2 1 3.67 3.92 26.62 25.33 22 174 196 
5 1 2 2 2.66 2.66 16.23 15.58 22 174 196 
6 1 2 0 3.17 2.91 22.73 23.38 22 174 196 
6 1 2 1 3.29 3.29 25.32 22.08 22 174 196 






PDGFRB EF, AUC 
shape K D R M EF(V) EF(P) ACTIVE DECOY TOTAL AUC(V) AUC(P) 
 
3 0 0 0 5.6 4.84 22 174 196 0.56 0.6 
 
3 4 2 0 4.58 4.33 22 174 196 0.56 0.58 
 
3 4 2 1 4.71 4.58 22 174 196 0.57 0.58 
 
3 4 2 2 1.14 1.14 22 174 196 0.51 0.51 
 
4 0 0 0 5.35 5.22 22 174 196 0.61 0.67 
 
4 2 2 0 4.33 4.58 22 174 196 0.6 0.62 
 
4 2 2 1 4.33 4.71 22 174 196 0.61 0.62 
 
4 2 2 2 2.8 2.67 22 174 196 0.55 0.55 
 
5 1 2 0 3.31 3.94 22 174 196 0.59 0.58 
 
5 1 2 1 3.94 3.82 22 174 196 0.6 0.59 
 
5 1 2 2 3.31 3.18 22 174 196 0.57 0.57 
 
6 1 2 0 3.82 3.18 22 174 196 0.59 0.6 
 
6 1 2 1 3.69 2.93 22 174 196 0.58 0.56 
 
6 1 2 2 3.82 3.94 22 174 196 0.63 0.62 
sub-
shape 
K D R M EF(V) EF(P) ACTIVE DECOY TOTAL AUC(V) AUC(P) 
 
4 2 2 0 2.92 3.31 22 174 196 0.59 0.61 
 
4 2 2 1 2.92 3.43 22 174 196 0.58 0.62 
 
4 2 2 2 2.92 2.92 22 174 196 0.55 0.55 
 
5 1 2 2 3.18 3.69 22 174 196 0.57 0.57 
 
6 1 2 2 3.94 3.82 22 174 196 0.65 0.65 
 
Recall@10% 
K D R M EF(V) EF(P) RECALL(V) RECALL(P) ACTIVES DECOYS TOTAL 
3 0 0 0 5.6 4.84 33.11 29.87 22 174 196 
3 4 2 0 4.56 4.3 27.92 26.62 22 174 196 
3 4 2 1 4.69 4.56 27.27 27.27 22 174 196 
3 4 2 2 1.14 1.14 5.85 5.85 22 174 196 
4 0 0 0 5.35 5.22 40.26 38.31 22 174 196 
4 2 2 0 4.3 4.56 33.12 34.41 22 174 196 
4 2 2 1 4.31 4.69 35.06 34.42 22 174 196 
4 2 2 2 2.79 2.66 14.94 16.23 22 174 196 
5 1 2 0 3.29 3.93 24.03 25.32 22 174 196 
5 1 2 1 3.93 3.8 27.27 25.97 22 174 196 
5 1 2 2 3.29 3.17 20.13 19.48 22 174 196 
6 1 2 0 3.8 3.16 24.67 22.73 22 174 196 
6 1 2 1 3.67 2.91 24.68 19.48 22 174 196 






SRC EF, AUC 
shape K D R M EF(V) EF(P) ACTIVE DECOY TOTAL AUC(V) AUC(P) 
 
3 0 0 0 7.46 5.27 21 168 189 0.8 0.74 
 
3 4 2 0 5.91 4.24 21 168 189 0.74 0.71 
 
3 4 2 1 3.98 3.47 21 168 189 0.63 0.62 
 
3 4 2 2 1.93 1.93 21 168 189 0.53 0.53 
 
4 0 0 0 5.66 4.11 21 168 189 0.73 0.71 
 
4 2 2 0 3.98 3.21 21 168 189 0.66 0.62 
 
4 2 2 1 3.6 3.73 21 168 189 0.63 0.63 
 
4 2 2 2 3.34 3.21 21 168 189 0.56 0.56 
 
5 1 2 0 3.73 3.21 21 168 189 0.64 0.64 
 
5 1 2 1 3.6 3.6 21 168 189 0.6 0.6 
 
5 1 2 2 3.98 3.85 21 168 189 0.58 0.58 
 
6 1 2 0 4.11 2.44 21 168 189 0.63 0.58 
 
6 1 2 1 3.08 2.96 21 168 189 0.6 0.58 
 
6 1 2 2 3.6 2.95 21 168 189 0.58 0.57 
sub-
shape 
K D R M EF(V) EF(P) ACTIVE DECOY TOTAL AUC(V) AUC(P) 
 
4 2 2 0 2.44 2.44 21 168 189 0.58 0.59 
 
4 2 2 1 3.08 3.21 21 168 189 0.62 0.63 
 
4 2 2 2 3.34 3.21 21 168 189 0.56 0.56 
 
5 1 2 2 3.73 3.47 21 168 189 0.58 0.58 
 
6 1 2 2 2.31 2.44 21 168 189 0.57 0.57 
 
Recall@10% 
K D R M EF(V) EF(P) RECALL(V) RECALL(P) ACTIVES DECOYS TOTAL 
3 0 0 0 7.46 5.27 53.06 36.05 21 168 189 
3 4 2 0 5.88 4.22 38.1 34.02 21 168 189 
3 4 2 1 3.97 3.45 27.89 27.21 21 168 189 
3 4 2 2 1.92 1.92 10.89 10.89 21 168 189 
4 0 0 0 5.66 4.11 36.74 31.97 21 168 189 
4 2 2 0 3.97 3.2 27.21 23.81 21 168 189 
4 2 2 1 3.58 3.71 26.53 24.49 21 168 189 
4 2 2 2 3.33 3.2 18.37 18.37 21 168 189 
5 1 2 0 3.71 3.2 27.21 25.17 21 168 189 
5 1 2 1 3.58 3.58 23.13 23.13 21 168 189 
5 1 2 2 3.97 3.84 23.13 22.45 21 168 189 
6 1 2 0 4.09 2.43 27.89 17.69 21 168 189 
6 1 2 1 3.07 2.94 23.81 19.05 21 168 189 






VEGFR2 EF, AUC 
shape K D R M EF(V) EF(P) ACTIVE DECOY TOTAL AUC(V) AUC(P) 
 
3 0 0 0 6.69 5.91 31 248 279 0.64 0.64 
 
3 4 2 0 5.14 5.27 31 248 279 0.65 0.65 
 
3 4 2 1 5.14 4.88 31 248 279 0.63 0.63 
 
3 4 2 2 2.18 2.18 31 248 279 0.51 0.51 
 
4 0 0 0 3.86 3.6 31 248 279 0.61 0.61 
 
4 2 2 0 2.95 2.83 31 248 279 0.6 0.56 
 
4 2 2 1 3.34 3.34 31 248 279 0.61 0.58 
 
4 2 2 2 2.7 2.57 31 248 279 0.53 0.53 
 
5 1 2 0 4.11 3.34 31 248 279 0.6 0.57 
 
5 1 2 1 4.49 3.47 31 248 279 0.58 0.57 
 
5 1 2 2 2.7 3.08 31 248 279 0.53 0.53 
 
6 1 2 0 4.24 3.47 31 248 279 0.62 0.58 
 
6 1 2 1 3.08 3.21 31 248 279 0.6 0.56 
 
6 1 2 2 3.6 3.08 31 248 279 0.55 0.55 
sub-
shape 
K D R M EF(V) EF(P) ACTIVE DECOY TOTAL AUC(V) AUC(P) 
 
4 2 2 0 2.05 2.31 31 248 278.71 0.55 0.55 
 
4 2 2 1 2.31 2.95 31 248 278.71 0.58 0.57 
 
4 2 2 2 2.7 2.57 31 248 278.71 0.53 0.53 
 
5 1 2 2 2.83 3.6 31 248 278.71 0.53 0.53 
 
6 1 2 2 3.08 3.6 31 248 278.71 0.55 0.55 
 
Recall@10% 
K D R M EF(V) EF(P) RECALL(V) RECALL(P) ACTIVES DECOYS TOTAL 
3 0 0 0 6.69 5.91 38.71 35.94 31 248 279 
3 4 2 0 5.13 5.25 27.19 27.19 31 248 279 
3 4 2 1 5.13 4.87 25.35 24.88 31 248 279 
3 4 2 2 2.18 2.18 7.84 7.84 31 248 279 
4 0 0 0 3.86 3.6 23.96 26.73 31 248 279 
4 2 2 0 2.95 2.82 18.89 18.89 31 248 279 
4 2 2 1 3.33 3.33 20.28 20.74 31 248 279 
4 2 2 2 2.69 2.56 11.52 11.98 31 248 279 
5 1 2 0 4.1 3.33 20.74 20.28 31 248 279 
5 1 2 1 4.48 3.46 23.04 20.28 31 248 279 
5 1 2 2 2.69 3.07 15.21 16.59 31 248 279 
6 1 2 0 4.23 3.46 22.58 18.89 31 248 279 
6 1 2 1 3.08 3.2 17.97 18.43 31 248 279 
6 1 2 2 3.59 3.08 23.5 21.66 31 248 279 
 
